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RESUMEN 
El sistema nervioso central adulto, a diferencia de otros tejidos, posee ciertas 
limitaciones en cuanto a su regeneración debido a la ausencia de nichos 
neurogénicos y al microentorno tóxico que se genera tras un daño o enfermedad. 
Por ello, las pérdidas de células neurales y de reconexión axonal, y por tanto la 
recuperación de las funciones perdidas, resultan en muchos casos irreversibles. 
Actualmente existen terapias encaminadas a la regeneración del sistema 
nervioso central tras sufrir un traumatismo o una enfermedad degenerativa, y 
éstas consisten en la implantación de células, la liberación de fármacos en el 
entorno del tejido dañado y la estimulación a través de electrodos. A pesar de 
que estos métodos han demostrado ciertas mejoras en la regeneración y la 
recuperación de funciones perdidas, éstas no son suficientes y en la mayoría de 
los casos producen mejoras transitorias. En este trabajo los esfuerzos se han 
centrado en el desarrollo de materiales estructurados (andamiajes) que permitan 
el crecimiento celular en el entorno del sistema nervioso central y, 
especialmente, en el tejido cerebral debido a daños como traumatismos e ictus. 
Además, estos materiales podrían ser vehículos de células y factores para suplir 
las poblaciones neuronales y crear un entorno más permisivo para la correcta 
reconexión axonal. 
Para el desarrollo de los andamiajes se pensó en materiales basados 
principalmente en la sal de sodio del ácido hialurónico, hialuronato. La elección 
de tal material fue en base a que se trata de un polímero natural presente en 
muchos tejidos, inclusive el tejido cerebral. Además, el hialuronato y derivados 
del mismo, que son empleados actualmente en algunas aplicaciones clínicas, 
han demostrado propiedades biológicas adecuadas para asistir al proceso 
regenerativo, así como buena compatibilidad y propiedades mecánicas similares 
a las del tejido cerebral. Sin embargo, el hialuronato sin modificar presenta un 
bajo tiempo de residencia en el entorno fisiológico debido a su alta solubilidad y 
rápida degradación, unas propiedades mecánicas difíciles de controlar, un alto 
grado de hinchado y una difícil manipulación para obtener materiales 
estructurados. Por todo ello, se han llevado a cabo modificaciones del mismo 
con el fin de obtener hidrogeles, empleando para ello dos estrategias: el 
entrecruzamiento con divinil sulfona obteniendo hidrogeles estables y 
estructurados, y la copolimerización de hialuronato modificado y acrilato de etilo 
para obtener redes copoliméricas semidegradables. 
El entrecruzamiento de hialuronato con divinil sulfona ha sido caracterizado 
física, mecánica y químicamente con tal de determinar el efecto del 
entrecruzamiento sobre las propiedades de los materiales desarrollados. Esta 
química se ha utilizado para el desarrollo de andamiajes porosos estableciendo 
un método repetitivo para su obtención. Además, se ha estudiado el efecto que 
tienen los tratamientos posteriores a la reacción de entrecruzamiento en la 
  
degradación enzimática de los hidrogeles. Por otro lado, se ha estudiado la 
viabilidad celular de estos materiales en términos de la citotoxicidad y efectos 
inflamatorios en diferentes células del entorno del sistema nervioso central 
(astrocitos, neuronas y células endoteliales), así como el efecto que tiene el 
grado de entrecruzamiento de los andamiajes en la colonización inicial de dichas 
células. 
Las redes copoliméricas basadas en hialuronato y polietilacrilato se han 
desarrollado con el objetivo de obtener nuevos materiales semi-degradables, 
combinando las propiedades biológicas del hialuronato y la buena compatibilidad 
del polietilacrilato con diferentes células, incluyendo las del entorno del sistema 
nervioso central.  Para la reacción de copolimerización fue necesaria una 
modificación previa del hialuronato, determinando su grado de modificación. Por 
otro lado, las características antagónicas que poseen ambos materiales permiten 
controlar las propiedades mecánicas y el grado de hinchado en entornos 
acuosos variando la composición de las redes copoliméricas. La composición 
experimental y las propiedades físicas y mecánicas de interés de las diferentes 
composiciones fueron determinadas por los métodos apropiados en cada caso. 
Además, se estudió la degradación enzimática de las redes copoliméricas, 
evaluando los fragmentos liberados así como la integridad del material, con la 
finalidad de garantizar la estabilidad del mismo durante un hipotético proceso 
regenerativo. Por otro lado, la viabilidad celular de estos materiales fue evaluada 
en base a los posibles efectos citotóxicos e inflamatorios sobre células del 
entorno del sistema nervioso central. Además, la colonización de estas células 
sobre las redes copoliméricas fue evaluada en estudios preliminares. 
  
  
 
 
RESUM 
El sistema nerviós central adult, a diferència d'altres teixits, té certes limitacions 
pel que fa a la seua regeneració per l'absència de nínxols neurogènics i al micro-
entorn tòxic que es genera després d'un dany o malaltia. Per això, les pèrdues 
de cèl·lules neurals i de reconnexions axonals, i per tant la recuperació de les 
funcions perdudes, resulten en molts casos irreversibles. Actualment existeixen 
teràpies encaminades a la regeneració del sistema nerviós central després de 
patir un traumatisme o una malaltia degenerativa, i aquestes consisteixen en la 
implantació de cèl·lules, l'alliberament de fàrmacs en l'entorn del teixit danyat i 
l'estimulació a través d'elèctrodes. Tot i que aquests mètodes han demostrat 
certes millores en la regeneració i la recuperació de funcions perdudes, aquestes 
no són suficients i en la majoria dels casos produeixen millores transitòries. En 
aquest treball els esforços s'han centrat en el desenvolupament de materials 
estructurats (matrius de suport) que permeten el creixement cel·lular en l'entorn 
del sistema nerviós central i, especialment, en el teixit cerebral a causa de danys 
com ara els traumatismes i el ictus. A més, aquests materials podrien ser vehicles 
de cèl·lules i factors per suplir les poblacions neuronals i crear un entorn més 
permissiu per a la correcta reconnexió axonal. 
Per al desenvolupament de les matrius de suport es va pensar en materials 
basats principalment en la sal de sodi de l'àcid hialurònic, hialuronat. L'elecció 
d'aquest material va ser degut a que es tracta d'un polímer natural present en 
molts teixits, fins i tot el teixit cerebral. A més, l ‘hialuronat i derivats del mateix, 
que són empleats actualment en algunes aplicacions clíniques, han demostrat 
propietats biològiques adequades per assistir al procés regeneratiu, així com 
bona compatibilitat i propietats mecàniques similars a les del teixit cerebral. No 
obstant això, el hialuronat sense modificar presenta un baix temps de residència 
en l'entorn fisiològic per la seua alta solubilitat i ràpida degradació, unes 
propietats mecàniques difícils de controlar, un alt grau d'inflament i una difícil 
manipulació per obtenir materials estructurats. Per tot això, s'han dut a terme 
modificacions del mateix amb la finalitat d'obtenir hidrogels emprant dues 
estratègies: l'encreuament amb divinil sulfona obtenint hidrogels estables i 
estructurats, i la copolimerització de hialuronat modificat i acrilat d'etil per obtenir 
xarxes copolimèriques semi-biodegradables. 
L'encreuament de hialuronat amb divinil sulfona ha estat caracteritzat física, 
mecànica i químicament per tal de determinar l'efecte de l'encreuament sobre les 
propietats dels materials desenvolupats. Aquesta química s'ha utilitzat per al 
desenvolupament de matrius de suport poroses establint un mètode repetitiu per 
a la seua obtenció. A més, s'ha estudiat l'efecte que tenen els tractaments 
posteriors a la reacció d'entrecreuament en la degradació enzimàtica dels 
hidrogels. D'altra banda, s'ha estudiat la viabilitat cel·lular d'aquests materials en 
termes de la citotoxicitat i efectes inflamatoris en diferents cèl·lules de l'entorn 
  
del sistema nerviós central (astròcits, neurones i cèl·lules endotelials), així com 
l'efecte que té el grau d'entrecreuament de les matrius de suport en la 
colonització inicial d'aquestes cèl·lules. 
Les xarxes copolimèriques basades en hialuronat i poli(acrilat d’etil) s'han 
desenvolupat amb l'objectiu d'obtenir nous materials semi-degradables, 
combinant les propietats biològiques del hialuronat i la bona compatibilitat del 
poli(acrilat d’etil) amb diferents cèl·lules, incloent les de l'entorn del sistema 
nerviós central. Per a la reacció de copolimerització va ser necessària una 
modificació prèvia de l ’hialuronat, determinant el seu grau de modificació. D'altra 
banda, les característiques antagòniques que tenen aquests dos materials 
permet el control de les propietats mecàniques i el grau d'inflat en entorns 
aquosos variant la composició de les xarxes copolimèriques. La composició 
experimental i les propietats físiques i mecàniques d'interès de les diferents 
composicions van ser determinades pels mètodes apropiats en cada cas. A més, 
es va estudiar la degradació enzimàtica de les xarxes copolimèriques, avaluant 
els fragments alliberats així com la integritat del material, amb la finalitat de 
garantir l'estabilitat del mateix durant un hipotètic procés regeneratiu. D'altra 
banda, la viabilitat cel·lular d'aquests materials va ser avaluada d'acord amb els 
possibles efectes citotòxics i inflamatoris sobre cèl·lules de l'entorn del sistema 
nerviós central. A més, la colonització d'aquestes cèl·lules sobre les xarxes 
copolimèriques va ser avaluada en estudis preliminars. 
  
  
 
 
SUMMARY 
Unlike other tissues, the regeneration in the central nervous system during 
adulthood is limited due to the lack of neurogenic niches and the toxic 
microenvironment after an injury or degenerative disease. For this reason, the 
loss of neuronal populations and axonal connexions results in most cases 
irreversible. Nowadays, there are therapies focused on the regeneration of the 
central nervous system after an injury or disease, and they consist in cell 
implantation, drug delivery and electrical stimulation using electrodes. Despite 
these methods have shown some improvements in the regeneration and the 
recovery of the loss functions, they do not produce complete recovery of the loss 
functions or are transient. In the present work, the efforts have been focused on 
the development of structured materials (scaffolds) to provide a support for the 
different cells from the central nervous system, especially, from the brain tissue 
after stroke or similar damages. Besides, these materials could act as vehicles 
for cells being a neuronal source and/or growth factors providing substances to 
create a more permissive environment for axon regrowth. 
In this work, the scaffolds are mainly composed of the sodium salt of hyaluronic 
acid, hyaluronan. This material has been chosen because of its natural origin in 
many tissues, including the brain one. Besides, some formulations based on 
hyaluronan and derivatives thereof are currently employed in clinical applications, 
and they have shown good biocompatibility and similar properties to the brain 
tissue. However, the unmodified hyaluronan have shown short residence times 
in the physiological environment because of its high solubility and fast 
degradation rate, lack of the control over mechanical properties, high swelling 
degree and hard handling to develop structured materials. In the present work, in 
order to develop stable and structured hydrogels, the hyaluronan has been 
modified following two strategies: crosslinking with divinyl sulfone, and the 
copolymerization of a hyaluronan derivative with ethyl acrylate to develop semi-
degradable copolymer networks. 
The crosslinking of hyaluronan with divinyl sulfone has been characterized by 
physical, mechanical and chemical methods with the aim of determining the effect 
of the degree of crosslinking on the properties of the hydrogels. This chemistry 
has been employed to develop porous scaffolds by a repetitive method. Besides, 
the posterior treatments after the crosslinking reaction have been evaluated in 
terms of their effect on the enzymatic degradation. On the other hand, the 
cytotoxic and inflammatory effects of these materials on different types of cells 
from the central nervous system environment (astrocytes, neurons and 
endothelial cells) have been studied. Moreover, the influence of the degree of 
crosslinking on the initial colonization of these cells has been evaluated. 
 
  
The copolymer networks based on hyaluronan and poly(ethyl acrylate) have been 
synthesized with the aim of developing novel semi-degradable materials, which 
combine the biological properties of hyaluronan and good compatibility of 
poly(ethyl acrylate) with different cells, including those of the central nervous 
system. However, the use of hyaluronan in polymerization reactions required its 
previous modification, and hence the degree of modification was determined after 
synthetizing the hyaluronan derivative. Moreover, the opposite properties of both 
materials permit to obtain copolymer networks with tuneable mechanical 
properties and swelling degree in aqueous environments. The experimental 
composition of each component, as well as some physical and mechanical 
properties were determined by the appropriate methods in each case. Besides, 
the enzymatic degradation of the copolymer networks was evaluated, 
determining the scissed fragments and the structural stability of the different 
materials with the aim to guarantee the integrity of the materials through a 
hypothetical regenerative process. On the other hand, the cytotoxic and 
inflammatory effects of these materials on cells from the central nervous system 
environment were evaluated. Additionally, preliminary studies of cell colonization 
on the copolymer networks were performed.  
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1.1 Tissue engineering in the central nervous system 
Tissue engineering is an emerging and rapidly growing field with potential 
applications for tissue repair. It is an interdisciplinary field including advanced 
material science, cell biology, biochemistry, engineering and medicine. The US 
National Institutes of Health (NIH) defines tissue engineering as: 
Regenerative medicine/tissue engineering is a rapidly growing multidisciplinary 
field involving the life, physical and engineering sciences that seeks to develop 
functional cell tissue, and organ substitutes to repair, replace or enhance 
biological function that has been lost due to congenital abnormalities, injury, 
disease or ageing. 
Many researchers have focused on addressing this novel area because of its 
wide range of applications in medicine. The aim of tissue engineering is to replace 
or restore the structure and function of injured or diseased tissues and organs. 
The normal function of an organ or tissue in the body is regulated by the activity 
of cells, extracellular matrix (ECM)-cells interactions, molecular signalling and 
other stimuli (mechanical, electrical…). Thereby, tissue engineering strategies 
include and combine cells, tissues, engineering biomaterials, biologically active 
molecules and stimulus. Therefore, tissue engineering is focused on the 
understanding of normal and pathological biological processes with the aim to 
recover the normal biological functions of damaged organs and tissues. 
Nowadays, tissue engineering is applied in a broad range of diseases and 
damages of several tissues, even those affecting the central nervous system 
(CNS). Additionally, degenerative neuronal disorders and traumatic injuries into 
the CNS may cause severe and irreversible damage. Nowadays there are few 
clinical therapies to treat the neuronal disorders, and they achieve a modest 
functional recovery. Most clinical therapies are based on drug administration for 
neurodegenerative diseases with well-defined targets, such as Parkinson’s 
disease (PD). However, there is no effective treatment in traumatic injuries, 
including traumatic brain injury (TBI), spinal cord injury (SCI) and stroke, to 
restore lost functions and the clinical approaches are symptomatic and based on 
minimizing the damage progression. In patients with no effective drug 
administration, clinical therapies based on electrical stimulation can be employed, 
making use of implantable electrodes to stimulate axon growth. On the whole, the 
limitations of current therapies underline the need to search for novel strategies. 
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1.1.1 Problems of regeneration in the central nervous system 
Regeneration in the adult CNS is limited compared with other tissues [1]; the 
regenerative response is different even between the peripheral nervous system 
(PNS) and CNS. Regeneration in the PNS is more successful due to the presence 
of Schwann cells (SCs), which provide nutrients, guide and myelinate the 
peripheral axons and synthesize growth factors. Therefore, in the PNS exists a 
unique structure, the bands of Büngner consisting in clusters of oriented SCs, 
whose processes remain after axon injury and promote axon regeneration. 
The limitation of regenerating the CNS is due to the lack of proliferation and 
regeneration of neurons and the inhibitory microenvironment for axon outgrowth. 
Although the developing CNS lacks of inhibitory effects on axon outgrowth, the 
predominant cells in the mature one are astrocytes and oligodendrocytes, which 
provide an inhibitory microenvironment for axon growth. The principal function of 
oligodendrocytes consists in supplying nutrients to neurons, but they express 
inhibitory proteins of axon growth as the myelin associated glycoproteins (MAGs) 
and tenascin R. Moreover, after CNS injury, astrocytes are activated to 
hypertrophic astrocytes, which are the principal cells of the glial scar. 
Hypertrophic astrocytes are clustered in layers giving a physical barrier for axon 
regrowth, and these cells also overexpress inhibitory molecules of axon growth, 
such as sulphated proteoglycans, MAGs and Nogo…[2]. 
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Figure 1. 1. Consequences of neural injury and strategies for repair [3]. 
 
In the case of traumatic injuries as TBI and SCI, the primary damage generates 
an abrupt loss of cells and may result in the disruption of the blood brain barrier 
(BBB) and the blood spinal cord barrier (BSCB), respectively. The breach in the 
BBB and BSCB permits infiltration of foreign cells such as macrophages and 
fibroblasts and inflammatory molecules activating hypertrophic astrocytes. The 
injury in neurodegenerative diseases lacks of an abrupt primary loss of neurons 
but the toxic microenvironment leads to a progressive neurodegeneration. The 
neuronal injury and the inhibitory microenvironment result in degeneration on a 
cellular level: demyelination, axonal retraction, aberrant axonal pathfinding and 
cell death. Tissue engineering strategies for repair the injured CNS take into 
account these mechanisms of cellular degeneration and loss with the aim to 
accomplish functional regeneration (see Figure 1. 1) [3]. 
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1.1.2 Damages and diseases in the central nervous system 
Despite the wide variety of damages and diseases affecting CNS, they may be 
classified in two groups depending of their initial impact and progression. TBI and 
similar brain damages, such as stroke and hypoxia, and SCI are characterized 
by an abrupt damage and great tissue loss at the initial steps. However, 
neurological disorders, such as PD, Huntington’s disease (HD), Alzheimer… 
show a progressive loss of neuronal subtypes at specific tissue regions, and 
many of these diseases ultimately lead to a loss of the patient autonomy. 
Moreover, pathology, damage progression and symptomatology are quite 
different between different neurological disorders. Below are described some 
habitual neurological diseases affecting humans [4]. 
In early stages of an abrupt brain or spinal cord injury, the damaged tissue 
presents necrosis due to physical trauma, haemorrhage and disruption of the 
blood brain barrier (BBB) or blood spinal cord barrier (BSCB), respectively, 
leading to ischemic processes. This disruption produces the infiltration of foreign 
components including fibroblasts, macrophages and cytokines, which are implied 
in the activation of astrocytes leading to the formation of the glial scar and 
inflammatory processes. After a few days, the apoptotic pathways are activated 
by the presence of a toxic microenvironment, giving a loss of glial cells and 
neurons without the possibility of replacement because of the absence of 
sufficient endogenous progenitors. Moreover, the microenvironment generated is 
inhibitory for axon regrowth giving loss of functions. Summarizing, the inhibitory 
nature of the CNS, due to the presence of astrocytes and oligodendrocytes, the 
lack of neurogenesis niches and the toxic microenvironment after injury avoid the 
regeneration in the brain and spinal cord. 
PD is a neurodegenerative disease affecting around 1 % of the population older 
than 60 years. It is caused by several factors but researchers have identified six 
gene mutations associated with this incidence, encoding α-synuclein, parkin, 
UCH-LI, PINK-1, DJ-1, and LRRK2/dardarin. PD pathology is characterized by 
the loss of dopaminergic neurons in the substantia nigra within the nigrostriatal 
tract. For this reason, the striatum reduces dopamine levels and neuronal 
projections. In addition, other aspect of PD pathology is the generation of 
abnormal intraneuronal aggregates of protein, especially α-synuclein, which are 
known as Lewy bodies. Further stages involve degeneration in the cerebral cortex 
and in the autonomic nervous system. The manifestation of PD includes tremor, 
bradykinesia, rigidity, cognitive decline and finally death. The animal model 
commonly employed to study the PD is obtained by administration of 6-
hydroxidopamine, which causes the lesion of dopaminergic pathways. In the 
initial stages of disease, ʟ-DOPA administration is the most potent therapy to 
improve motor functions. However, this treatment becomes less effective in 
further stages, making necessary to find new therapies.  
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HD is a dominantly inherited neurodegenerative disease that results from the 
expansion of the polyglutamine expansion in the gene encoding the huntingtin 
protein. This disease is characterized by the loss of brain striatal GABAergic 
neurons, and the degenerative process progressively extends to other brain 
regions including the cortex. The pathogenesis of HD and the function of 
huntingtin are not well understood, but this pathology is characterized by the loss 
of medium spiny neurons in the striatum and loss of neurons in the cortex leading 
to movement disorders (chorea), dementia, and eventually death. 
Alzheimer’s disease is characterized by the formation of neurofibrillary tangles in 
multiple areas of brain. Despite the initial stages of the disease remain unclear; 
the formation of neurofibrillary tangles is produced by the hyper-phosphorylation 
of the protein tau leading to neuronal loss. Early stages of the disease are 
characterized by memory impairment, and later stages affect other functions with 
a final loss of autonomy.  
The amyotrophic lateral sclerosis (ALS) is a neurological disorder affecting motor 
neurons, producing a progressive degeneration of cortical and spinal neurons. 
Pathology of ALS is not well understood but it seems that the reason of the 
disorder lies on the alteration of the redox regulation both in neurons and 
astrocytes. The symptomatology includes alteration of motor functions, both 
involuntary and voluntary movements. 
 
1.1.3 Cell therapy 
Despite the discovery of neurogenesis in the CNS, an important problem of CNS 
injuries is that these processes cannot overcome massive cell death. Cell therapy 
tries to supply the injured CNS with neurons, glial cells, extracellular matrix 
components, adhesion molecules and neurotrophic factors. In general, implanted 
cells may provide a neuroprotective effect, remodel glial and neuronal cells, 
promote angiogenesis and synaptogenesis and modulate the inflammatory 
response. Several authors have employed a wide range of cells to help 
regeneration in the injured CNS: glial cells, adult stem cells (neural stem cells 
(NSC), mesenchymal and adipose tissue derived stromal cells), embryonic stem 
cells (ESCs) and induced pluripotent stem cells (iPSs) [5]. 
One of the most commonly studied cell types in the CNS regeneration are glial 
cells because of their ability to support axon outgrowth and release neurotrophic 
factors. Due to their role in axon regeneration in the PNS, SCs are widely 
employed in preclinical studies of SCI, even some clinical trials have been 
reported [6]. SCs are cells, which promote regeneration in the PNS due to their 
ability to establish a permissive environment for axon regeneration and to provide 
neuroprotection. They produce growth and neurotrophic factors, secrete proteins 
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stimulating axon growth, remove myelin debris following damage, supply myelin 
and provide pathways for regenerating axons. The implantation of SCs in the 
damaged spinal cord has demonstrated ability to promote axonal regeneration 
and myelination and a modest functional recovery [7]. However, the use of SCs 
in CNS regeneration is limited because of their ability to activate astrocytes 
contributing to the formation of glial scar [8].  
Glial cells from the CNS including astrocytes, oligodendrocytes and microglia 
have been also studied in connection with CNS regeneration. However, the 
process of regeneration by macrophages is unclear and they can inhibit axonal 
growth after SCI [9] and their action could be limited to the elimination of myelin 
debris [10]. On the other hand, transplantation of glial cells, including astrocytes 
and oligodendrocytes, has been addressed by implantation in SCI models of 
neural progenitors restricted to differentiate into glial lineages. These cells have 
shown some benefits associated to their role in providing neuroprotection and 
remyelination and less glial scar formation than SCs [11]. However, only 
moderate functional recovery has been observed when neural progenitors are 
differentiated both, neural and glial cells lineages. 
Olfactory ensheathing cells (OECs) constitute an interesting type of glial cells in 
CNS regeneration strategies, because of their phenotypic similarities to SCs [12], 
astrocytes [13] and oligodendrocytes [14]. OECs, in their natural environment, 
support axons from the PNS to the CNS and do not produce unfavourable 
interactions with the glial scar components. One shortcoming of these cells may 
be their inability to remyelinate axons, although this point has been debated. 
Some studies have demonstrated partial functional recovery when these cells are 
implanted in the injured spinal cord of paralyzed dogs [15], in the injured spinal 
cord of rats with respiratory deficits [16] and in the ischemic brain of rats  [17]. 
Moreover, OECs have shown good results in some controversial clinical studies 
in stroke and SCI but they require further studies [18]. 
Adult stem cells from different origins (bone marrow, adipose tissue derived and 
NSCs) have been transplanted in several traumatic injuries and 
neurodegenerative diseases in preclinical studies, and in clinical trials of stroke 
[19] and SCI [20]. The main property exploited in mesenchymal and adipose 
tissue derived stem cells is their ability to differentiate into cells secreting 
neurotrophic factors, while neural stem cells can differentiate in both glial cells 
and neurons [21]. Other types of adult cells such as the adrenal chromaffin cells 
[22] and human retinal pigment epithelium cells (hRPEs) [23] have been 
employed in clinical trials to restore functions in PD, since they can be employed 
as suppliers of L-DOPA in situ. Both adrenal chromaffin cells and hRPEs have 
demonstrated modest functional improvements. However, these cells show a 
poor survival and only a small fraction is able to secrete L-dopa or dopamine, or 
is secreted in small amounts. 
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ESCs [24] and iPSs [25] are emergent sources of cells with many possibilities in 
CNS regeneration. Their use, however, is limited by ethical considerations in the 
case of embryonic stem cells, and by the unsolved problem of teratoma formation 
in the case of iPSs.  
Preclinical and clinical trials have shown that cells provide transient benefits to 
CNS regeneration based on paracrine effects. However, pure cell supply therapy 
has produced only modest results lagging behind initial expectations, due 
probably to different factors such as a poor cell permanence in the implantation 
site and survival in an aggressive environment leading to an inappropriate axon 
reconnection and guidance. 
 
1.1.4 Biomaterials in central nervous system regeneration 
Biomaterials have been defined as substances other than drugs or foods 
employed in diagnostic and therapeutics of tissues, organs and biological 
functions. The biomaterials and the by-products derived during the degradation 
thereof must accomplish a general characteristic, biocompatibility, evoking a 
minimal inflammation and toxicity in the physiological environment. Currently, 
ceramic, metallic, polymeric and composite biomaterials are employed 
depending on their application. Additionally, the biomaterials for tissue 
engineering are natural or synthetic and can be developed as temporary 
(biodegradable biomaterials) or permanent (biostable biomaterials) structures. 
Depending on the application, the biomaterials must grant some requisites: in the 
present work, polymeric materials have been developed as three-dimensional 
structures (scaffolds) with the aim to mimic the ECM of a target tissue, allowing 
cell support in the regenerating tissue. Scaffolds directly affect cells behaviour, in 
terms of their adhesion, proliferation, migration, differentiation, and maintenance 
of phenotype. Scaffolds requirements might be variable depending on the target 
tissue and pathological process, but biomaterial scaffolds for tissue engineering 
should gather some general criteria: 
• They should support specific cells retaining their functions such as 
proliferation, differentiation, phenotype maintenance, migration… 
• Scaffolds should be biocompatible without excessive immune response 
and cytotoxic effects. Biocompatibility should be satisfied by the 
biomaterial and, if it is the case, by its degradation products. 
• In general, biodegradable materials are preferred to biostable ones. In 
any case, the mechanical integrity of the scaffolds should be maintained 
through all the regenerative process. 
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• Biomaterials should permit nutrient diffusion and cell ingrowth in order to 
allow the viability of cells and regenerating tissue. For this reason, 
biomaterials are usually produced as hydrogels or highly porous 
scaffolds. 
• Scaffolds design and properties should be tailored depending on the 
requirements of the implantation site. Whenever possible, scaffolds 
should ensure batch-to-batch reproducibility. 
 
The use of scaffolds in tissue engineering covers a broad range of tissues and 
organs, including bone, cartilage, eye, nervous system, etc. In the case of neural 
tissue engineering, the biomaterial-based scaffolds are performed with the aim to 
guide and stimulate axon outgrowth and give a neuroprotective effect in the toxic 
microenvironment generated after injury. For many decades, researchers have 
investigated the cues implied in axon growth and guidance by several in vitro 
studies. These cues are related to substrates (structure, composition, mechanical 
properties…), physical stimuli (electrical signals and mechanical stretch), cells 
(glial and other cell types) and permissive and inhibitory molecules of axon growth 
(ECM components, neurotrophic factors…). Employing biomaterials and 
biohybrids (combination of biomaterials with therapeutic cells and/or therapeutic 
molecules) might help to supply the necessary cues for an appropriate neural 
regeneration. At same time, biomaterials have been engineered and implanted in 
animal models of different CNS diseases and injuries. However, due to the variety 
of pathologic processes after injury or disease and the heterogeneity of the CNS 
tissues, biomaterials for CNS regeneration are engineered in a different way 
depending on the target tissue (see Figure 1. 2). 
In this section are collected the different in vitro strategies using biomaterials to 
study the cues affecting axon regrowth. Moreover, in vivo studies in animal 
models and clinical trials employing different biomaterials to address the most 
common CNS injuries and diseases are described. Special attention is focused 
on the biomaterials employed in the present work, hyaluronan and poly(ethyl 
acrylate), whose applications in CNS tissue engineering are widely described in 
their corresponding sections [26]. 
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Figure 1. 2. Topographical motifs included in the biomaterials employed as scaffolds for CNS 
regeneration. A) Typical conduits based on an external channel and an inner matrix for peripheral 
nerve and spinal cord regeneration (from IP. Clements et al. [27] with authorization). B) 
Micropatterned substrate (from WC. Huang et al. [28] with authorization). C) Multichannel conduit 
based on poly(ethyl acrylate), inset: detail of the cross-section (own our group). D) Microfilaments of 
poly(ε-caprolactone) obtained by micro-extrusion, inset shows a detail of the microfilament surface 
(own our group). E) Crosslinked hyaluronic acid scaffolds with interconnected porous structure (own 
our group). F) Poly(ethyl acrylate)-based scaffolds containing interwoven microchannels (own our 
group). G) Aligned electrospun fibres of poly(ʟ-lactic acid) (from CC. Gertz et al. [29], with 
permission). 
 
1.1.4.1 In vitro studies using biomaterials 
Topographical cues 
Cell differentiation and other cell processes are dependent of external stimuli and 
are well known that cell-substrate interaction and particularly topographical cues 
are important in this cellular behaviour. Bellamkonda discussed the anisotropy of 
both molecular and substrate topography as an important cue to obtain a faster 
and more orientated axon regeneration [30]. This idea has provided a wide variety 
of investigations, where researchers have studied axon outgrowth, both in vitro 
and in vivo, in anisotropic substrates such as surfaced patterns, fibres and 
conduits. These 3D structures with pronounced anisotropy have been obtained 
by different micro and nanofabrication techniques.  
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Therefore, nano- and micropatterns have been fabricated by techniques such as 
lithography, photolithography, moulding templates, reactive ion etching, etc. 
Micropatterns are referred to scales above 1 μm and their influence in cell 
behaviour occurs at a cellular level: their role in axon guidance is to support entire 
cells, both glia and neurons, and guide their cytoskeleton and processes [31–34]. 
Besides, nanopatterns present discrepancies in cell-substrate interactions since 
their small dimensions cannot harbour cell bodies and their influence is limited to 
neurites and to the assembly of ECM components and processes [35,36]. Despite 
the different effect of nano- and micropatterns on cell behaviour, authors suggest 
that their dimensions may influence neurite orientation, length and sprouting 
[37,38]. 
One of the most common methods in order to obtain scaffolds with topographic 
cues is based on stacking layers of fibres. Nanofibrous scaffolds are usually 
obtained and aligned by electrospinning technique, while microfibers were 
produced by extrusion moulding with different morphologies. A wide range of 
synthetic and natural polymers have been electrospun to study axon outgrowth 
and guidance, such as aliphatic polyesters, polyamides, poly(methacrylates), 
polyacrylic acids, polydioxanone (PDS), collagen, gelatine, chitosan and 
hyaluronic acid… The natural ones show good biocompatibility and similar 
properties to neural tissues and the most employed synthetic biomaterials 
correspond to aliphatic polyesters including poly(lactic acid) (PLA), polyglycolic 
acid (PGA) and poly-ε-caprolactone (PCL) since they are biodegradable and 
some of them are approved by the Food and Drug Administration (FDA) for some 
clinical applications. Electrospun scaffolds have been employed as artificial 
matrices for neurons and glial cells, resulting in differentiation of NSCs and ESCs 
to neural lineages [39,40], and aligned fibres as substrates have resulted in 
neurite orientation and longer processes [41–43]. Micro fibres as substrate for 
axon and glia guidance constitute an unexplored field compared to nanofibres. 
However, some studies have demonstrated that synthetic microfibers are able to 
induce migration and orientation of glial and neural cells and promote axon 
extension [44–46]. 
Conduits have been widely researched for neural regeneration, especially 
focused on those cases where nervous fibres are coupled in bundles: peripheral 
nerves and spinal cord tracts.  In vitro studies using conduits are usually carried 
out by assembly conduits containing inner structures, which confer to the 
substrates of anisotropy for glial cell migration and axon guidance. Habitually, the 
inner conduit is composed [47] or supports [48] electrospun fibres with the aim to 
provide topographical cues for glial and neural cells. These in vitro studies have 
shown that topography influences migration of cells and axon outgrowth, resulting 
in enhanced neurite lengths and migration in those using aligned fibrous meshes 
[48]. However, topographical cues can be accomplished using microfibers as 
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inner meshes of conduits [44]. In this case, fibre diameter has shown to affect glia 
migration and neurite outgrowth. Even neurite growth can be faster than glia 
migration combining microfilaments with molecular cues, suggesting that a 
permissive environment allows axon ingrowth with independence of glia 
migration. Moreover, anisotropic conduits are accomplished using microchannel 
scaffolds, which are principally developed employing fibres templates, laser 
irradiation, freeze-drying, dipping and ion capillarity. Cultures of NSCs on 
microchannel conduits promote differentiation into glial and neural lineages, and 
some degree of infiltration of both types of cells has been observed within the 
channels [49]. Moreover, laminin (LN)-derived peptides (IKVAV and YIGSR) have 
been coupled on the inner surface of microchannels in order to address the 
synergetic effect of topographical and molecular cues [50] on cell colonization 
and neurite outgrowth compared to the separate effect of each one. 
 
Electrical stimulation 
Electrical stimulation of neural cells has led to the development of new frontiers 
for neural tissue engineering in the recent decades, including investigations of 
new conductive biomaterials and fabrication of electrodes to address several 
damages in the CNS. Currently, efforts have been focused on the study of 
conductive polymers because of some of them may act as the current organic 
polymers employed for tissue engineering. The electrical properties of these 
polymers are due to the presence of loosely held electrons in their backbones, 
which form conjugated π bonds, and with the help of doping chemicals, the 
polymer can be charged negatively or positively. Traditionally, the employed 
dopant agents were inorganic compounds; however, the introduction of active 
biological dopants is more attractive from the point of view of biomedical 
applications [51]. The most commonly studied conductive polymers include 
polypirroles (PPy), polyaniline (PANI) and polythiophene derivatives, specially, 
the poly(3,4-ethylenedioxythiphene) (PEDOT). Other emergent polymers such as 
carbon nanotubes and nanofibres (CNTs and CNFs) [52] and piezoelectric 
polymeric materials [53,54] are promising in developing new conductive polymers 
for neural tissue engineering. Several studies have shown that PPy is 
biocompatible with different cell types [55] and, particularly, with neural cells [56]. 
In recent years, PANI and PEDOT constitute and emerging growing field as 
conducting polymers for general tissue engineering applications. Recent studies 
have demonstrated the lack of cytotoxicity of PANI and PEDOT by in vitro studies, 
showing the biocompatibility of these alternative biomaterials [57,58]. Moreover, 
the tissue response to PPy, PANI and PEDOT substrates has been achieved in 
some preliminary in vivo studies, resulting in not toxic effects and an acceptable 
inflammatory response [59–61]. External electrical stimuli can be applied to a cell 
or tissue, producing an artificial action potential; this phenomenon is termed as 
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electrical stimulation. Electrical stimulation can influence cellular activities such 
as proliferation, migration, differentiation, extension of processes and protein 
expression [62–64]. Therefore, electrical fields, both direct and alternating 
currents (DC and AC, respectively) can affect neuron activity. Some researchers 
have observed how an electrical stimulation influences the direction and 
extension of neurite outgrowth [59,65]; as well as, the alignment of other cellular 
types such as astrocytes [66]. In other studies, electrical stimulation has been 
found to increase neurite extension in differentiated PC-12 cells cultured on PPy 
films [55]. Most recent studies have corroborated the enhancement of neurite 
outgrowth with electrical stimulation in other cell types and different conductive 
biomaterials including NSCs on PANI [67,68], cochlear neural explants on PPy 
[69] and dorsal root ganglia (DRG) explants on PPy [70]. Moreover, these studies 
have demonstrated, as Patel et al. [71] suggested, that one explanation for the 
increment in neurite lengths is due to the electrophoretic accumulation of proteins 
on the surface of the substrate. 
 
Mechanical stimuli 
The CNS is one of the softest tissues in the body, with elastic modulus between 
0.1 and 10 kPa [72]. Elasticity owns an important role at early stages of 
embryogenesis and development of tissues and, particularly in the CNS, since 
secretion of ECM components and migration of cells is influenced by mechanical 
cues. The rigidity of the brain increases with aging and the spinal cord shows the 
highest values of elastic modulus compared with other CNS tissues [73]. 
Therefore, the substrate rigidity may modulate the differentiation of neural 
precursors into glia or neurons. For example, ESCs differentiate into glia on softer 
substrates whereas to neurons in the more rigid ones [74], and neural progenitor 
cells (NPCs) and NSCs show a similar behaviour, differentiating preferably into 
neurons on softer substrates with modulus between those of the neonatal and 
the adult brain [73,75]. 
In general, axon extension increases on softer substrates, so elastic biomaterials 
are more suitable to address axon regeneration. The most commonly employed 
substrates with modulated stiffness in neural regeneration are gels including 
hyaluronic acid, fibrin, hydroxyl poly(methacrylates), polyacrylamide and 
poly(ethylene glycol) (PEG) due to their similar mechanical properties to the CNS 
tissue. Similar trends in axonal extension and branching have been observed in 
different types of neurons, the softer or more elastic substrates generally increase 
neurite length, neuron attachment and branching compared to slightly stiffer ones 
[74,76,77]. However, axonal extension decreases in very soft substrates, when 
they present elastic moduli much lower than those of the CNS tissue [78,79]. 
Nevertheless, neurons have shown good attachment and large neurite extension 
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on poly(dimethylsiloxane) (PDMS) substrates with elastic modulus higher than 
the CNS tissue [80]. Co-cultures of astrocytes and neurons on hydrogels with 
tuneable mechanical properties have shown that, contrary to neurites, astrocytes 
attachment decreases on soft substrates. This interesting result has highlighted 
the beneficial uses of soft substrates to address CNS injuries with presence of 
glial scar [74].  
 
Physical and chemical cues of substrates 
Some research are related to the study the effect on neural cells of many 
properties of biomaterials surfaces including charge, distribution of functional 
groups and wettability. Surface wettability can be modified by several techniques 
such as plasma polymerization, even gradients of wettability can be patterned on 
surfaces. Hippocampal neurons on substrates with wettability gradients have 
shown major cell density, longer processes and a faster development of longer 
processes than uniform substrates and hydrophobic regions [81]. The surface 
gradients seem to promote interactions between neighbouring cells and the 
development of neuronal networks. Similar results were found by culturing PC-
12 cells onto polyethylene surfaces with wettability gradients prepared by a 
corona discharge treatment [82]. Cell density was highest at intermediate 
wettability, around 55 º, but the length of neurite processes increased on more 
hydrophilic regions, suggesting an important role of surface hydrophilicity on the 
differentiation of cells into neurons. 
The functional groups of the biomaterials employed can affect cell attachment 
since surface charge, like wettability, is determinant on the biocompatibility of the 
biomaterials. Cells in general prefer to attach on positive surfaces because the 
residues of sialic acid from cell membranes produce a net negative charge. 
Moreover, hydrophilicity and hydrophobicity govern the formation of the non-
specific protein layer that can cause inflammation and the binding of other 
proteins involved in cell attachment [83]. 
 
1.1.4.2 Biomaterials for brain injuries 
The justification for employing biomaterials for brain is principally due to the lack 
of cell support after injury, thus biomaterial scaffolds may mimic the natural 
environment of cells promoting their attachment and/or entrapment aiding the 
regenerative process. Scaffolds can lodge the cells in a 3D context, allow 
diffusion of nutrients and function as a substrate for cell survival, neurite 
extension, axon regeneration and cell infiltration. The selection of the 
biomaterials in brain regeneration is based on the principles to achieve 
neuroprotection of the surrounding native tissue avoiding the secondary cell 
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death, and neuroregeneration of the damaged tissue to restore functions. From 
the biological point of view, a basic requirement of any material used is its 
biocompability, avoiding adverse cell response, such as formation of glial scar 
and/or acute inflammation. Besides, if possible, the biomaterial should be 
biodegrade without leaving any foreign residue as the regenerating tissue 
replaces it. 
Structure size is an important aspect of the biomaterials because of invasive 
surgery can cause further tissue injury. Besides, biomaterial morphology is crucial 
to ensure cell attachment and colonization of the entire structure; thus, the 
structures employed should provide high surface/volume proportions 
(interconnected porous structures, microspheres, nanofibres…). Moreover, 
nutrient transport throughout the internal architecture of the scaffold and 
vascularization are also required for neurons survival. The preclinical strategies 
with biomaterials to address brain damages employ different structures based on 
these requirements for brain neuroprotection and neuroregeneration. Most of 
these structures include in situ formed gels [84] and porous interconnected 
scaffolds [85]. Furthermore, other types of structures such as fibres [86] and 
microchannels [87] have been also proposed. Normally, the use of natural 
polymers is preferable rather than synthetic ones because most of these 
biomaterials are present in the tissues and their effects are well known; many 
synthetic biomaterials have though a good integration with brain tissue and 
present some advantages respect to the natural ones, including lower costs, 
enhancement of mechanical properties, handling, etc. 
 
Natural biomaterials for brain regeneration 
Natural polymers have similarities with substances present in the tissues 
(polysaccharides and glycosaminoglycans (GAGs)), even many natural 
biomaterials form part of the ECM compounds such as collagen and hyaluronic 
acid. Thus, implanted devices based on natural polymers own in general higher 
biocompatibility with the host tissue. Moreover, in some cases, they may provide 
signals to cells improving cell-substrates interactions and modelling cell 
behaviour. They are usually biodegradable by enzymatic degradation, making 
them good candidates for implantable devices in brain. Most common natural 
polymers studied for brain implants include hyaluronic acid, collagen, chitosan, 
methylcellulose, other ECM compounds and peptides. One promising natural 
polymer for brain regeneration is methylcellulose since it has been approved by 
FDA in nerve repair. However, this material has been combined with other 
polymers in order to increase biodegradability [88]. Novel and promising in situ 
gels have been developed from self-assembling peptides nanofibres (SAPNs), 
which constitute peptides with the ability to form nanofibrous gels in contact with 
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physiological ions [89]. Natural polymers are usually exploited by their ability to 
form in situ gels reducing invasive surgery, even they have been combined with 
NSCs [84], mesenchymal stem cells (MSCs) [90,91] and neurotrophic factors [92] 
increasing brain regeneration. In addition to good biocompatibility, employing 
natural biomaterials has resulted, in some cases, in a reduction of lesion volume, 
stimulation of growth factors production, promotion of neurogenesis, reduction of 
inflammatory response, neurite infiltration, stimulation of angiogenesis and 
slightly functional recovery [90–93]. However, materials such as chitosan, which 
possesses a positive charge, have demonstrated higher inflammatory response 
discouraging its use in brain regeneration [94]. 
 
Synthetic biomaterials for brain regeneration 
The possibility to obtain a broad range of structures and properties using 
synthetic polymers has encouraged their use in brain regeneration. Therefore, 
biodegradable or biostable substrates with similar properties to those of neural 
tissue can be produced, mimicking the natural ECM. The most common synthetic 
materials in brain regeneration include aliphatic polyesters and 
poly(methacrylates), but other polymers have been investigated in order to 
address brain regeneration, such as poly carbonates, CNTs and silicon [95–97]. 
Employing aliphatic polyesters is attractive because of some of them are FDA 
approved for many medical applications. These materials have been used to 
develop several structures for brain regeneration, including electrospun 
nanofibres [86], porous scaffolds [98] and channels [87]. Aliphatic polyesters 
have shown good biocompatibility, reduction of secondary damages, neurite 
infiltration and low microglia and astrocyte activation. Silicon is commonly 
employed in neural interfaces electrodes [96] and CNTs require further studies in 
order to improve their biocompatibility with brain tissue [97]. 
 
1.1.4.3 Biomaterials for spinal cord regeneration 
Despite most brain structures, axons within the spinal cord form longitudinal 
bundles, tracts, and they are similar to the nerve fascicles that compose the 
peripheral nerves. Thus, several researchers have proposed the use of nerve 
conduits for SCI because of their success in peripheral nerve repair. However, 
the spinal cord presents some physiological differences and the regeneration is 
more complex due to the limitation of regenerating the CNS. Owing to the 
complex geometries, the partial transection derived from spinal cord lesions and 
the need of invasive surgeries for the implantation of guidance conduits, many 
researchers have considered firstly the use of hydrogels. 
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Scaffolds for spinal cord regeneration should include guiding structures for a 
correct axon regrowth, because the tracts in the spinal cord are clustered in 
aligned bundles of axons. Particularly, the tracts in the spinal cord have diameters 
about 100-1000 µm, so the implanted scaffolds in the spinal cord must be 
permissive to the formation of axon bundles around these diameters. The 
swelling degree of a material under physiological conditions is important to 
maintain an appropriate alignment and avoid the compression of the regenerating 
tracts. Other properties are important to design scaffolds for spinal cord 
regeneration, including biocompatibility, controlled biodegradability, high 
surface/volume allowing cell attachment and the correct nutrient transport, similar 
mechanical properties to the host tissue, etc. The complex regeneration of the 
spinal cord forming aligned axons and tracts requires guidance structures, which 
can be fabricated by different techniques; the most common employed ones 
include rolled sheets of aligned electrospun fibres, freeze-drying, and moulding 
combined with particle leaching to generate porosity or by printing the polymers 
by CAD software. 
 
Natural biomaterials for spinal cord regeneration 
Natural polymers employed in spinal cord regeneration include fibrillary proteins, 
polysaccharides, GAGs and carbohydrates. The most common natural polymers 
employed include ECM components (collagen and hyaluronic acid) [99,100], 
polymers derived from algae (agarose and alginate) [101,102], and proteins 
derived from blood plasma (fibrin and fibronectin) [103,104]. They are potential 
materials for the purposes of spinal cord regeneration because of their 
possibilities in forming hydrogels in situ, avoiding invasive surgeries. However, in 
situ gels lack of effective axonal regrowth and guidance and scaffolds are 
commonly obtained as porous scaffolds and guidance conduits [105] to permit 
axon regeneration in an aligned manner. In addition to the current forms to obtain 
guidance conduits, some natural polymers can be submitted to a cooling gradient 
in a freeze-drying process [106] or ionic gelation leading to aligned microchannel 
conduits [107]. Collagen constitutes one of the most studied natural polymers for 
SCI since the FDA has approved some collagen-based conduits (NeuroMatrix™, 
Neuragen® and Neuroflex™) for nerve regeneration. Employing SAPNs for SCI 
is an emergent and interesting method due to the possibility to avoid invasive 
surgery and generating fibrous matrices that might favour the correct axonal 
regrowth [108,109]. Implants for SCI based on natural polymers have shown, in 
general, good biocompatibility, axon regrowth, lack of excessive inflammation 
and slightly functional recovery. In addition, regeneration can be enhanced by 
combinational therapies including proteins, growth factors and neural stem cells 
in biomaterial matrices [101,110–112]. However, regeneration is not full achieved 
and only small gaps have been partially restored. 
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Synthetic biomaterials for spinal cord regeneration 
Most synthetic polymers permit design a broad range of structures for spinal cord 
repair, including conduits forming bridges between the rostral and caudal stumps. 
The most studied synthetic polymers for spinal cord tissue engineering include 
biodegradable ones, such as aliphatic polyesters (PLA, PGA, PCL, etc.), and 
biostable ones, such as methacrylate-based hydrogels including 
poly(hydroxyethyl methacrylate) (PHEMA) and poly(hydroxypropyl methacrylate) 
(PHPMA).  
Aliphatic polyesters constitute promising polymers for spinal cord regeneration 
because of their biodegradability can be tailored by combining the different 
subtypes, even some of them are FDA approved as conduits for peripheral nerve 
regeneration: Neurotube®, which is composed of PGA, and Neurolac®, which is 
a copolymer of poly(ᴅʟ-lactide-ε-caprolactone). PLA scaffolds have been 
designed obtaining different structures: aligned channels using a freeze-drying 
technique [113], porous interconnected scaffold [114] and conduits containing 
random and aligned electrospun fibres [115]. However, implantation of those 
structures in the injured spinal cord of rats has shown slightly regeneration just in 
the electrospun conduits. The inclusion of exogenous SCs expressing brain-
derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) in PLA porous 
scaffolds resulted in a modest regeneration, but cell survival was low. On other 
hand, other problems associated with PLA conduits are referred to their structural 
stability through the regenerative process. Employing copolymers of poly(lactic-
co-glycolic acid) (PLGA) enhances the properties of implantable conduits and 
allows a better control over the degradation rate [116]. PLGA has been implanted 
principally as microchannel conduits, but microparticles have been injected in 
order to avoid invasive surgery [117].  PLGA conduits have demonstrated better 
results that those employing PLA regarding neuroprotection and 
neuroregeneration [117,118]. Moreover, PLA conduits have been combined with 
neurotrophic factors or SCs in order to improve regeneration and increase 
neuroprotective effect [118,119]. NSCs in combination with these conduits 
preferably to differentiate to neural lineages when they are implanted in rat 
models of SCI [120]. Other aliphatic polyester studied for spinal cord regeneration 
is PCL. Multichannel conduits have been developed from a PCL derivative, 
poly(ε-caprolactone fumarate) (PCLF), for spinal cord regeneration [121]. PCLF 
conduits have resulted in major number of axons in the compared with those 
composed of PLGA. Moreover, PCL in combination with PLGA has been 
employed to obtain electrospun fibres conduits containing an internal matrix of 
based on SAPNs, RAD16-I, growth factors and neurotrophic factors to enhance 
axon attachment and motor functions of spinal cord [122].  
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1.2 Hyaluronan 
1.2.1 Sources and structure 
Hyaluronic acid was first isolated from vitreous humour from bovine eyes by 
Meyer & Palmer in 1934 [123]. Hyaluronic acid is usually associated with the 
environmental cations and it is interchangeably referred as its sodium salt, 
hyaluronan (HA). HA isolation supposed the finding of a novel GAG, which is a 
family comprising other important molecules such as heparin, chondroitin 
sulphate, heparin sulphate... Over the following years, HA was found in several 
tissues of all the vertebrates. It is the major constituent in the ECM of some 
human tissues, such as the synovial joint fluid (1400-3600 µg/mL), the vitreous 
humour of the eye (140–340 µg/mL), cumulus cells around the oocyte prior to 
ovulation (500 µg/mL) and the umbilical cord (4100 µg/mL). However, HA is 
presented in a minor amount in other human tissues, such as dermis (200–500 
µg/mL), epidermis (100 µg/mL), cartilage and CNS. Moreover, HA is produced in 
other animal species, such as rooster, whose combs contain the highest 
concentrations of HA ever reported for animal tissues (7500 µg/mL), and it can 
be produced by some bacteria, including Streptococcus equi zooepidemicus 
[124,125]. These both sources of HA are commonly employed in medicine for 
intra- and cutaneous applications. 
The primary structure of HA is composed of two repeat units consisting in an 
uronic acid, ᴅ-glucuronic acid (GLcA), and an aminosugar, N-acetyl-ᴅ-
glucosamine (GLcNAc), linked by alternating β 1-3 glycosidic and β 1-4 glycosidic 
bonds forming a lineal unbranched polymer (Figure 1. 3). HA constitutes a 
polyanion because of the carboxylic group from the GLcA unit and, at 
physiological conditions of pH and salt concentration, this group is widely 
hydrolyzed and balanced with the environmental cationic counterions, such as 
Na+. HA is a polymer with high molecular weight ranging between 200 kDa and 
10000 kDa (where each disaccharide is approximately 400 Da, including sodium 
as counterion). Each polymeric chain is terminated by both reducing end and 
non-reducing ends. Reducing end is referred as the monosaccharide whose 
anomeric carbon (C1) is not involved in a glycosidic bond. The non-reducing end 
corresponds to the termination where C1 is joined by a glycosidic bond. The 
reducing end forms an equilibrium between the cyclic acetal and the opened 
aldehyde group, while the non-reducing end remains in the stable cyclic acetal 
form. 
Introduction 
 
- 37 - 
 
 
Figure 1. 3. Primary structure of hyaluronan including the reducing and non-reducing ends. 
 
HA possesses singular properties, because of its polyanionic nature and high 
molecular weight, differentiating it from other linear unbranched polymers and 
affecting its secondary and tertiary structures. Assays using X-ray diffraction and 
Nuclear Magnetic Resonance (NMR) showed the presence of longer distances 
than the corresponding to C-C, C-O, etc. bonds, suggesting interchain 
interactions such as hydrogen bonds [126,127]. Therefore, the secondary 
structure is characterized by the relative rigidity of the glycosidic linkage and the 
intramolecular hydrogen bonds. These facts restrict the rotational freedom of the 
molecule affecting its conformation and impeding proteins and other globular 
molecules to diffuse through the HA matrix [128].  Moreover, other studies have 
demonstrated the presence of intramolecular and intermolecular hydrogen bonds 
[129]. These weak interactions allow multiple conformations of HA depending on 
the molecular arrangement and the nature of environmental cations: double helix, 
two antiparallel helices without coiling around each one, single helices in a tighter 
arrangement, six chains in an ordered arrangement, chains in a more compact 
arrangement and fully extended individual chains. Despite these conformations 
were found such a stable ones in the dry state, HA in water and under 
physiological conditions showed that intramolecular and intermolecular hydrogen 
bonds were formed and broken continuously giving transient networks [130]. This 
fact is due to energy differences of hydrogen bonds, whether HA is hydrogen 
bonded to itself or with water molecules. 
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1.2.2 Rheology of hyaluronan solutions 
The HA solutions contain unique properties due to singularity of HA molecules: 
polyanionic nature, common high molecular weight, relative rigidity of chains and 
the ability to form hydrogen bonds and other interactions. Thus, properties of 
aqueous solutions are strongly influenced by HA concentration and molecular 
weight, as well as the composition of the electrolyte (pH, ionic strength and type 
of ions). In order to unify conditions and mask electrostatic repulsions, HA 
aqueous solutions are usually studied at neutral pH with ionic strengths up 0.1 M. 
Partial spatial volume of HA is about 0.56 mL/g and the highest concentrations of 
HA employed in the studies are around weight fractions of 8 %. Under these 
conditions, the HA solutions are governed by hydrodynamic interactions and 
rheology is a potent method to determine their viscous properties.  Rheology is 
carried out by subjecting HA solutions to different share rates and dynamic 
oscillatory conditions. These methodologies are employed in determining intrinsic 
and specific viscosity of HA and predicting solvent viscosity and molecular weight 
of chains. 
Intrinsic viscosity [η] (mL/g) can be related with the molecular weight when HA is 
studied in dilute solutions and at very low or zero shear rates. Therefore, intrinsic 
viscosity has been fitted to two distinct regions; low and high molecular weight 
regions [131]. Solutions behaviours, at both regions, follow the Mark-Houwink-
Sakurada equation, [η] = k·Mα, where M is the relative viscosity average 
molecular weight, and k (mL/g) and α are constants with different values 
depending on the molecular weight region (Equation 1. 1). 
 
    a.η=1.29 × 10-3M1.056 for M<105            
b.η=3.39 × 10-2M0.778 for 105<M<106
  c.η=3.95 × 10-1M0.604 for M>106                                     [Equation 1. 1] 
  
Thus, [η] is a measure of the hydrodynamic volume of the HA chains in solution, 
and hence its conformation. In the low molecular weight region, chains show a 
free-draining chain conformation, while they are in a ball-like configuration at 
higher molecular weights.  Under similar shear rate conditions, it is possible to 
determine specific viscosity, ηsp, as a simple function of the concentration and the 
relative viscosity average molecular weight, implicit in the [η] term, employing the 
Equation 1. 2 [132]: 
 
ηsp=cη+k'cη2+ k'
2
2! cη3+ k
'3
3! cη4                   [Equation 1. 2] 
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where, the first term of the equation, c[η], is the ηsp at infinite dilution, while the 
entire right side of the equation is c[η] multiplied by an expanded factor, (k’ c[η]), 
truncated to include only the first four terms. The term k’ c·[η] is a measure of the 
degree at which the domain of the coils overlaps in dilute and semi-dilute 
solutions. Thereby, the first two terms of Equation 1.2 are enough to predict ηsp 
in dilute solutions. However, higher concentrations require the four terms to 
consider intermolecular interactions. In Figure 1. 4 the dependence of ηsp with 
c[η] is fitted.  
 
 
Figure 1. 4. Specific viscosity of hyaluronan as a function of the variable c·[η]. Modified from [130]. 
 
The models described above allow to study the viscosity of HA solutions under 
static conditions. However, viscosity of HA solutions depends on the applied 
shear rate because of chain entanglement. In order to investigate the influence 
of flow on solution properties, HA solutions have been measured at different 
shear rates and under dynamic oscillatory conditions [133,134]. Increasing flow 
rate leads to the measure of the shear rate at which viscosity drops (critical shear 
rate). This parameter is the inverse of the relaxing time, which is proportional to 
the solvent viscosity and the hydrodynamic volume in dilute solutions. On the 
other hand, dynamic oscillatory measures allow determination of changes in the 
storage elastic modulus, E’, and viscous loss modulus, E’’. At low frequencies, 
HA solutions behave as a viscous solution, while at higher frequencies they 
behave elastically. This inflection point is the critical shear rate, at which the 
curves of E’ and E’’ intersect. The transition from the viscous to the elastic 
behaviour of HA solutions is highly dependent on concentration and molecular 
weight; the higher the concentration and molecular weight, the earlier the 
transition occurs.  
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HA solutions under the conditions described above are widely studied and show 
similarities with the physiological environment. However, other environmental 
conditions have been studied because of their interest in producing HA 
derivatives [130,135]. Thus, viscosity depends on temperature, the higher 
temperature, the lower intrinsic viscosity. This relation for dilute solutions with 
temperatures over the range 25-65 ºC can be explained using Equation 1.2. The 
addition of alkalis into the solutions leads to the reduction of viscosity because 
HA chains become more contracted, by eliminating intermolecular hydrogen 
bonds. Paradoxically, acidic conditions produce a reduction of viscosity due to 
the protonation of carboxyl groups and reduction of electrostatic repulsions since 
the HA possesses a pKa of 3.2 [130]. However, in the presence of salts this 
phenomenon is masked because of acidic conditions favour intermolecular 
hydrogen bond formation. Similarly, increasing ionic strength reduces viscosity 
by masking the electrostatic effect. However, depending on the type of 
counterion, viscosity is affected in a different way, for example HA chains in 
solutions at a constant ionic strength show similar hydrodynamic volume in 
solutions containing Na+ or K+ ions, but they are more contracted in electrolytes 
with Ca+2. Moreover, certain agents, including urea or ethanol, can disturb 
partially hydrogen bonds reducing viscosity of HA solutions. The effects on the 
conformation of the HA molecule due to the ionic strength and pH of the medium 
are difficult to compared from previous works because of the discrepancies in the 
methodologies employed. However, the hydrodynamic radius of HA dissolved in 
de-ionized water, 0.5 M NaCl and 0.5 M NaOH has been compared resulting in 
values of 95, 33.5 and 17.5 nm, respectively [135]. The hydrodynamic radius is 
directly related with the gyration radius, and hence it results in a measure of the 
flexibility of the chains. In this case, the HA behaves as a semi-rigid molecule in 
de-ionized water (high hydrodynamic radius), whereas the chains become 
flexible when NaCl or NaOH is added. In addition, the discrepancies found 
between the hydrodynamic radius in NaCl and NaOH at similar concentration are 
only explicable by the disruption of hydrogen bonds in alkaline media.  
 
1.2.3 Degradation 
Fermented and extracted HA is, in general, a polydisperse polymer. Thus, it is 
usually characterized by its average molecular weight and polydispersity index. 
In order to determine chain sizes and dispersion, the authors have developed 
different techniques: viscosimetry and related methods (osmometry, 
sedimentation, diffusivity…); electrophoresis by exploiting its own polyanionic 
nature; and low-angle (LALS) and multi-angle light scattering (MALS) coupled to 
size exclusion chromatography (SEC) [136].  
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On the other hand, HA from healthy tissues, such as other physiological 
substances, suffers a catabolic pathway and is continuously synthesized, 
degraded to lower molecular weights and secreted out the body or employed in 
other processes. Thus, a group of enzymes, hyaluronidases (HYALs), degrades 
specifically HA and they are considered responsible for much of its catabolism. 
Despite HYALs are the principal field involved in HA cleavage, other agents can 
degrade the molecule including physical ones (irradiations, ultrasounds and high-
speed stirring) and chemical reagents (acidic and alkaline media and free 
radicals). Thus, some of these agents are involved in the degradation of HA in 
some diseases and inflammatory processes, as well as in obtaining HA 
fragments. Degradation consists in the depolymerization of chains in smaller 
fragments, but this phenomenon sometimes takes place together chemical 
modifications within chains and monomeric units. 
 
Hydrolysis 
The hydrolysis of HA in aqueous solutions is spontaneously induced by the 
nucleophilic attack of water molecules within carbons involved in glycosidic 
bonds. The rate of hydrolysis is low under neutral pH and moderate temperatures, 
but the degradation is increased under acidic or basic conditions and higher 
temperatures [137,138]. Chain scission by hydrolysis occurs in a random fashion 
and it obeys to a first order kinetics [139,140]. However, there are significant 
differences in cleaving glycosidic bonds when performed under acidic or basic 
conditions: acids break glycosidic bonds in one step, whereas alkalis make it in 
two steps [138]. 
Cleavage of glycosidic bonds under acidic conditions involves three intermediate 
steps. First, a fast electrophile attack of protons leads to the protonation of both 
O-glycosidic atoms leading to an equilibrium between native and protonated 
forms of HA. Subsequently, take place the kinetic-determining step where the 
protonated form gives a carbonium-oxonium ion and a non-reducing end group. 
Finally, water molecules are fast added to the carbonium-oxonium ion leading to 
the formation of a reducing end group. Moreover, acids may perform a 
nucleophilic attack within O-1 atoms of glucuronic acid, opening rings and leading 
to chemical modified subunits. The authors suggest that acid hydrolysis cannot 
attack the N-acetylglycosamine unit since the N-acetyl group is protonated 
drawing electrons from the glucusodic oxygen. 
Hydrolysis under basic conditions begins with a nucleophilick attack of water 
molecules and hydroxides within the C-1 and C-2 of the N-acetylglucosamine 
subunit breaking the pyrose ring. A second nucleophilic attack of water and 
hydroxides within the oxygen atoms of β(1-4) glycosidic bond and the O-1 from 
the N-acetylglucosamine group generates two possible chain scissions. This 
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process yields to chemical modifications of the native chains leading non-
reducing end and ring-opened species. Moreover, basic media favours the 
equilibrium of the amino form of the N-acetyl group. Under this form, hydroxides 
produce a nucleophilic attack to the carbon of the N-acetyl group linked to the 
nitrogen atom generating deacetylation and producing a modified group with a 
primary amine. 
Despite acid and basic hydrolysis produce a reduction of HA molecular weight, it 
is in a random fashion manner yielding a mixture of oligomers with high 
polydispersivity and chemical modification in the native subunits.  These methods 
are also not employed to obtain fragments, because of the possible presence of 
undesirable products and needing to separate HA chains in monodisperse sizes. 
The effect of temperature on hydrolysis can be explained by an Arrhenius-type 
relationship. Slow degradation rates were observed at temperatures in the range 
of 25-90 ºC, while faster degradation was observed, even at short times, at 
temperatures around 130 ºC [137,141]. The combination of acidic and basic 
media with temperatures up to ambient ones produces faster kinetics of chain 
scission. 
 
Degradation using ultrasounds 
Ultrasonic degradation or sonication produces chain cleavage in a non-random 
fashion, leading to bimodal molecular weight distributions [142]. Moreover, the 
kinetic of depolymerization during sonication follows a linear relationship [143]. 
Ultrasonic degradation allows obtaining small HA fragments with molecular 
weights of few kDa. However, complete degradation to monomeric units is not 
accomplished by this method, even employing longer times and higher energies. 
Sonication is an efficient method in order to reduce chain sizes to intermediate 
molecular weights without significant chemical modifications [144]. 
 
Degradation by oxidants 
Oxidants, particularly reactive oxygen species (ROS), are important degrading 
agents of HA during different physiological processes. ROS in the body are 
generated from different sources including the activity of cells, enzymes, 
chemicals and physical irradiations. Degradation and synthesis of HA is in 
equilibrium in healthy tissues, whereas many diseases affecting synovial fluid in 
the joint, including osteoarthritis and rheumatoid arthritis, are characterized by 
high concentrations of ROS and a harmful action. Most typical ROS implied in HA 
molecular weight reduction include superoxide anion radicals, peroxides, 
hydroxyl radicals, singlet oxygen and nitric oxide [145]. 
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The mechanism of degradation of HA chains is different depending of ROS 
chemical nature. In general, ROS randomly abstract a hydrogen atom from either 
HA subunits leading to the formation of macroradicals within chains, and 
subsequent electronic rearrangements give carbon-centred radicals in carbons 
implied into the glycosidic bonds. For example, hydroxyl radicals can subtract 
hydrogens from all the C-H bonds in the glucuronic acid and at all sites, except 
the N-acetyl group and C-2, within the N-acetylglucosamine subunit. Whereas, 
hypochlorous acid attacks the nitrogen atom of the N-acetyl group and posterior 
electronic rearrangement leads to the formation of carbon-centred radicals at C-
4 of the glucuronic acid unit, generating glycosidic bond scissions. Moreover, the 
reduction of molecular weight using ROS and other oxidant species is usually 
accompanied by chemical modifications of the fragments, such as oxidations, 
extraction of hydrogen atoms and scission of functional groups.  These chemical 
modified species are those implied in inflammatory processes in diseases 
associated with reduction of molecular weight of HA by ROS [146,147]. 
 
Degradation by physical irradiations 
Several authors have studied the effect of physical irradiations on HA 
degradation, including microwaves, UV rays and gamma-irradiations [148,149]. 
Understanding effect of irradiations on HA is important since most of them are 
usually employed in order to obtain sterilized (using gamma-irradiation) or 
disinfected (using UV) materials for clinical applications. The authors suggest that 
irradiations on HA act similarly to oxidant species. These methods induce radical 
and singlet oxygen formation with the ability to attack chains giving carbon-
centred radicals within carbon atoms involved in glycosidic bonds. Subsequently, 
these radicals are followed by cleavage of glycosidic linkages. Moreover, HA 
solutions and swollen hydrogels are in general more affected by irradiations, 
resulting in higher rates of chain scissions that those employing HA powder or 
dry hydrogels [150]. 
Depending on radiation nature, exposition times and dose, the degradation of HA 
is qualitatively and quantitatively different. Gamma-irradiation and Hg lamp 
irradiations (wavelengths up 297 nm) give significant loss of molecular weight 
and chemical modifications within the monosaccharide units, even at low dose. 
On the other hand, degradation under microwaves and UV imply lower rates of 
reduction of molecular weight lacking significant chemical modifications. 
However, harsher conditions (acidic or alkaline pH) may produce chemical 
modifications and increases degradation rates [151]. 
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1.2.4 Biodegradation 
HA is localized in the ECM of most tissues and it is principally present in its high 
molecular weight form in healthy tissues. HA is continuously synthesized and 
degraded, in order to maintain the equilibrium of its catabolism. The degradation 
is principally carried out by a group of enzymes, which were defined as 
hyaluronidases (HYALs) by Karl Meyer [152]. HA is present in eukaryotic and 
prokaryotic cells, hence its HYAL-mediated degradation occurs in large amount 
of organisms observing some differences [145,153], and it is increased in some 
pathological diseases, including the CNS damages [154]. In mammals, the 
degradation of hyaluronan may occur by two pathways: local digestion, where HA 
internalization and degradation is conducted by cells within the host tissues; and 
drainage into the vasculature and clearance in cells of the lymph nodes, liver and 
kidneys. In any case, the mechanism of degradation is similar beginning with the 
partial degradation of high molecular weight HA in the host tissues. Partially 
degraded chains can be internalized by receptor-mediated mechanism or 
endocytosis into the lysosomal compartment of cells and HA is fragmented in 
smaller oligosaccharides. Moreover, the organism usually secretes these 
fragments, but they are often degraded to monosaccharides by other types of 
enzymes, exoglycosidases, within the lysosomal compartments. Enzymatic 
degradation of HA is habitually performed at low pH (4-5.5), where HYAL activity 
is optimal. For this reason, most of the degradation studies in vitro are carried out 
at low pH using acetic buffers. However, some hyaluronidases from the 
eukaryotic organisms show activity in a broad range of pH, even at neutral ones. 
Biodegradation of HA requires several enzymes to cleave the larger chains till 
obtaining monosaccharides. However, HYALs are also referred to those 
enzymes able to cleave glycosic bonds of HA oligosaccharides and larger chains 
obtaining smaller fragments with disaccharides as repeat unit. Therefore β-
exoglycosidases, which remove single sugar units from HA chains, are not 
considered as HYALs. The enzymes β-exoglycosidases are present in 
prokaryotic and eukaryotic cells and include β-exoglucuronidase and exo-β-N-
acetylglucosaminidase, which remove single glucuronic acid and N-
acetylgucosamine units, respectively. On the other hand, HYALs belong to the 
enzyme family β-endoglycosidases and are localized in bacterial and eukaryotic 
cells of many organisms. Depending on the mechanism to cleave the glycosidic 
bond HYALs are classified in three groups: microbial β-endoglycosidases, β-
endoglucuronidases and endo-β-N-acetylhexosaminidases. The last two groups 
are eukaryotic β-endoglycosidases.  
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Prokaryotic β-endoglycosidases cleave randomly chains of HA and other GAGs 
by a lyase mechanism by the β(1-4) glycosidic linkage [155,156]. Thus, 
degradation of chains is performed by β-elimination yielding tetra-and penta-
saccharides with unsaturated groups. Hence, the action of these HYALs 
produces chemical modifications. 
β-endoglucuronidases are present in eukaryotic organisms including certain 
annelids and crustaceans. These hyaluronidases produce random scission by a 
hydrolysis mechanism of the β(1-3) glycosidic linkage. These enzymes cleave 
HA generating tetra- and hexa-saccharides with glucuronic acid at the reducing 
end. The mechanism of hydrolysis does not give chemical modifications. 
Endo-β-N-acetylhexosaminidases are present in eukaryotic organisms of 
vertebrates including mammals. These hyaluronidases are localized in 
mammalian spermatozoa, lysosomal compartments and different venoms of 
reptile and insects. These enzymes cleave randomly HA chains by hydrolysis of 
β(1-4) glycosidic linkage yielding oligosaccharides of different lengths with N-
acetyl glucosamine at the reducing end. The mechanism of action has been 
widely studied and includes several intermediate stages, but it is partially 
understood [145]. First, the HA substrate and the HYAL are bonded and the 
carbonyl oxygen of the N-acetyl group is positioned next to the β(1-4) glycosidic 
bond. Subsequently, both groups form a covalent intermediate breaking the 
glycosidic bond. The glucuronic acid becomes protonated donating its H atom to 
the detached glycosidic oxygen. The intermediate covalent bond is also cleaved 
leading to the re-protonation of the glucuronic acid. Finally, the HA product is 
released from the hyaluronidase.  
Mammalian species show different types of hyaluronidases; in mouse genome 
has been identified seven hyaluronidase-like gene sequences, while in humans 
have been found six sequences [157]. The hyaluronidase genes are known as 
hyaluronicglucosaminidase (Hyals) genes and they are localized in two different 
chromosomes in humans. The expression of these gene sequences gives three 
different types of HYALs named as Hyal1, Hyal2, Hyal3, Hyal4, Hyalp1 and PH-
20. 
The most important and the major expressed HYALs in human somatic tissues 
are Hyal1 and Hyal2 [158]. Hyal1 was the first somatic hyaluronidase isolated 
from human plasma. It is a single polypeptide glycoprotein of 57 kDa or 45 kDa 
(in its processed form) [158]. Hyal2 is anchored to the plasma membrane and 
cleaves HA of high molecular weight to fragments around 20 kDa [159]. While 
Hyal1 degrades HA of any chain size, yielding oligosaccharides, principally tetra-
and hexa- saccharides. Thus, these enzymes constitute the first degradation step 
of HA from the ECM. 
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PH-20 or SPAM-1 is known as testicular hyaluronidase because of its localization 
and important role in the fertilization process of mammals [160]. It is localized in 
the sperm surface an in the lysosome-derived acrosome, and its function is to 
degrade the HA-rich cumulus layer involving the egg. It is a polypeptide 
synthesized with a molecular weight of 64 kDa, and it is processed during 
maturation in two fragments linked by disulphide bridges with two terminal 
domains of 41-48 and 27 kDa, respectively. However, its presence in tissues with 
certain malignancies suggests that PH-20 have other functions. PH-20 yields to 
small oligosaccharides as the case of Hyal1 [161]. 
The other human HYALs (Hyal3, Hyal4 and Haylp1) are not well understood yet 
because of the difficulty in determining hydrolase activity. Hyal3 has been found 
in chondrocytes, testis and bone marrow and it is widely expressed during 
differentiation of fibroblast to chondrocytes [162]. Hyal3, as well as Hyal2, is up-
regulated by inflammatory cytokines including IL-1 and TNFα. Surprisingly, recent 
studies have shown Hyal4 has no evidence of hydrolytic activity on HA, exhibiting 
activity towards other GAGs such as chondroitin sulphate [163]. This enzyme has 
been localized in different tissues such as the placenta, skeletal muscle, and 
testis, suggesting that its activity is restricted to specific tissue functions. In a 
similar way, murine Hyalp1 has shown no hydrolytic activity on HA. This enzyme 
has been observed in mice testes and its functions may overlap to those HYALs 
involved in fecundation [164]. 
Unlike bacterial HYALs, determination of activity in hydrolase ones is by 
conventional methods. The lack of chemical modifications in degraded HA 
products, such as those produced by bacterial Hyal, impedes the activity 
measurement by spectrophotometry. Thus, the current methods in determining 
hydrolase activity are based on the measurement of the formed N-acetyl 
glucosamine at the reducing end or by viscosity and turbidity methods. 
 
1.2.5 Biological properties 
1.2.5.1 Biosynthesis 
The biosynthesis of HA in the mammals is regulated by three different 
transmembrane glycosytranferase isoenzymes, known as hyaluronan synthase 
(HAS1, HAS2 and HAS3) [165,166]. Their gene sequences are located in 
different chromosomes, but their amino acid sequences are identical at 50-71 %. 
However, each isoenzyme synthetize HA chains with different ranges of 
molecular weight. HAS3 synthetize HA of low molecular weights around 100-
1000 kDa, while HAS1 and HAS2 produce HA in a broader range from 200 kDa 
to 3.9 MDa). HA is present in all vertebrate tissues, but is especially abundant in 
connective tissues molecular weights between 800 kDa and 10 MDa. 
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Despite GAGs are usually synthesized within the Golgi apparatus, HA 
polymerization is performed on the plasma membrane. Synthesis of the 
saccharides taking part in the HA structure requires employing uridine 
diphosphate glucuronic acid (UDP-GlcUA) and uridine diphosphate N-
acetylglucosamine (UDP-GlcNAc) as substrates.  HAS isoenzymes extrudes HA 
form the plasma membrane onto the cell surface or the ECM. These enzymes 
possess two components, one of them adds the glucuronic acid subunit and 
another one couples the N-acetylglucosamine group, alternating the coupling of 
both saccharides. 
 
1.2.5.2 Hyaluronan-binding proteins 
HA chains possess certain binding sites with several cell receptors and ECM 
proteins. These proteins are known as hyaladherins and include intracellular 
receptors, both plasmatic and transmembrane ones, and extracellular proteins 
taking part in the ECM structure (see Figure 1. 5). HA have also two important 
functions mediated by binding proteins: structural and modulation of signalling 
pathways [167]. Some of the known HA-binding receptors include cell-surface 
glycoprotein 44 (CD44), receptor for hyaluronate-mediated motility (RHAMM), 
lymphatic vessel endothelial HA receptor (LYVE1), hyaluronan receptor for 
endocytosis (HARE), toll-like receptors (TLR-4/2), layilin and liver endothelial cell 
clearance receptor (LEC receptor). On the other hand, some of the extracellular 
hyaladherins include versican, aggrecan, fibrinogen and neurocan. Therefore, 
HA can bind to large amounts of ECM proteins forming aggregates and acting as 
a structural matrix [168,169]. Extracellular hyaladherins are HA-binding 
proteoglycans of the ECM in the different tissues: versican present in soft tissues, 
aggrecan and fibrinogen predominant in cartilage, neurocam and brevicam 
important in CNS, etc. 
 
Cell-surface glycoprotein CD44 
CD44 is the most common HA-binding receptor and it is localized on the 
membrane of all cell types. CD44 is a type I cell transmembrane glycoprotein that 
can interact with other molecules, including ECM proteins, growth factors and 
cytokines. This glycoprotein is expressed in different isoforms due to alternate 
splicing of 20 exons. In general, each isoform contains four domains, including 
intracellular, extracellular and transmembrane domains. Its affinity to bind HA is 
influenced by polypeptide sequence, glycosylation and oligomerization. The 
different isoforms show molecular weights in the range between 75-250 kDa. 
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CD44 is overexpressed by cytokines such as IL-1 and TNFα and growth factors 
including the TGF-β superfamily and endothelial growth factor (EGF). In some 
tissues, such as cartilage, the higher CD44 expression implies increasing the 
ability for HA binding, its internalization and degradation.  CD44 up-regulation by 
IL-1 influences the proliferation of certain cell types including smooth muscle cells 
and may contribute to the development of pathological lesions. EGF is a growth 
factor that can stimulate over-expression of CD44 in fibroblasts, tumoral cells and 
epithelial cells. The production of bone morphogenetic protein (BMP), which 
belongs to the superfamily TGF-β, is also stimulated giving an osteoinductive 
effect [170]. 
In addition, CD44 can be associated with a large amount of ligands including 
fibroblast growth factor (FGF), osteopontin, matrix metalloproteases, kinases, 
GTPases, while HA can bind to other hyaladherins implied in the regulation of 
cell functions or taking part of the ECM [171]. Thereby, HA-CD44 interaction may 
function as a docking of proteins, growth factors and other molecules on cell 
membranes, acting as a co-receptor/co-regulator agent. Most specific cellular 
functions of the HA-CD44 binding include cell-cell aggregation, motility, 
adherence, proliferation, signal transduction, endocytosis and degradation of HA 
[172]. Thus cells enriched in HA have been found in processes where migrating 
and proliferating cells play important roles: embryonic development, wound 
healing, tumorogenesis and metastasis, vascularization…[171,173]. 
 
Hyaluronan-mediated motility receptor (RHAMM) and Layilin receptor 
RHAMM is an extensively coiled-coil protein with a globular head with a molecular 
weight ranging from 59-80 kDa. Contrarially to other intracellular hyaladherins, 
RHAMM does not constitute a transmembrane protein and it is also present on 
cell surface, within the cytoplasm and in the nucleus. RHAMM can interact with 
several sulphated GAGs, as well as with biotinylated HA [174]. This receptor has 
been observed in cells such as fibroblasts, endothelial cells, smooth cells, 
macrophages and many types of tumoral cells [175]. RHAMM form association 
with actin and microtubule cytoskeleton, centrosomes and cell lamellae and other 
proteins associated with motility [176]. Thereby, RHAMM interacts with 
microtubule associated proteins (MAPs) from the cytoskeleton and transforming 
acidic coiled-coil domains (TACCs) involved in cell cycle and differentiation. 
Moreover, this receptor can modulate the extracellular signalling regulated by 
kinases showing a targeting action to specific substrates [177]. Particularly, HA-
RHAMM binding has an important role in tissue repair, inflammation, proliferation 
and tumorogenesis [178,179]. 
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Layilin is a type I transmembrane glycoprotein of 55 kDa with similar sequence 
to C-selectin. However, Layilin domains have no homology with other known HA 
receptors [180,181]. This molecule is involved in the association between cell 
membrane and actin cytoskeleton. Thus, layilin plays an important role on 
adhesion, and hence affects migration and the mediation of signals form ECM. 
 
Hyaluronan receptor for endocytosis (HARE) and lymphatic vessel endothelial 
receptor 1 (LYVE-1) 
HARE is an integral membrane glycoprotein generated by the protolithic cleavage 
of stabilin 2 or FEEL2 and it has been identified two forms with different molecular 
weights: 175 and 300 kDa. This molecule is typical of the lymphatic endothelium, 
but it has been observed in endothelial cells of other tissues, such as brain, 
kidney, eye and heart [182].  HARE possesses several binding motifs, including 
HA, fascilin and EGF binding domains. The principal known function of HARE is 
its role in endocytosis and subsequent degradation of HA via catherin co-
localization. 
LYVE is a membrane glycoprotein similar to CD44 in structure and its function 
localization and functions is similar to HARE. Thereby, LYVE has been observed 
in lymphatic endothelium, endothelial cells of other tissues and macrophages and 
it is related to the internalization and degradation of HA [183]. 
 
Toll-like receptors (TLRs) 
TLRs are receptors from the interleukin-1 receptor family.  These transmembrane 
receptors are characterized by its very rapid response and they are broadly 
expressed in many tissues. TLRs are associated with the innate mature 
response, by activating dendritic cells, monocytes and macrophages [184–186]. 
TLR-2 can recognize mycobacteria and Gramm positive bacteria, while TLR-4 
are activated by the inflammatory molecule, lipopolysaccharide (LPS) [187]. 
The role of the HA-TLR binding is size-dependent: HA of high molecular weight 
induces the expression of kinases, which interrupt TLR signalling, while 
oligosaccharides induce TLR signalling regulated by NF-kB and AP1 pathways, 
which are activated by chemokines and cytokines [188]. 
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Figure 1. 5. Signalling cascade of the most important hyaluronan receptors and their role in cell and 
tissue functions [188]. 
 
1.2.5.3 Size-dependent biological roles of HA 
HA presents different biological functions depending on its size, even HA of high 
(up to 400 kDa) and low (0.2-400 kDa) molecular weights can regulate opposite 
signalling pathways and functions [189]. HA catabolism is regulated by the 
synthesis of new HA and degradation of the existing one. All the processes 
involved in the catabolism of HA are regulated by HYALs activity, and HA 
receptors play an important role in maintaining equilibrium between the low and 
high molecular weight forms, and as a consequence, catabolism regulates 
biological functions where HA is implied. Under certain pathologies synthesis of 
HA, enzymatic activity of HYALs, endocytosis of HA and presence of ROS are 
increased, and can alter this equilibrium. In addition, the presence of abnormal 
sizes and concentration of HA in the blood stream or tissues may act as indicator 
of certain diseases.  
Focusing on physical properties, HA of high molecular weight grants tissues 
lubrication, hydration and shock absorption, these functions are especially 
important in joints. Moreover, HA of high molecular weight shows the ability to 
bind molecules including cytoskeletal proteins and cell receptors. Thus, it acts as 
a structural molecule of the ECM, clusters receptors and gathers proteins on cell 
membranes, modulating several signalling pathways. Biggest chains have a 
protective effect on tissues against damages since it possesses anti-
inflammatory and immunosuppressive effects. These chains also cover receptors 
from cell surfaces impeding the activation. In wound healing, HA of high 
molecular weight favours the access for removing debris and bacteria and binding 
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to fibrinogen. In cancer, it may suppress tumour progression because of its anti-
angiogenic effect and inhibition of migration. However, high molecular weight 
chains can impede regeneration of certain tissues, for example in cartilage it 
suppresses transcription factors such as collagen type II, implied in tissue repair. 
On the other hand, HA fragments shows in many cases opposite effect to high 
molecular weight chains. The HA of low molecular weight displaces bigger HA 
chains from cell surfaces, destabilizing the native structures of the ECM and 
providing accessibility of stimuli to receptors on cell membrane. In addition, 
fragment sizes have specific responses in signalling pathways; receptor-bindings 
domains of HA have been observed in large chains (around 400 kDa) and in 
oligosaccharides containing only four saccharide units. In general, chains and 
oligosaccharides of low molecular weight up-regulates cellular functions including 
proliferation, adhesion, migration, angiogenesis and the immune response 
[189,190]. Thus, HA fragments have an important role in the inflammatory 
processes since they increase chemokine and cytokine production leading to the 
activation of macrophages and dendritic cells. In wound healing, HA of low 
molecular weight is responsible for the inflammatory stage and subsequent 
angiogenesis and fibroblast proliferation involved in the regenerative process. 
Moreover, HA fragments play important roles in the regeneration of other tissues, 
such as cartilage regeneration. However, HA oligosaccharides increase cancer 
progression because of their ability to cleave the receptor CD44, promoting cell 
proliferation (tumorogenesis) and migration (metastasis). In addition, HA 
fragments regulate other processes implied in cancer including stimulation of 
angiogenesis and suppression of apoptosis. 
 
1.2.6 Chemical modifications 
HA directly obtained from bacteria or found in animal tissues constitutes a GAG 
of high molecular weight. Despite the high molecular weight, therapeutic 
applications using HA are limited because of its poor mechanical properties, high 
solubility, fast degradation rate in physiological environment and poor adhesion 
with most cell types. Therefore, to expand the applications of HA for medical 
purposes, several chemical modifications have been studied in order to obtain 
insoluble derivatives and HA-based hydrogels. HA modifications are intended to 
improve its properties obtaining mechanically stable artificial ECMs, but retaining 
some biological properties of natural HA. The polyanionic nature and 
conformation in solution of HA determine the possibilities and conditions to 
perform chemical modifications. Therefore, the HA molecule shows two principal 
targets for chemical modifications: the carboxyl group from the GLcA unit and the 
unique primary hydroxyl from the GLcNAc unit. 
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Chemical modifications of HA are aimed to obtain insoluble derivatives and 
crosslinked hydrogels from the direct crosslinking of native HA molecules or 
derivatives thereof. For these purposes, reactions are usually carried out in 
aqueous solutions. However, in these conditions, several reactions are pH-
dependent and some reagents must be protonated. Thus, reactions in aqueous 
solutions present a difficult control of the degree of substitution and a high batch-
to-batch variability, even extreme acidic or basic solutions are required inducing 
hydrolysis of HA chains [191]. For these reasons, several authors have 
investigated chemical modifications of HA in organic solvents, principally 
dimethylformamide (DMF) and dimethyl sulfoxide (DMSO). However, native HA 
associated with Na+ cations is insoluble in organic solvents and it requires some 
previous modifications, including reduction of its high molecular weight and/or 
conversion into its acidic form or tetrabutylammonium (TBA) salt. 
 
1.2.6.1 Chemical modifications by the carboxyl group 
 Amidation employing carbodiimides 
The modification of HA with carbodiimides is commonly employed to functionalize 
HA chains since these reactions are relatively simple and it can be carry out into 
aqueous solutions. Carbodiimides modification is principally performed 
employing 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC), which 
activates HA and, in the presence of an amine,  an amino-acid ester is generated  
[192]. Therefore, EDC amidations consist in a two-step reaction; first EDC 
activates the carboxyl groups of HA chains forming an intermediate product (O-
acyl-isourea) and, subsequently the amine or diamine produce a nucleophilic 
attack on the intermediate product leading to the amino-acid ester bond formation 
by an addition-elimination reaction. The reaction must be conducted at a pH 
range 3.5-6 because of the carboxyl group of HA is half hydrolysed and EDC 
protonation requires low pH. However, the optimal pH for nucleophilic attack is 
alkaline one since amines require high pH to be deprotonated enough. Moreover, 
O-acyl-isourea intermediate have a high reactivity and forms a by-product with 
water (N-acyl-urea). Thus, the requirement of different optimal pH values for each 
step and the formation of a secondary product constitute a difficult control on the 
reaction and low degrees of substitution (less than 40 %) [193]. 
In order to improve reactions by carbodiimides, researchers have developed 
some variations in the synthesis. Certain amines, such as 4-vinylaniline, show a 
less basic pKa value, and are more protonated at lower pH avoiding by-products 
formation in the nucleophilic attack [194]. Moreover, Biscarbodiimides can be 
employed as reagent itself to generate crosslinked hydrogels by stable N-acyl-
urea bonds. On the other hand, higher degrees of functionalization of HA chains, 
up to 55 %, may be reached replacing diamines by dihydrazides and 
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sulphohydrazides because of their lower pKa values (2-3) [195]. In addition, the 
intermediate can be stabilized employing substances such as N-
hydroxysuccinimide (NHS) [196] or 1-hydroxybenzotriazole (HOBt) [197], 
accomplishing greater reactivity toward the amine. However, the highest degrees 
of substitution, between 60-80 %, in HA amidation using carbodiimides have been 
achieved by performing the reaction in organic solvents, either employing HA into 
its acidic form and TBA salts of HA [198]. 
Despite the disadvantages found employing carbodiimide in amidation reactions, 
they are widely used because of the possibilities to perform them in aqueous 
solutions and the lack of excessive cleavage of HA chains. Particularly, 
dihydrazides, such as adipic dihydrazide (ADH), are commonly employed to 
obtain functionalized groups for further modifications. This system has been 
investigated for coupling other polymers in HA chains, such as PEG [199], and 
drugs for cancer treatment including Taxol [200] and doxorubicin [201]. Moreover, 
HA functionalized with dihydrazides has been employed to develop crosslinked 
hydrogels [195]. 
 
 Amidation using halogenated compounds 
Amidation of HA chains can be performed employing highly reactive compounds 
in order to activate carboxyl, including halogenated compounds. For these 
purposes, the most studied compound is the 2-chloro-1-methylpyridinium iodide 
(CMPI), whose reaction is performed in organic media such as DMF and DMSO 
to avoid CMPI hydrolysis [202]. The use of organic solvents requires to convert 
native HA in its TBA salt. CMPI acts as activator of carboxyl groups and produces 
a pyridinium intermediate by releasing Cl-, whose charge is neutralized by TBA 
ions. This amidation have been widely employed to obtain HA hydrogels by 
crosslinking the activated HA with diamines, which act to lead the nucleophilic 
attack. This crosslinking reaction improves the efficiency and it reaches degrees 
of substitution of 100 %, accomplishing rigid hydrogels with lower absorption of 
water. When no diamines are employed in the reaction, activated carboxylic 
groups of HA may react with its own hydroxyls giving an auto-crosslinked 
hydrogel by the formation of ester bonds between chains [203]. The advantage 
of these auto-crosslinked hydrogels is the lack of intermediate molecules, 
ensuring that hydrogels are formed only by native molecules. Thus, the 
degradation products of auto-crosslinked hydrogels by this method avoid 
undesirable products upon degradation [204]. 
In order to avoid the employment of organic solvents for obtaining HA derivatives 
by amidation, a novel halogenated compound have been studied, 2-chloro-
dimethoxy-1,3,5-triazine (CDMT) [205]. This compound activates the carboxylic 
groups of native HA chains by performing the reaction in mixtures of water and 
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acetonitrile, and the released Cl- are neutralized by adding N-
methylmorpholinium (NMM). The HA intermediate has been reacted with amines, 
including 7-amino-4-methylcoumarin and propylamine, obtaining degrees of 
substitution between 3 and 20 %, respectively. This novel method has been 
employed to obtain functionalized HA chains but not crosslinked hydrogels. 
However, the authors suggest that hydrogels and higher degrees of substitution 
could be reached. 
 
 Amidation with 1,1’-carbonyldiimidazole 
This method patented by Fidia consists in the activation of carboxyl groups from 
HA-TBA salt employing 1,1’-carbonyldiimidazole (CDI) in organic solvents [206]. 
The imidazole intermediate is more stable compared with previous described 
compounds, but its reaction time is longer. However, the reaction products of this 
amidation (CO2 and midazole) show not toxicity. This amidation has been 
investigated to graft poly(N-isopropylacrylamide) [207] and lipoic acid [208] into 
HA chains, obtaining thermoresponsive and more degradation-resistant 
hydrogels. Therefore, HA activated with 1,1’-carbonyldiimidazole may be 
interesting for applications such as drug and cell delivery. 
 
 Esterification by alkylation 
Esterification of HA chains using alkyl halides allows the synthesis of amphiphilic 
HA derivatives from HA-TBA salts in organic chains.  HA esterified with dodecyl 
and octadecyl chains employing alkyl bromides has been studied suggesting 
potential uses in viscosupplementation [209]. This reaction allows to modulate 
the degree of esterification of HA chains giving solutions with similar rheological 
properties to healthy synovial fluid because of the formation of transient 
hydrophobic interactions. Moreover, esterification by alkylation may be 
accomplished by activating carboxylic groups of HA with tosylate compounds, 
including PEG-tosylate to grafting PEG chains into HA [210]. However, these 
alkylation methods are not able to generate crosslinked HA hydrogels. For this 
reason, ditosylated compounds are employed to form crosslinks between HA 
chains, such as tetraethylene glycol ditosylate [210]. 
The firm Fidia (Italy) patented the esterification of HA using halides and alcohols 
(aliphatic, araliphatic, cyclo-aliphatic, aromatic, cyclic and heterocyclic series) 
under the trade name of HYAFF [211]. Fidia has developed a wide range of HA 
esterified derivatives with different properties by varying the degree of 
substitution and the employed alcohol/halide. These derivatives are water 
insoluble and maintain some biological properties of native HA with several 
improvements, such as longer degradation times and handling (they can be 
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extruded and employed to fabricate scaffolds). HYAFF materials are employed 
for wound healing and are hopeful for other biomedical applications. 
 
 Esterification using epoxides 
Epoxides, particularly glycidyl methacrylate (GM), have been employed to obtain 
functionalized HA with glycidyl methacrylate groups (HAGM) with the aim of 
incorporating double bonds. GM reacts with carboxyl groups of HA by ring 
opening and with hydroxyl ones by transesterification, but the reaction by 
hydroxyls is reversible and carboxyl esterification is predominant [212]. The 
reaction is usually performed in aqueous media employing excess of GM and 
triethylamine as a catalyst, but the degree of substitution is low and shows a high 
batch-to-batch variability. Therefore, several researchers have performed the 
reaction in organic solvents using HA-TBA salt with GM, obtaining higher degrees 
of substitution and a more controllable reaction [213]. Incorporating double bonds 
into HA chains, made it available for further polymerization in order to obtain 
blended hydrogels with improved properties [214] and photocrosslinked 
hydrogels for in situ polymerization [213]. Moreover, HA functionalized with GM 
can be employed to graft other polymers for drug delivery [214] and attach HA on 
biomedical polymeric devices to avoid platelet adhesion [215]. 
 
 Hydrogels by UGI’s and Passerini’s condensations 
In the Passerini condensation a carbonyl and an isocyanide are condensed 
forming a protonated intermediate, which reacts with the carboxylic groups 
yielding, after rearrangement and translocations, an ester bond with the acid. In 
the UGI’s reaction is included an amine which condenses fist with the carbonyl 
forming an imine, and the resulting compound consists in the carboxylic acid 
chain linked by amide bonds [216]. UGI’s reactions to form HA hydrogels were 
carried out in acidic media employing formaldehyde, cyclohexylisocyamide and 
a diamine (lysine methyl ester or 1,5-diaminopentane), this mixture of reagents 
allows crosslink HA chains by the carboxylic groups [216,217]. This process 
accomplishes degrees of crosslinking from 3 to 10 % showing different properties 
on swelling and mechanical properties, but further investigations are required in 
order to address a full knowledge of thee hydrogels. 
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1.2.6.2 Chemical modifications by the hydroxyl group 
 Ether formation using epoxides 
The reaction between epoxides and the HA hydroxyl groups is usually carried out 
in aqueous media under controlled pH giving an ether bond. This etherification 
consists in the ring opening of the epoxy group forming an electrophile 
intermediate which reacts with the hydrolysed anionic species into the HA chain. 
Epoxides can also react with both, carboxyl or hydroxyl groups of HA chains, 
depending on the pH of the reaction media [218]. Thus, at pH values up to 10 
(pKa of hydroxyl groups), HA hydroxyl groups are deprotonated and the reaction 
forming ether bonds is predominant, whereas lower pH values generate, 
principally, esterification by the carboxyl groups. Despite the reactivity of both HA 
groups with epoxides, etherification is carried out commonly under alkaline 
conditions and heating forming the bond by the hydroxyls groups, principally, 
using bisepoxides to obtain crosslinked HA hydrogels. Laurent et al. patented the 
first HA hydrogel ever in 1964 employing 1,2,3,4-diepoxybutane leading to 
explore new systems in the subsequent years. Thus, several bisepoxides have 
been studied for HA hydrogels, including 1,4-butanediol diglycidyl ether (BDDE), 
Ethyleneglycol diglycidyl ether and polyglycerol, polyglycidylether, 
epichlorohydrin and 1,2,7,8-diepoxyoctane. BDDE chemistry is habitually 
employed for HA hydrogels with some therapeutic and cosmetic applications, 
including commercially available products such as Restylane® (Medicis Corp., 
AZ), Perlane® and Juvederm™ [219]. These products are employed as dermal 
fillers and have potential uses in other biomedical applications. 
 
 Ether formation with divinyl sulfone 
Divinyl sulfone (DVS) is a chemical broadly employed to give HA crosslinked 
hydrogels [220,221]. The reaction is performed in alkaline conditions, typically 
with pH up 13, giving a bis-ethyl sulfone crosslink between the hydroxyls groups 
of HA chains (see Figure 1. 6). The etherification by DVS consists in a Michael 
addition, and alkaline medium is needed to deprotonate hydroxyls groups of HA 
and provide a source of OH-. In alkaline media, DVS and deprotonated hydroxyls 
from HA react forming two ether linkages leading to the HA-DVS crosslinked 
hydrogel (Hylan). Unlike epoxides, this reaction occurs in few hours in alkaline 
media and at room temperature avoiding excessive cleavage of HA chains and 
undesirable products. On the other hand, despite the high toxicity of DVS reagent, 
HA-DVS hydrogels have shown not toxic degrading products [222]. The first HA-
DVS hydrogel was patented by Balazs et al. [223] and since then, other authors 
have studied HA-DVS hydrogels. Hylans were the first HA-based hydrogels 
approved by the FDA for biomedical applications, concretely for dermal filling 
treatments. Balazs fabricated this first hydrogel in the early 1980s and, currently, 
Introduction 
 
- 57 - 
 
it is commercialized under the trade name of Hylaform® (Genzyme, NJ). In the 
recent years, other hylans have been developed for several biomedical 
applications, including ophthalmic viscosurgery (Hylashield® (Genzyme, NJ)), 
lubrication for knee joint (Synvisc®) and anti-adhesion in surgery (Sepragel®) 
[219,224]. In addition, DVS crosslinking have been employed with the aim to 
obtain HA/collagen hydrogels, resulting in non-cytotoxic effects and suggesting 
further use as dermal filler [225]. DVS is usually employed to crosslink HA 
molecules, whereas DVS and HA reaction can be stopped before completion 
obtaining unreacted vinyl groups, which are able to further conjugation of drugs 
and polymeric chains [226]. 
 
 
Figure 1. 6. Crosslinking reaction of divinyl sulfone with hyaluronan. 
 
 Ether formation using ethylene sulphide 
A more recent method has been investigated in order to include ether bonds 
within the HA hydroxyls groups using ethylene sulphide as reagent [227]. The 
reaction is performed in alkaline media (pH 8.5-10) with further addition of 
dithiothreitol (DTT) to reduce any residual disulphide bond. The ethylene sulphide 
bond is opened by the action of protons from hydroxyls groups, giving a cationic 
molecule which performs an electrophilic attack into the deprotonated hydroxyls. 
As a result, the reaction generates HA chains with sulphide functional groups 
without crosslinking. The incorporation of sulphide groups reduces HA cleavage 
and shows a protective effect on chondrocytes under ROS, and this material may 
be also employed for the replacement of synovial fluid. 
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 Hemiacetal formation employing glutaraldehyde   
Glutaraldehyde can be employed to form crosslinks between the hydroxyls 
groups of HA, leading hemiacetal bonds. The reaction may be performed in 
acetone-water mixtures or pure water under acidic conditions (pH=2) because of 
protons act as activators and catalysts [228,229]. In this reaction, protons from 
media bond to oxygen atoms from glutaraldehyde producing carbocations, which 
produces an electrophilic attack on HA hydroxyls and a hemiacetal crosslink is 
formed. However, the remaining glutaraldehyde is hard to remove and the 
hemiacetal crosslinks are unstable and can be hydrolysed in acidic media to its 
original products, generating cytotoxic and immunogenic responses [221]. In 
order to reduce glutaraldehyde residua it may be introduced in its vapour phase, 
avoiding unreacted reagents [230]. 
 
 Carbamate formation  
Cyanogen bromide has been employed to synthetize HA derivatives from its 
native sodium salt [231]. The reaction is performed in aqueous media at pH 10 
obtaining high degrees of substitution with an excess of reagents in only one 
hour. Thus, the cyanogen bromide reacts with the HA hydroxyls groups giving an 
activated HA cyanate ester, which is able to react with nucleophilic reagents such 
as amines. The reaction with amines also gives an HA carbamate product and 
an HA isourea by-product. HA derivatives with a broad range of tuneable 
properties can be obtained by varying the amount of reagents and the length of 
the amine chains [232]. 
 
 Ester formation 
Ester formation onto the hydroxyls groups of HA has been achieved employing 
several methods of synthesis: activated compounds such as acyl-chloride 
carboxylate compounds in organic solvents and anhydrides, such as octenyl 
succinic and methacrylic anhydrides, in aqueous media under alkaline conditions. 
The use of acyl-chloride carboxylate compounds was first reported with the aim 
to graft poly(lactic) oligomers onto the HA chains [233]. The compound to be 
grafted is previously activated by chloroacylation and the grafting is performed in 
DMSO by converting HA to its cetyltrimethylammonium bromide (CTA) salt.  
Toemmeraas and Eenschooten patented a novel method to obtain HA derivatives 
forming ester bonds using aryl/alkyl succinic anhydrides (ASAs) in aqueous 
media at pH 9 [234]. ASA-HA derivatives have been synthesized using octenyl 
and phenyl succinic anhydrides, reaching degrees of substitution up 40 % [235]. 
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These ASA-HA derivatives have demonstrated resistance against reactive 
oxygen species aiming its use for protecting organs and tissues [236]. 
Methacrylic anhydride (MA) has been widely used to graft unsaturated groups 
onto the HA chains by the formation of an ester bond (see Figure 1. 7 A).  Smeds 
et al. was the first to synthetize this hydrogel, since then, several authors have 
employed this system [237]. The reaction is usually carried out in alkaline 
aqueous media at pH 9-12 in a cold ice bath by adding an excess of MA, which 
reacts with HA hydroxyls by transesterification. The synthesis of methacrylated 
hyaluronan (MeHA) shows a difficult control because of the formation of 
methacrylic acid as by-product and the low degree of substitution reached. 
However, even low substituted MeHA may be further employed to perform photo-
crosslinked networks by free radical polymerization (see Figure 1. 7). The 
properties of MeHA networks may be tailored by varying native HA molecular 
weight, degree of substitution of the synthesized MeHA and its concentration in 
the prepolymer solution [73,238]. Thus, MeHA hydrogels have been obtained 
with volumetric swelling ratios from 8 to 48, compressive moduli from 2 to 100 
kPa and degradation times, in the presence of hyaluronidase, from a few hours 
to over one month. MeHA-based networks have been combined with collagen in 
order to obtain semi-interpenetrated networks (semi-IPNs) improving cell 
adhesion and mechanical properties [239]. The copolymerization of MeHA and 
poly(amino acids) leads to networks with longer degradation times than MeHA-
based alone, and makes them able for drug release because of its behaviour in 
a pH-dependent manner [240]. Moreover, degradation times can be controlled by 
copolymerization of MeHA with hydrolytically degradable spacers including lactic 
acid and ε-caprolactone [241]. The MeHA product has been used to generate 
beads for chondrocyte encapsulation, suggesting future uses as injectable cell 
delivery vehicles [242]. Despite properties and in vitro cultures of MeHA networks 
have been researched by several authors, only few in vivo studies have been 
published. Thus, one in vivo study in rabbits with corneal laceration has 
demonstrated that MeHA hydrogels lack of excessive inflammation and permit 
the proliferation of stromal cells [243]. 
 
Introduction 
 
- 60 - 
 
 
Figure 1. 7. Synthesis of methacrylated hyaluronan (MeHA) (A) and further polymerization (B). 
 
1.2.6.3 Other modifications 
 Modification by the N-acetyl group 
The reactions by the N-acetyl group from N- acetyl- ᴅ-glucosamine unit of HA 
require its previous deacetylation. Thus, the deacetylation of N-acetyl group gives 
an amino group, which is able to react with electrophilic substances. The first 
method to carry out N-deacetylation included an aggressive reaction such as 
degradation using hydrazine sulphate over long times and at high temperatures 
[206]. However, this method produces a reduction of molecular weight, and milder 
treatments have thereby reported by reducing hydrazinolosis times and addition 
of protecting functional groups [193,244] and employing the N-deacetylase 
enzyme [161]. Subsequently, deacetylated HA is usually reacted with acids to 
form amide bonds. The amidation of deacetylated HA has been employed to 
perform HA crosslinked hydrogels using glutaraldehyde [244], alginate obtaining 
copolymers [245], and UGI’s reagents giving auto-crosslinked HA hydrogels 
[217]. 
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 Oxidation 
Oxidation of hydroxyls and reducing end modifications produce reactive 
aldehydes, which are able for further modifications such as peptide attachment 
and crosslinking formation. The oxidation is usually performed using sodium 
periodate in HA aqueous solutions. The oxidized HA has been further employed 
to obtain in situ crosslinked hydrogels [246] and composites containing HA 
derivatives [247] other GAGs, such as heparin [248], and attached HA-peptides 
[249]. Moreover, HA derivatives have been oxidized to perform auto-crosslinked 
hydrogels, including thiolated HA oxidized using air, and HA-tyramine by adding 
horse-radish peroxidase (HRP) and peroxides [250,251]. However, this method 
can produce chain cleavage with reduction of molecular weight and undesirable 
immunogenic groups. On the other hand, reducing end modification is unexplored 
and limited to low molecular weights by the lack of large amounts of reducing 
ends in the biggest chains. This method has been employed to graft PLL onto HA 
chains by reductive amination between the reducing end of HA and the ε-amino 
groups of PLL employing sodium borate such as oxidizer agent [252]. 
 
 Hyaluronan complexation 
HA has a polyanionic nature and its ability to form hydrogen bonds making it 
useful to form complexes with cationic and other substances. Cations such as 
Fe+3 may chelate HA chains forming highly viscous semi-stable gels. Thus, The 
FDA approved in 2001 a novel HA hydrogel under the name of Intergel® 
(LifeCore, MN) obtained by chelation with ferric hydroxide. This hydrogel was 
employed to prevent adhesions during gynaecological surgeries [253]. However, 
the FDA is now urging customers to stop using this product because of the 
apparition of late post-operative pain by foreign body reaction. Moreover, HA has 
been employed to form complexes with other natural polysaccharides such as 
chitosan [254–257], which shows a polycationic structure with a large amount of 
hydroxyl groups leading to the formation of hydrogen bonds and electrostatic 
interactions between both polymers. Complexes composed of HA and chitosan 
have been manufactured by extrusion and layer-by-layer self-assembly 
techniques obtaining beds, films and membranes for drug delivery and tissue 
engineering purposes. On the other hand, HA may be complexed with 
substances, including DNA and RNA for gene delivery [258], BMP-2 for growth 
factor release in bone regeneration [259] and as a drug carrier [260]. 
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1.2.7 Medical applications of hyaluronan and its derivatives 
HA was first employed in burn and ulcer cares in 1960 and, at present, in a wide 
range of medical and cosmetic applications. As has been mentioned, HA is an 
important constituent of the ECM of several tissues granting the safety for 
therapeutic purposes because of its lack of excessive immunological response, 
compatibility and non-adherence with the surrounding host tissue. Moreover, HA 
interactions with some types of cells, such as chondrocytes and NPCs, regulating 
its functions. In addition, HA solutions show unique physicochemical properties 
because of its high molecular weight and polyanionic nature encouraging their 
use in some biomedical applications. From the viewpoint of the therapeutic use, 
the most important physicochemical properties of solutions containing high 
molecular weight HA include their ability to occupy large hydrated volumes and 
swelling. The viscoelastic properties of HA solutions conferring them applications 
such as filling spaces and protecting damaged tissues. In this direction, Balazs 
classified the therapeutic applications of HA based upon its viscoelastic 
properties: viscosurgery, viscosupplementation, viscoaugmentation, 
viscoprotection and viscoseparation. Nowadays, novel biomedical uses of HA are 
emerging, for example the preparation of drug and other carriers, and the 
fabrication of biomaterials for tissue engineering [261]. 
The first application of HA formulations on medicine were first performed in 1960 
and 1970 by clinical trials in the ophthalmic surgery for corneal transplantation, 
providing protection to eye during the manipulation. This special surgery 
methodology is known as viscosurgery, and it is based on the principle that the 
vitreous humour of the eye is a viscoelastic fluid, whose major component is HA. 
Posterior findings provided highly purified HA leading to the first commercial 
product for viscosurgery, Healon® (Biotrics, MA), which are formulated as 
viscous solutions. Due to the promising results of this product, the use of HA was 
investigated for other ophthalmic surgeries, such as cataract ones, even it was 
employed in arthroscopic surgery to protect tissues and avoid their water loss. 
Since then, new Healon® formulations and products were launched into the 
market with several HA molecular sizes. In order to obtain improvements in 
mechanical properties and long-term persistence, HA was mixed with other 
GAGs such as chondroitin sulphate, Viscoat (Alcon Labs, TX), and with 
hydroxypropylmethyl cellulose [262]. The problem of the current HA formulations 
is low residence time, and new HA based materials are also investigated, 
including crosslinked HA. The first crosslinking agents developed in preliminary 
studies of viscosurgery were DVS and formaldehyde, but the lack of structural 
coherence in these materials presents a problem [263]. Recently, new promising 
crosslinked hydrogels have been studied, including oxidized HA crosslinked with 
ADH [264]. Investigations are focused on optimizing crosslinked HA because of 
its better mechanical properties and long-term stability. 
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Viscosupplementation employing HA is useful for orthopaedic surgery and 
rheumatology to replace damaged synovial fluid in joints affected by arthritis.  
Joints contain synovial fluid, which is composed of high molecular weight HA, 
between 2 and 7 MDa, giving lack of frictions and pain during movement. A 
disorder, such as arthritis, causes the degradation of the HA contained in the 
synovial fluid; its molecular weight decreases by the effect of neutrophils 
degenerating its viscoelastic properties and leading to chronic inflammation [265]. 
These disorders can be treated employing high molecular weight and 
concentrated HA, which is also required to obtain similar viscoelastic properties 
of the healthy synovial fluid. Viscosupplementation employing HA was initiated in 
1989 for the treatment of arthritis, and it is based on intra-articular injections of 
different HA formulations. Commonly, HA with high molecular weight, in the range 
of original one in the synovial fluid, was employed including different Healon® 
formulation (Pfizer, NY). However, formulations employing low molecular weight 
HA (about 1MDa) are available, for example Hyalgan® (Fidia, Italy) and Artzal® 
(Seikagaku, Japan). Thus, low molecular weight HA have been demonstrated 
improvements on reducing pain without long-term effect [266]. In addition, 
bifunctional crosslinked HA has been formulated using epichlorohydrin obtaining 
hydrogels with high molecular weight (around 6 MDa), Synvisc® (Genzyme, MA). 
Injections of HA lead to some benefits in the patients; restoration of the 
viscoelastic properties of the synovial fluid, stimulation of chondrocyte 
proliferation and endogenous HA synthesis, moderation of inflammation due to 
the regulation of pro-inflammatory species, and analgesic effect [267]. 
The high hydrodynamic volume and water absorption of HA have been exploited 
for biomedical applications, which are referred as viscoaugmentation therapies. 
In viscoaugmentation, space filling of some tissues is required such as the filling 
of wrinkles and scars in cosmetics [268], Otolaryngology [269] and urinary 
incontinence [270]. Despite the appropriate use of HA for these purposes, its 
residence time is short and it is absorbed in a few days when is injected in 
solution. For this reason, researchers have investigated HA modifications to 
obtain crosslinked HA gels since 1960. The first crosslinked product surged in 
1980 and it consisted in a DVS crosslinked HA hydrogel. Nowadays, they are a 
wide range of crosslinked HA gels in the market and approved by the FDA for 
dermal filling, crosslinked with DVS, Hylaform® (Genezyme Biosurgery Inc., MA), 
and 1,4-butanediol diglycidyl ether,  Restylane® (Medicis Corp., AZ). These 
commercial products have demonstrated good results and improvements in 
residence time respect to collagen materials in cosmetics [271]. Clinical trials 
employing HA gels for glottal fold insufficiency have been performed in recent 
years with promising results and longer residence times than collagen gels [272]. 
Despite the efficacy and safe of deep vocal fold injections of HA gels, other 
studies are necessary because of superficial applications have shown problems 
derived from its migration form the implant site [273]. HA solutions containing 
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dextranomers and formulated as injections for urinary incontinence have been 
approved by the FDA; for clinical trials, Zuidex® (Q-med, NJ) and clinical uses, 
Deflux® (Salix Pharmaceuticals, NC) [274,275]. 
Other therapeutic applications of HA solutions and gels are focused on wound 
healing and tissue repair. The aim to employ HA in these fields is due to its ability 
to protect tissue surfaces from dryness or environmental agents, viscoprotection, 
and prevent adhesions of connective tissue and glial scar formation produced in 
surgical procedures or injuries, viscoseparation. Moreover, the potential uses of 
HA in wound healing and tissue repair are due to its anti-inflammatory properties, 
in high molecular weight formulations, and the angiogenic properties of its 
degrading products [167].  In recent years, HA has been present in a few clinical 
studies to determine its benefits in the treatment of ulcers, chronic wound and 
burns. For these purposes, authors have been employed several HA 
formulations, such as high molecular weight HA solutions [276], solutions 
containing bioactive molecules such as Hylactive® (Promedic, Spain) [125], and 
esterified HA such as Hyaff (Fidia, Italy) [277]. Despite the improvements found 
when HA is applied for wound healing, further studies are necessary to 
corroborate these results. 
 
1.2.8 Engineering of hyaluronan-based scaffolds 
At present, they are a few HA-based solutions and derivatives approved by the 
FDA and this fact has supposed the interest of several researchers on exploiting 
it for other biomedical applications. The current products of HA in the market are 
limited to HA solutions and a few derivatives and crosslinked hydrogels. However, 
in the last years researchers are interested on obtaining novel HA derivatives, 
hydrogels and materials with ECM-mimic structures (scaffolds) for a broad range 
of tissue engineering applications. Moreover, the use of HA to fabricate scaffolds 
shows many advantages because of its chemical structure, properties and 
presence in several tissues [278]. HA is a natural biodegradable material which 
is in many tissues, even it is the major component of connective tissue, playing 
important roles in cell behaviour, and it improves the healing because of its 
presence in all the steps of the wound healing process. Due to its chemical and 
conformational structure, HA can be easily modified to incorporate functional 
groups, active molecules and crosslinks. The HA molecule has low affinity for 
non-specific proteins, reducing scar formations and inflammation, but it shows 
domains for specific interactions with cell receptors involved in cell behaviour 
(CD44, RHAMM, etc.). The ability of HA to form hydrated domains, make it 
adequate for cell infiltration and nutrient transport. Thus, in this section are 
compiled the different methods to obtain HA-based materials, with special 
attention those where scaffolds of HA and derivatives thereof are obtained. 
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1.2.8.1 Phase separation 
Fabrication of scaffolds by phase separation consists on a thermodynamic 
demixing of a polymer solution into two phases: polymer-rich and polymer-poor 
phase. Demixing can be accomplished applying a non-solvent or chemicals, 
which form an insoluble phase, and cooling the solution below its freezing point. 
Then, the solvents are extracted by several methods including extraction, 
evaporation and sublimation obtaining a solidified structure of polymer from the 
polymer-rich phase. In the case of HA, its intrinsic ability to absorb large amounts 
of water is exploited. Therefore, hydrogels and scaffolds of HA by phase 
separation are usually performed from HA aqueous solutions without employing 
other solvents. This method is known as freeze-extraction and it is based on 
freezing HA solutions and a subsequent sublimation. The structure is 
accomplished because of the growing ice nuclei through the polymer phase, and 
the further sublimation allows the formation of a solidified HA structure. Pore size 
and interconnectivity can be controlled varying ice nuclei formation applying 
different freezing temperatures and including salts, obtaining pore diameters 
below 200 µm [278]. However, pore shapes are also influenced by HA 
concentration, molecular weight and composition (using native or HA derivative). 
This method allows obtaining 3D macrostructures with interconnected pores, but 
the disadvantage is the limited control of porosity. Manufacture of macroporous 
crosslinked HA scaffolds by freeze-drying have been widely explored, and 
several crosslinking agents have been employed, including glutaraldehyde, 
carbodiimide activation and DVS, resulting in differences in mechanical 
properties and swelling [279]. Despite the mentioned chemistries are the most 
employed to performance freeze-dried hydrogels, though, other ones have been 
studied including oxidized HA, crosslinking by epichlorohydrin, using derivatives 
such as methacrylated HA…  
Several authors have focused their attention on obtaining composites of HA 
crosslinked with other polysaccharides and structural proteins, principally using 
carbodiimides. For these purposes, collagen has been widely crosslinked 
together HA by EDC-NHS chemistry, obtaining hydrogels with pores ranging from 
100 to 200 µm with improved mechanical properties and longer degradation times 
[280,281]. In order to obtain interpenetrating polymer networks (IPNs) of 
collagen/HA, collagen containing HAGM derivative has been crosslinked by 
carbodiimide reaction (semi-IPNs) and HAGM has been subsequently 
photopolymerized (full-IPNs) [282]. In addition, the collagen derivative, gelatine, 
has been linked to HA performing uniaxial porous structures around 150 µm by 
controlling the freezing gradient, providing hydrogels excellent mechanical 
properties (elastic module until 2.9 MPa) [283]. Chitosan and agarose are both 
polysaccharides employed on obtaining composite scaffolds in combination with 
HA resulting in scaffolds with pore sizes between 100 and 200 µm, improved 
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mechanical properties, longer degradation times and enhanced cell adhesion 
[284,285]. 
The principal limitation using HA-based scaffolds is the lack of binding sites for 
cell adhesion. For this reason, several authors have included proteins and 
sequences of peptides into HA chains by different methods.  Grafting peptides is 
usually accomplished by activating HA scaffolds with CDI, thereby coupling 
proteins such as LN [286] and sequences of peptides including IKVAV [85] and 
RGD [287]. However, other methodologies couple molecules and fabricate HA 
derivatives-scaffolds simultaneously applying different chemistries, this system 
has also been employed on including fibronectin (FN) fragments [288], poly-ᴅ-
lysine (PDL) [289] and sequences of peptides such as RGD [290]. In addition to 
the incorporation of peptides and proteins, other molecules have been linked into 
HA scaffolds, including the antibody anti-Nogo-66 [291], growth factors [292] and 
DNA [293]. 
 
1.2.8.2 Particle leaching and templating 
Unlike phase separation methods, the use of particle leaching and templates for 
scaffold fabrication allows the control over pore shape and porosity varying the 
porogen size and its relation respect to the HA solution, respectively. Particle 
leaching is based on mixing a polymer solution with porogen and subsequent 
removal of the solvent by different methods; whereas the use of templates implies 
a previous sintering of the porogen and the polymeric solution is introduced 
between the interstices of the resulting template.  Currently, particle leaching is 
widely employed to fabricate porous scaffolds from a broad range of polymers, 
nevertheless this method is unexplored to develop structured HA hydrogels. HA-
based scaffolds by particle leaching are usually prepared employing salts as 
porogen agents [294,295]. Despite salt leaching allows the control over pore 
sizes, the irregular shape of the particles leads to low porosities (around 70 %) 
and low connectivity. Similarly to the use of salt, ice particulate leaching has been 
employed as porogen obtaining similar results, because of their similar 
morphology [296]. The lack of high connectivity has aimed several authors to use 
templates, such as sintered poly(methyl methacrylate) (PMMA) beads by heating 
[297] or chemical solvents [298]. 
Regarding employed chemistries on HA-based scaffolds by particulate and 
template leaching, different crosslinking methods have been developed including 
EDC chemistry [296], incorporation of reactive acrylic groups [297] and employing 
benzyl ester derivatives such as HYAFF® [295]. Moreover, HA has been 
crosslinked with protein-derived molecules such as gelatine by EDC chemistry 
leading to composites with enhanced mechanical properties (elastic module 
around 5 MPa) [296]. In order to elicit bioactive scaffolds, several molecules have 
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been incorporated within these HA scaffolds by different methods including 
polyplexes containing DNA-encoding for angiogenic growth factors [297] and 
covalently bonded peptides such as RGD [298]. 
Recent investigations are focused on obtaining porous structures by particle and 
template leaching of other polymers coated with HA hydrogels. Thus, HA-coated 
structures have been performed for different polymers including PCL [299], PLLA 
[300] and poly(ethyl acrylate) [301]. Moreover, chemical bonded HA forming 
coatings in porous scaffolds based on PLGA have been developed using 
pegylated molecules with amines and EDC chemistries [294].  
 
1.2.8.3 Electrospinning 
Electrospinning is a versatile system to perform polymeric thin fibres with 
diameters ranging from nano- to few micrometres. The principal differences of 
fibrous scaffolds respect porous conventional ones are their large surface area-
to-volume ratio, and high porosity with small pore sizes. In addition, the possibility 
of modifying several electrospinning parameters allow to fabricate a widely range 
of fibrous scaffolds morphologies including random and aligned fibres and more 
complex and precise structures, making this method able to perform biomaterials 
with topographical cues. The principle of the electrospinning process consists in 
the extrusion of a polymer solution through a small orifice at very high voltages, 
subsequently the evaporation of the solvent and the projection of the jet onto a 
metallic collector yield to a superposition of fibres forming a fibrous matrix. Size 
and morphology of the fibres can be modified by varying operation parameters 
such as polymer concentration, viscosity, polymer-solvents interaction, distance 
from the collector, applied voltage and external variables (temperature and 
humidity) [302].  
Particularly, electrospinning of HA is difficult because the high viscosity and 
surface tension of HA aqueous solutions and its ability to retain large amounts of 
water produces a partial solubilisation of the HA fibres deposited on the collector 
due to the non-evaporated water. In order to reduce surface tension, 
electrospinning of HA is usually carried out from solutions containing organic 
solvents such as DMF [302]. On the other hand, HA aqueous solutions show high 
viscosity because the ability of HA to produce chain interactions and 
entanglement above the critical overlap concentration of polymer chains. 
However, the solution viscosity can be reduced using acids [303], alkalis [304] 
and dopant polymers such as poly(ethylene oxide) [305]. Moreover, water 
evaporation can be enhanced employing additional solvents such as ethanol 
[304], using electro-blowing [306], which incorporates a heater and a blower, and 
collecting the electrospun nanofibres in an ethanol bath [307]. 
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Despite the difficulties on obtaining HA electrospun fibres, they can be performed 
with diameters in the range of 60-200 nm, using the appropriate conditions. 
However, direct application of HA nanofibres into aqueous media, such as body 
tissues, shows a fast solubilisation of HA. In order to avoid a fast absorption of 
HA fibres, they must become water-resistant after or simultaneously the 
electrospinning process. The conventional methods include formation of HA 
fibres and posterior crosslinking using EDC chemistries [308] and not crosslinking 
methods have been developed to accomplish water-resistant fibres applying 
post-treatments including HCl vapour and acidic alcohol solutions [309]. Novel 
methods for obtaining crosslinked fibres are based on including a crosslinker 
agent into the electrospinable solution, for example this method has been 
employed in fibres based on HA-DVS [304] and 3,3′-dithiobis(propanoic 
dihydrazide)-modified HA (HA-DTPH) [305]. Other current methods consist in 
electrospinning of HA-derivatives such as MeHA, which is further polymerized 
[310]. 
The use of HA nanofibres for tissue engineering applications shows the 
disadvantage of a hard ingrowth of cells into the structure. For this reason, sieved 
NaCl has been uniformly dropped into the fibre during the electrospinning 
process, leading to nanofibrous scaffolds with porous structure [311]. Moreover, 
another major problem of HA fibres is its low ability to promote cell attachment, 
soft mechanical properties and high degradation rates. In order to enhance these 
properties, HA is usually electrospun simultaneously with structural proteins such 
as collagen [308] and gelatine [307] or co-electrospun with other polymers such 
as PLLA [304]. Moreover, when the requirement consists in improving cell 
attachment, peptide sequences such as RGD can be conjugated with HA-
derivatives yielding fibres containing peptide motifs [312]. 
 
1.2.8.4 Rapid prototyping and patterning 
Rapid prototyping is used to obtain 3D scaffolds at micrometric scale by building 
successive layers of polymer under the control of a CAD software [313] or 
photopolymerization employing micro-mirrors that form reflective patterns [314]. 
The strategies employed on layer-to-layer fabrication are differentiated by the ink-
jet printing method, and include polymeric binders, fused deposition modelling 
and stereolithography applying photopolymerization to finish each layer. Rapid 
prototyping techniques have been developed using HA-derivatives solutions and 
each layer was solidified applying heat or photopolymerization methods. In order 
to improve water resistance, solidification by heating requires the combination of 
HA with other polymers [315], whiles stereolithography is carried out with 
methacrylated HA containing radical initiators [282]. However, HA derivatives are 
habitually printed in combination with other polymers including natural and 
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synthetic ones. Moreover, printing of HA-based 3D structures can be performed 
by including cells and proteins [316]. 
On the other hand, patterning allows surface modifications on material surfaces 
at micro- and nanoscale. Therefore, they can be accomplished by common 
techniques including capillary force lithography, photolithography and electron-
beam lithography. Due to the poor adhesion of cells on HA, capillary force 
lithography has been employed in the incorporation of HA pathways on 
substrates with the aim to obtain patterned surfaces with different ability for cell 
attachment [317]. Co-cultures onto these substrates resulted in the formation of 
aligned and separated cultures of each cell and favour cell-cell junction formation. 
Photolithography by spatially controlled light exposure of HA and collagen blends 
has been developed for obtaining photocrosslinked full-and-semi-IPNs [282]. 
 
1.2.8.5 Micro- and nano-carriers 
In the last years, micro-and nano-carriers have been widely studied with the aim 
to obtain novel therapeutic systems with controlled drug release. According to the 
carrier nature, there are different types including solid lipids, dendrimers, 
polymers, nanogels, liposomes and aggregates of amphiphilic copolymers 
(micelles and vesicles). The possibility of incorporating different molecules into 
the carriers has encouraged researchers to apply these systems for several 
therapies such as gene therapy, drug release and protein delivery. Microcarriers 
have been principally synthesized for obtaining inhaled carriers, while nano-
carriers are destined for performing injected systems. Currently, nano-carriers 
are in the focus of a broad range of investigations in order to obtain novel 
prodrugs with non-cytotoxic effects and longer circulation times. 
The principal highlight of using HA as drug carrier is its biocompatibility, 
biodegradability, negative charge and their broad range of chemical and physical 
modifications. HA can be modified to incorporate drugs and obtain gels with 
tailored properties such as higher degradation times. The anionic nature of HA 
allows the modification of some common nano-carriers since positive charges 
form aggregates with serum proteins producing cytotoxicity and inflammation 
processes. HA-based carriers show great interest as tumor-targeting 
components because of a large number of HA-binding receptors are present into 
HA chains including the cell surface glycoprotein CD44, which is overexpressed 
in many tumoral cells. However, other HA-binding motifs are present such as the 
receptor for HA-mediated motility (RHAMM), the HA receptor for endocytosis of 
synovial epithelial cells in the liver (HARE), the lymphatic vessel endocytic 
receptor of endothelial cells (LYVE-1), and also intracellular HA-binding proteins 
including CDC37, RHAMM/IHABP, P-32, and IHABP4. 
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Micro-carriers are usually fabricated by spray drying techniques, where the HA 
solution is extruded from a syringe at high flows and rapidly dried [318]. While 
nano-carriers are normally obtained by phase separation techniques, which 
consist in an emulsion of water and oil containing surfactants as stabilizers. On 
the other hand, drugs are usually conjugated with HA by chemical or physical 
linkages during carrier formation in order to obtain a more controlled and suitable 
release. Physical conjugation can be accomplished by non-covalent linkages 
such as ionic interactions, hydrophobic forces and hydrogen bonds, whereas 
chemical conjugation is performed by different reactions including amidation, 
esterification and etherification of HA carboxylic and hydroxyl groups and by 
amidation at its reducing end. The most habitual drugs conjugated with HA are 
those employed in chemotherapy in cancer, including Doxorubin [201], Taxols 
[319], hystones such as butyric acid [320], carbozanen containing boron atoms 
[321] and bisphosphonates [322]. Moreover, another compounds including nano-
crystal semiconductors (Quantum Dots) [323] and gold nanoparticles [324] have 
been coupled into HA for imaging tumor cells and radiotherapy. Gene therapy is 
other promising area for cancer treatment. Thus, gene and oligonucleotides 
expressing anti-tumoral factors such as anti-vein endothelial growth factor 
(VEGF) have been included into HA nano-particles employing single-stranded 
DNA or RNA molecules [325,326]. Despite the development of HA carriers is 
principally focused on targeting tumor cells, some researchers have investigated 
alternative applications including conjugation with formyl peptide receptor like 1 
(FPRL1) for inflammatory diseases [325], encapsulation of recombinant human 
insulin [318] and human growth hormone (hGH) [327] for diabetes treatment, and 
incorporation of erythropoietin (EPO) for renal insufficiency [328]. 
HA particles as carrier systems must avoid the release of drug in the physiological 
fluids before reaching the target. Therefore, depending on the type of 
stabilization, HA-carriers can be classified as chemical crosslinked, ionic 
complexes and hydrophophic associated complexes. Chemical crosslinked 
carriers are the most stable ones because of the incorporation of covalent bonds. 
In order to achieve covalent crosslinks, common chemistries have been 
employed including CDI-ADH chemistry, amide crosslinking using dihydrazides, 
ether formation using DVS, disulphide bonding from thiolated HA and using PEG-
aldehyde terminated groups [328]. The ionic complexation avoids the use of 
surfactants, organic solvents and chemicals that can affect the normal biological 
activity due to the entrapped molecules. Also, particles synthesized by ionic 
gelation require milder conditions, because of they are generated by electrostatic 
interactions between the HA carboxyl groups and components of cationic nature, 
such as chitosan [329]. An interesting method for obtaining HA carriers is by 
hydrophobic association of grafted segments coupled into HA chains, leading to 
micelle formation. Hydrophobic segments include polymers or copolymers such 
as PLGA, PEG, PCL, PLA and other substances, which are grafted using 
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common chemistries previous micelle formation [330–332]. Amphiphilic micelles 
are further produced by interactions between the hydrophobic segments, 
requiring additional steps including sonication, exchanging and precipitation 
methods. Moreover, HA is widely employed for coating the surfaces of previously 
formed nanoparticles. In this case, HA acts as protector increasing the circulation, 
targeting tumor cells and reducing protein adhesion [333]. 
 
1.2.9 Hyaluronan-based materials for CNS regeneration 
HA is an ECM component from the developing and mature CNS that has been 
employed as biomaterial for nervous system regeneration (PNS and CNS) 
because of its good integration with the host tissue (absence of immune response 
and glial scar formation), its similar mechanical properties with the neural tissue 
and the possibility to modify its properties (degradation and stiffness). HA-based 
biomaterials for neural regeneration have been commonly studied in 3D in vitro 
cultures [279], encapsulating cells [334], controlled release [319] and 
implantation in vivo after injuries in nerve [335], brain [286] and spinal cord [100]. 
Moreover, HA plays a fundamental role in brain development since neural 
precursor cells (NPCs) express this GAG in large amounts through the fetal 
stage, even these cells bind to this molecule modulating their differentiation 
[336,337]. 
HA shows interesting properties for brain regeneration purposes, including 
biocompatibility, biodegradability and a high swelling degree. The HA products 
derived from its degradation process stimulate endothelial cell proliferation and 
migration promoting angiogenesis. The high swelling degree permits to 
accommodate and cover the whole lesion cavity, conferring mechanical 
properties similar to those of the brain tissue and allowing nutrients, ions and 
solutes transport. Besides, the high molecular weight HA has an anti-
inflammatory effect, allowing the control of microglia activation and avoiding 
foreign body reaction. HA-based scaffolds implanted in the brain have 
demonstrated to own angiogenic activity, inhibit formation of glial scar and 
secondary cavity, envelopes and cell aggregation [286]. The major limitation of 
HA is its poor cell adhesion; for this reason, it is usually employed with adhesion 
molecules or in combination with other polymers. HA-based scaffolds with 
immobilized LN have demonstrated improvements in the astrocyte response and 
the stimulation of neurite ingrowth, suggesting that HA-based scaffolds with these 
proteins promote neuroregeneration [286]. HA-based scaffolds with peptides 
such as IKVAV show similar effects than with LN immobilization, that is, a limited 
and localized inflammatory response, angiogenesis, neurite ingrowth and the 
complete integration of the scaffold with the host tissue [85]. The limitation to 
implant HA scaffolds is the invasive surgery required, but HA can be combined 
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with other polymers to form gels in situ. For example, combining methylcellulose 
with HA thermoresponsive gels can be obtained, which, similarly to HA scaffolds, 
reduce the lesion cavity and attenuate microglia activation [338]. The combination 
of HA hydrogels with neuroprotective molecules, such as erythropoietin (EPO), 
promotes migration and proliferation of NSCs and NPCs from the subventricular 
zone (SVZ), reduces apoptosis and increases the amount of neurites, suggesting 
some neuroregeneration in the injured cortex [88]. The neuroregenerative effect 
of HA biomaterials can also be promoted by attaching receptor antibodies of 
inhibitory molecules for neural growth, such as NoGo [289]. 
Hyaluronic acid scaffolds, like collagen scaffolds, shows a good compatibility with 
spinal cord tissue but do not promote axon attachment and growth impeding 
regeneration. However, the implantation of HA gels in spinal cord lesions is able 
to reduce the lesion cavity, inflammation and glial scar in the surrounded tissue. 
The reduction of inflammation and gliosis is due to the own nature of HA: its 
anionic nature inhibits cell attachment and its CD44-binding motifs limit 
inflammatory effects [100]. However, HA can be functionalized or combined with 
other polymers to improve axon attachment and regeneration. The incorporation 
of PLL into HA gels can promote neurite attachment, while the incorporation of 
nogo66 receptor antibody promotes axon regrowth due to the agonist interaction 
with the inhibitory molecule nogo66 [339]. This system has yielded to the 
reduction of glial scar at injury sites promoting wound healing, angiogenesis and 
regeneration of both myelinated and unmyelinated axons. The combination of HA 
with methylcellulose (HAMC) produces gels in situ, which are employed for brain 
damages and SCI. The HAMC gel shows the advantage of forming porous gels 
in the lesion site covering entirely the lesion cavity and the possibility of 
incorporating factors or other neuroprotective compounds enhancing SCI 
regeneration. For instance, the incorporation of epidermal growth factor (EGF) 
and EPO in the HAMC gels has enhanced neuroprotection in the implant site and 
increased neuron density [340,341]. Thereby, HAMC hydrogels have been 
employed as NSCs and growth factor delivery in rat models of SCI showing 
improvements respect the implantation of cells alone. This system combining 
material as support, NSCs encapsulation and growth factor delivery increases 
survival of host oligodendrocytes and neurons, decreases lesion site and 
improves functional recovery. 
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1.3 Poly(methacrylates) and poly(acrylates) 
Poly(methacrylates) and poly(acrylates) are commonly referred to a wide family 
of polymers synthesized from the polymerization of methacrylate and acrylate 
monomers, which are esterified derivatives of methacrylic or acrylic acids, 
respectively (see Figure 1. 8). These monomers are composed of an ester group 
and a vinyl group. Vinyl groups become these monomers in Michael acceptors of 
radicals allowing the polymerization by addition reaction. They are commonly 
polymerized by radical polymerization using REDOX systems, thermal initiators 
or photoinitiators [342–344]. There is a broad range of initiators to perform this 
polymerization reaction and they are selected depending on the energy required 
for their decomposition and solubility in the prepolymer solution. Initiators require 
lower activation energies than methacrylate monomers to generate radicals and 
each molecule yields to the formation of two radicals by homolytic rupture. 
Subsequently, radicals react with the vinyl groups of the monomers giving an 
active carbon site at the monomeric unit. The reaction of polymerization continues 
by the reaction of the active site with new vinyl of other monomers leading to the 
propagation of the reaction. The termination reaction in the polymerization is 
produced by the combination of two active sites or the transference of hydrogens 
within the active site. These termination processes yield the formation of inactive 
macromolecules (polymeric chains). 
In order to obtain crosslinked polymer networks, methacrylate monomers are 
usually polymerized together with crosslinking agents such as glycol-based 
molecules containing almost two acrylate groups [343]. The incorporation of 
crosslinks within the network allow the control over properties and they produce 
materials with improving stability. In addition, monomers or polymers lacking of 
double bonds may be methacrylated by several chemical pathways such as the 
case of MeHA [241] described above. The incorporation of double bonds allows 
the polymerization and copolymerization of these molecules via radical, leading 
to a wide range of new polymers and copolymers.  
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Figure 1. 8. Methacrylic and acrylic acids and some derivatives thereof. 
 
The most common poly(methacrylates) and poly(acrylates) employed in tissue 
engineering include two differentiated groups depending on the end termination 
of their ester chain: poly(methacrylates)/poly(acrylates) and their hydroxy forms. 
The ester chain in poly(methacrylates) and poly(acrylates) is composed of simple 
alkane groups, while their hydroxy forms contain a hydroxyl group at the 
termination of the ester chain. The principal differences between both groups are 
their hydrophilicity and solubility in water: poly(methacrylates) and 
poly(ethylacrylates) are relatively hydrophobic and soluble in organic solvents, 
while the hydroxyl forms are hydrophilic polymers with some degree of solubility 
in water. On the other hand, networks based on these polymers show differences 
related to their swelling properties in aqueous media; thus, poly(methacrylate) 
and poly(acrylates) polymer networks lack of significant swelling in aqueous 
media and the polymer networks based on the hydroxy forms can absorb relative 
large amounts of water. 
The properties of each polymer are quite different and depend on monomeric or 
co-monomeric compositions, polymerization conditions and the addition of 
crosslinking agents [345]. The methacrylate polymers show better chemical, 
mechanical and thermal properties than acrylate ones, and the hydroxy-polymer 
forms show in general a reduction of these properties. Normally, the larger the 
lateral ester chains, the lower the thermal properties (temperatures of vitreous 
transition and fusion), chemical resistance and mechanical properties (reduction 
of rigidity). This variation in properties is consistent with interactions and packing 
of functional groups in the repeat units along the polymeric chain. Additionally, 
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hydroxy-polymer forms show higher temperatures of vitreous transition than the 
poly(methacrylates) and poly(acrylates) ones. 
Particularly, poly(ethyl acrylate) (PEA) block polymer possesses temperatures of 
vitreous transition around -10 ºC (this temperature noticeably varies for PEA 
networks and depends on the conditions employed in the polymerization 
reaction) [346,347]. Unlike PMMA, which has a temperature of vitreous transition 
around 110 ºC, PEA networks are completely amorphous at physiological 
temperatures, leading to flexible polymers and networks. Therefore, PMMA 
shows Young’s modulus around 2-3 GPa, while PEA one is around 2 MPa. 
 
1.3.1 Poly(methacrylates) and poly(acrylates) in tissue engineering 
Poly(methacrylates) were the first synthetic polymers employed in tissue 
engineering as contact lenses. Since then, poly(methacrylates), poly(ethyl 
acrylates) and the hydroxy forms thereof  have been widely employed in several 
tissue engineering applications including clinical treatments. Some of these most 
studied in tissue engineering include PMMA, poly(ethyl methacrylate) (PEMA), 
poly(methyl acrylate) (PMA) and PEA. In addition, the hydrogel nature of the poly-
hydroxy forms has encouraged their use in many tissue engineering applications, 
of which the most employed include PHEMA and PHPMA. 
All these polymers are bioestable materials and PMMA is the one with higher 
mechanical, thermal and chemical resistance properties. Therefore, this polymer 
is the most widely employed in therapeutic applications, principally, for permanent 
bone and dental cements. Moreover, PMMA was employed in the fabrication of 
rigid contact lenses because of its good optical properties [348], and this material 
is currently used as replacement of the native cornea. Other emergent application 
of this polymer includes its use as dermal filler together with hydrogels. However, 
high rigidity and hydrophobicity of PMMA encouraged its combination with other 
acrylate or methacrylate polymers, such as PHEMA giving a more flexible and 
hydrophilic material, and PEA in order to obtain more flexible and impact resistant 
dentures. In addition, the different methods to polymerize methacrylates have 
leaded a broad range of application forms in clinic: injections of microparticles, 
previous moulded prosthesis and polymerization in situ [349,350]. 
Contrarily to PMMA, PEA constitutes a less explored material for tissue 
engineering applications. However, PEA shows interesting properties make it 
attractive for some applications, especially in those where flexibility is required 
such as soft tissue engineering. Moreover, PEA has been polymerized by 
different techniques in order to obtain scaffolds with different shapes: aligned and 
interwoven channels and porous scaffolds [49,301,344]. Porosity leads to PEA-
based scaffolds lower mechanical properties reducing its Young’s modulus from 
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2 MPa, in block polymers, to 0.1-0.2 MPa, in porous ones. Habitually, 
polymerization of PEA includes a crosslinking agent leading to networks with 
improved bioestability. The principal potential fields of PEA include soft tissue 
engineering such as neural one. 
 
1.3.2 Poly(methacrylates) and poly(acrylates) in central nervous system 
regeneration 
In general, substrates based on poly(methacrylates) and poly(acrylates) present 
good adhesion of cells and may be obtained in multiple fashion [31]. The 
hydroxyl-terminated polymers may be tailored with similar properties to CNS 
tissues, but they show lower cell adhesion than the non-hydroxyl-terminated 
ones. Several in vitro studies employing neural cells have been developed using 
methacrylate polymers and derivatives thereof, including patterned substrates 
[351], aligned fibres [27], channel conduits [49] and porous scaffolds [344].  
Micro- and nano-patterns of PMMA and its derivatives have resulted in good 
neural adhesion and the ability to orient neurite outgrowth. Moreover, sprouting 
and length of the processes can be increased by selecting the appropriate 
dimensions of the patterns [31,36]. Conduits containing sheets of aligned fibres 
based on PMMA and acrylonitrile copolymers have been developed for SCI 
models [48]. Cultures of DRG neurons in these constructs have resulted in the 
aligned outgrowth of axons. In addition, these conduits have been combined with 
an electrode array recording evoked neural activity [27]. Neurite growth has been 
oriented by combining molecular cues, such as growth factors and proteins, with 
polymeric substrates. In this sense PMMA sheets have been combined with LN 
pathways with different width observing improved neurite outgrowth and 
orientation in those with dimension between 30-50 µm [351]. On the other hand, 
porous scaffolds composed of PHEMA containing NT-3 and NGF gradients have 
resulted in the regrowth of axons to the higher growth factor gradients [352]. In 
vitro studies have shown that PEA is a good biomaterial as substrate for different 
glial and neural cells, including Schwann cells and NSCs [21,353] and endothelial 
cells [354]. In the case of NSCs cultures, the differentiation of these cells to neural 
lineages was improved employing copolymers of PEA and PHEA with higher 
hydrophilicity than PEA alone [21]. 
The PHEMA and PHPMA are the most common methacrylate substrates studied 
for brain regeneration, because of its ability to form hydrogels, yielding substrates 
with similar properties to the natural tissue. Both polymers show a good 
biocompatibility and integration with the host tissue adhering firmly to the 
surrounding brain tissue [355]. The implantation of crosslinked PHEMA and 
PHPMA porous scaffolds leads to a dense glial scar and chondroitin sulphate 
proteoglycans (CSPGs) surrounding the material, whereas this glial layer is 
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discontinuous promoting the infiltration of astrocytes, tissue compounds 
(fibroblasts, collagen and blood vessels) and a small amount of neurites. 
Interestingly, the inhibitory substances and cells of axon growth (CSPGs and 
inhibitory cells including oligodendrocytes and microglia) did not invade the 
hydrogels. PHPMA scaffolds show improvements for brain regeneration with 
respect to PHEMA ones due to the infiltration of larger amounts of neurites and 
connective tissue into the hydrogels. However, these hydrogels present a low cell 
adhesion, which can be enhanced by the incorporation of adhesive peptides. 
Thus, the immobilization of IKVAV peptide on PHPMA leaded to the structural 
continuity across cavity, resulting in a more adequate substrate for axonal 
ingrowth [356]. The immobilization of RGD peptides on PHPMA porous scaffolds 
enhances cellular attachment and infiltration; even they promote neurite regrowth 
and ameliorate astrocyte reactivity [357]. These systems have been combined 
with engineered fibroblasts to express neurotrophic factors obtaining larger 
amounts of regrowing axons, less astrocyte proliferation and similar inflammatory 
response when both neurotrophic factors are secreted together [358]. In addition 
to these common polymer employed in brain regeneration, PEA scaffolds with 
aligned and interwoven channels have been implanted near the SVZ of rat brains. 
This study suggests that PEA channels are able for the ingrowth of neural, glial 
and endothelial cells. 
Similarly to brain regeneration, PHEMA-and PHMA-based hydrogels have been 
compared in studies of spinal cord repair [357]. Both hydrogels show a good 
integration with the host tissue, presenting a minimal glial scar and cystic 
formation and the infiltration of connective tissue. The hydrogels have been found 
to promote the infiltration of blood vessel and axons into the pores, even axons 
have grown into the central part of the hydrogels after eight weeks. Moreover, 
SCs infiltrate into the hydrogels and along the axons, suggesting the possibility 
of obtaining meylinated axons. These hydrogels can be modified with peptides 
and neurotrophic factors to improve axon regeneration and generate 
neuroprotection. Thus, the incorporation of the cell adhesive site of FN, RGD 
(NeuroGel™), into PHMA hydrogels with a porous structure obtained by freeze-
drying has been found to promote the axon regeneration in spinal cord repair 
[357]. These systems provoke an early inflammation at few days post-
implantation, which decreases after a few days. One week after implantation, the 
proliferation of capillary sprouts, glial scar surrounding the implant and few 
amounts of fibroblasts, fibrocytes and macrophages can be observed. Over the 
next weeks, the implants showed ingrowth of capillaries, infiltration of connective 
tissue, glial processes and axons. Moreover, the implants presented neither 
cystic formation nor secondary axon degeneration, and the axonal pathways 
were altered into the rostral stump, showing signs of morphological changes and 
regeneration indicating growth cone formation. Similar studies on PHPMA 
hydrogels with immobilized RGD and neurotrophic factors (BDNF and CNTF) 
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have resulted in a major number of axons growing in the hydrogels compared 
with unmodified ones [358]. Conduits of PHEMA-co-methyl methacrylate with 
different internal matrices (collagen, fibrin, matrigel and methylcellulose) and 
growth factors (FGF and NT-3) have been compared with multichannel conduits 
and have demonstrated improvements in the regeneration of selective tracts in 
spinal cord injuries [110]. This study shows that all the internal matrices increase 
the axons density within the channels except the collagen matrix without growth 
factors and the multichannel conduits without fillings. The internal matrix did not 
influence the regeneration of sensorial axons and axon growth factors decrease 
their ability to regeneration. The different matrices and growth factors affect 
selectively to different tracts: fibrin promotes the greatest axonal regeneration of 
reticular neurons, methylcellulose of vestibular and red nucleus neurons, FGF 
increases the axonal regeneration of vestibular neurons, and NT-3 decreases the 
total amount of axons regenerating from brainstem neurons. In addition, fibrin 
and multichannels accomplish improvements in the locomotor function. With the 
aim to improve axon regeneration in the injured spinal cord, PHMA- and PHEMA-
based hydrogels have been combined with MSCs, which show the ability to 
deliver neurotrophic factors [359]. In a preliminary study, the survival of MSCs 
within PHMA and PHEMA implants has been compared, being it higher in the 
PHMA hydrogels. Besides, this work also demonstrated that most of the cells 
locate in the pores but a few cells migrate to the border zones of the spinal cord, 
pointing out that the use of these hydrogels can be helpful as carriers of stem 
cells and their delivery in the lesion site of the spinal cord. 
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Table 1. 1. Summary of the characteristics of the CNS tissue and comparison of the main 
physicochemical and biological properties of HA and PEA. 
CNS HA PEA 
Tissue composed of 
different cell types and 
structures including the 
neuronal network, the 
microvasculature and 
support cells (glia). Unlike 
other tissues, its ECM 
lacks of large amounts of 
collagen and it is mainly 
based on GAGs combined 
with proteins and other 
molecules. The cell 
structures and ECM 
components provide a 
highly porous and hydrated 
tissue with soft mechanical 
properties (Young’s 
modulus between 0,1 and 
10 kPa, depending on age 
and specific CNS tissue) 
It is characterized by a 
limited regeneration ability 
because of the lack of 
neurons replacement and 
the inhibitory environment 
generated after a damage, 
yielding to a secondary cell 
death and permanent loss 
of functions 
Natural GAG occurring in 
the ECM of several 
tissues 
Synthetic polymer derived 
from acrylic acid 
Biodegradable Biostable 
Hydrophilic and forms 
hydrogels when is 
crosslinked 
Hydrophobic and the 
polymer networks thereof 
are characterized by a low 
water uptake 
High molecular weight 
forms are characterized 
by a low adhesion of cells 
and proteins, protection of 
cells against chemicals, 
suppression of the 
immune response and 
angiogenesis 
Low molecular weight 
forms favour 
angiogenesis, proliferation 
and migration of cells, and 
induce inflammatory 
effects 
Fibrillogenesis and cell 
attachment is stimulated 
onto its surface 
Polyelectrolyte containing 
negative charges and 
hydrogen bonds between 
adjacent disaccharides 
Uncharged polymer owing 
low interactions between 
groups 
In the solid state, it is a 
vitreous material at 
physiological temperature 
and lacks of thermal 
transitions in a wide range 
of temperatures 
Amorphous with a 
elastomeric behaviour at 
physiological temperature 
(Tg around -10 ºC) 
Soft mechanical 
properties of swollen 
crosslinked hydrogels 
(Young’s modulus ranging 
from few Pa to a few 
hundreds kPa) 
Young’s modulus between 
0.1 and 2 MPa 
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1.4 Hypotheses and objectives 
1.4.1 Hypotheses 
The aim of this work is the development of structures, mainly based on 
hyaluronan derivatives, having long residence time in the physiological 
environment, resistance to the hyaluronidase activity, tuneable mechanical 
properties and swelling degree, structural stability during the regenerative 
process and good compatibility with cells belonging to the brain tissue. 
The specific hypotheses are the following: 
• the crosslinking of HA with DVS allows the development of insoluble 
scaffolds containing a stable structure 
• the degree of crosslinking might modulate the mechanical properties, 
swelling degree and the initial colonization of glial, neural and endothelial 
cells 
• the post-treatments on the crosslinked HA with DVS may inhibit the action 
of hyaluronidase 
• the methacrylation of HA using MA may provide vinyl groups in the HA 
molecule, and hence this HA derivative, MeHA, may be copolymerized with 
other monomers 
• the copolymerization of MeHA with other monomers permits the 
development of copolymers combining the properties of HA and other 
polymers 
• the copolymerization of MeHA and EA yields semi-biodegradable 
copolymers with tuneable properties and structural stability during the 
regenerative process 
• the initial cell colonization of glial, neural and endothelial cells may be 
improved in these copolymers due to the PEA fraction 
 
1.4.2 Objectives 
The main goal in this work is the development of HA-based materials with longer 
resistance against enzymatic degradation, longer residence time in the 
physiological environment and controllable properties (mechanical and 
biological). In order to accomplish this main objective, two strategies have been 
explored: 1) crosslinking of HA with divinyl sulfone (DVS) followed by post-
treatments to improve the resistance against to hyaluronidase activity, and 2) 
copolymerization of a HA derivative, methacrylated HA (MeHA), with a biostable 
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polymer, poly(ethyl acrylate) (PEA), to yield novel semi-degradable materials, 
poly (MeHA-co-PEA) copolymer networks.  
From each strategy, several specific objectives were derived: 
HA crosslinked with DVS 
• characterization of the crosslinking of HA with DVS taking into account the 
polyelectrolyte nature of HA polymer networks. The characterization 
includes the development of a semi empirical method to determine the 
degree of crosslinking and determine the efficacy of the crosslinking 
reaction 
• development of a repetitive process to obtain HA crosslinked scaffolds with 
tailored properties 
• chemical, physical and mechanical characterization of the HA crosslinked 
scaffolds 
• determination of the influence of the post-processes employed in water 
removal over the degradation of HA polymer networks 
• biological evaluation of the crosslinked HA scaffolds with cell populations 
mimicking those found in the brain environment (endothelial, neural and 
glial cells). Additionally, the effect of the degree of crosslinking on the initial 
colonization will be determined 
 
Poly(MeHA-co-EA) copolymer networks 
• modification of HA to provide double bonds with the aim to perform further 
polymerization reactions. Determination of the substitution degree 
• development of novel semi-degradable copolymer networks, poly(MeHA-
co-EA), with different compositions 
• determination of the real components using several techniques and study 
of the phases distribution in the different copolymer networks 
• physical, chemical and mechanical characterization of the copolymer 
networks determining the relation between composition and properties 
• determination of the hyaluronidase effect over the copolymer networks 
studying the integrity of the biostable component and the by-products 
produced during the degradation 
• biological evaluation of the copolymer networks in terms of its cytotoxic 
and inflammatory effects on endothelial, glial and neural cells
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2.1 Materials and cell lines 
2.1.1 Polymers and monomers 
 Hyaluronan sodium salt from Streptococcus equi. (HA, 1.63 × 106 Dalton) was 
supplied by Fluka.  
 
 
 Ethyl acrylate (EA, 99 %) was purchased from Aldrich. 
 
EA was employed in the copolymerization with modified HA. 
 
 Methacrylic anhydride (MA, 94 %) was purchased from Aldrich. 
 
MA was employed in the HA methacrylation process. 
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 Poly(ethyl methacrylate) (PEMA, 50 kDa), Elvacite® 2043, was supplied by 
Lucite International, Inc. 
 
PEMA spherical beads with particles sizes from 140 to 220 µm were employed 
as porogen. 
 
2.1.2 Crosslinking agents 
 Divinyl sulfone (DVS, at 97 %) was provided by Aldrich. 
 
DVS was employed as crosslinking agent of HA chains. 
 
 N,N′-methylenebisacrylamide (MBAA, at 99.5 %) was supplied by Aldrich. 
 
MBAA was employed as crosslinking agent in the free radical polymerization 
reaction. 
 
2.1.3 Initiator  
 Potassium persulfate (K2S2O8, 99 %) was supplied by Aldrich. 
 
K2S2O8 was employed as thermal initiator in the free radical polymerization 
reaction. 
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2.1.4 Other reagents 
 Sodium hydroxide (NaOH, 98 %) was provided by Scharlab. NaOH was 
employed as catalyser in the crosslinking reaction of HA. 
 Acetone and ethanol (synthesis grade) were provided by Scharlab. Acetone 
and ethanol were used in the extraction process.  
 N,N-dimethylformamide (DMF, 99 %) was purchased from Scharlab. DMF 
was employed as solvent in the chemical modification of HA. 
 Phosphate Buffered Saline (0.15 M PBS). 0.15 M PBS was employed as 
solvent in the chemical modification of HA. 
 
2.1.5 Cell lines and culture media 
 Human Cerebral Microsvacular Endothelial Cell line (hCMEC/D3) 
Human Cerebral Microvascular Endothelial Cell line (hCMEC/D3) is immortalized 
after transfection with Simian Vacuolating Virus 40 T antigen (SV40 TAg) and a 
human telomerase. hCMEC/D3 cell line were provided by the group of Pierre-
Olivier Couraud (Department of Cell Biology, Institute Cochin, Paris, France). 
hCMEC/D3 cell line was expanded on fibronectin-coated culture flasks in 
Endothelial Cell Basal Medium (ECBM, see below). hCMEC/D3 cell line were 
sub-cultured twice a week at a dilution 1:3 from confluence and employed for 
different assays between passages 25-30 and using ECBM as culture medium. 
 
 Pig brain endothelial cells (pBECs) 
Pig Brain Endothelial Cells (pBECs) were extracted from pig brains and provided 
by Dr. Freese (Institut für Pathologie, Universitätsmedizin Mainz, Germany). 
pBECs primary cells were expanded on FN-coated culture flasks in ECBM as 
culture medium for 2 weeks. pBECs were used after the  first passage. ECBM 
was replaced twice a week. 
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 Human glioblastoma-astrocytoma cell line (U373) 
Human glioblastoma-astrocytoma cell line (U373; ATCC code HTB-17) was 
purchased from the American Type Culture Collection (ATCC). U373 cell line was 
expanded on culture flasks with minimum essential media (MEM, supplemented 
with 15 % of Foetal Calf Serum (FCS), 10000 units/mL penicillin, 10000 μg/mL 
streptomycin, 1 % Glutamax and 1 % sodium pyruvate) supplied by Gibco. U373 
cell line was sub-cultured at a dilution 1:3 from confluence, with the same 
medium, twice a week. The in vitro experiments were performed using U373 cell 
line at passages 20-25 using ECBM as cell culture medium. 
 
 Neuroblastoma cell line (SH-SY5Y) 
Human neuroblastoma cell line (SH-SY5Y; ATCC code HTB-11), a thrice cloned 
(SK-N-SH -> SH-SY -> SH-SY5 -> SH-SY5Y) sub-line of the SK-N-SH 
(neuroblastoma cell line), was supplied by the American Type Culture Collection 
(ATCC, Manassas, VA). SH-SY5Y cell line was expanded using Dulbecco's 
Modified Eagle Medium/Nutrient Mixture F-12 (DMEM/F12, supplemented with 
10000 units/mL penicillin and 10000 μg/mL streptomycin) and supplied by Gibco. 
SH-SY5Y cell line was sub-cultured twice a week and employed between 
passages 15-20, using ECBM cell culture medium. 
 
 ECBM 
hCMEC/D3, pBECs, U373 and SH-SY5Y cell populations were cultured in 
endothelial cell basal medium (ECBM, containing 28 mM hydroxyethyl piperazine 
ethanesulfonic acid (HEPES)) and supplied by Promo Cell. ECBM was 
supplemented with 15 % of FCS, 10000 units/mL penicillin and 10000 μg/mL 
streptomycin purchased from Gibco, 10 μg/mL sodium heparin and 2.5 ng/mL 
basic fibroblast growth factor (bFGF) and supplied from Aldrich. 
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2.2 Methods 
2.2.1 Crosslinking of hyaluronan polymer networks 
Divinyl sulfone-crosslinked hyaluronan polymeric networks (solvent-cast HA-DVS 
polymer networks) with different HA:DVS molar ratio, referred as molar ratio of 
HA monomeric unit to DVS, were obtained (see Table 2. 1). First of all, a solution 
of 50 mg/mL of hyaluronan sodium salt in 0.2 M sodium hydroxide was prepared 
shaking for 24 hours and subsequently stirring at 200 rpm for 1 hour. Afterwards, 
the corresponding amount of DVS was added dropwise into 10 mL of the HA 
solution and stirred at 300 rpm for 1 minute. Finally, the resulting solution was 
poured on a petri dish (8.5 cm of diameter) and the reaction was carried out for 
24 hours at room temperature. 
In order to remove the unreacted DVS and residues of inorganic salts from the 
HA-DVS polymer networks, the samples were washed several times as follow: 3 
times in acetone/water 1/1 (v/v) for 24 hours each and 3 times in deionized water 
for 24 hours each. Afterwards, the films were dried for 6 hours at 40 ºC and stored 
in the dark under vacuum until use. 
In addition, an uncrosslinked hyaluronan film (HA film) was obtained by a solvent 
casting process (see Table 2. 1). Briefly, a solution of 10 mg/mL of hyaluronan 
sodium salt in deionized water was prepared and shacked for 24 hours. The 
solution was poured in a petri dish and the water was evaporated for 24 hours at 
room temperature and subsequently extracted under vacuum for 24 hours. The 
resulting HA film (1 mm of thickness) was stored in darkness under vacuum until 
use. 
In order to determine some properties of self-polymerized DVS (pDVS) (see 
Table 2. 1), it was synthesized. 1 mL of DVS was mixed in 10 mL NaOH 0.2 M 
for 1 minute and poured in a plastic petri dish (8.5 cm of diameter). The reaction 
was carried out for 24 hours at room temperature. The resulting pDVS was 
washed twice in de-ionized water for 24 hours each and dried under vacuum for 
24 hours. 
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Table 2. 1. HA-DVS based materials in which the water is removed by solvent-casting processes. 
Sample group HA:DVS molar 
ratio Nomenclature 
Nomenclature of 
sample group 
Divinyl sulfone-
crosslinked 
hyaluronan 
polymer networks 
1:0.6 solv_HA:DVS 1:0.6 
solvent-cast HA-
DVS polymer 
networks 
1:0.9 solv_HA:DVS 1:0.9 
1:1.5 solv_HA:DVS 1:1.5 
Uncrosslinked 
hyaluronan film 1:0 HA film HA film 
Self-polymerized 
divinyl sulfone 0:1 pDVS pDVS 
 
2.2.2 Preparation of crosslinked hyaluronan scaffolds 
Porous and interconnected divinyl sulfone-crosslinked hyaluronan scaffolds (HA-
DVS scaffolds) with different HA:DVS molar ratio (see Table 2. 2) were obtained 
using a template technique. The crosslinking reaction was performed in the 
interstices of PEMA beads templates to obtain a porous structure. Furthermore, 
the washing process was slightly modified and additional steps were included to 
remove the template and dry the samples. 
Templates were obtained by a compression and sintering process of PEMA 
beads, previously sieved between 180-250 µm. PEMA beads were compressed 
in a mould of 15 × 20 cm2 between two plates in a Gumix T0-250/20 machine, 
with a power of 7.5 kW (Gumix S.A.). The process was carried out in two steps: 
first, the beads were compacted applying a pressure of 100 bars over a sheet of 
1 mm of thickness at 110 ºC for 8 minutes, afterwards the compacted template 
was sintered applying a pressure of 100 bars over a sheet of 1.5 mm thickness 
at 110 ºC for 3.5 minutes. Between each step, the template was cooled until 40 
ºC by hydraulic refrigeration. The resulting PEMA template consisted in a 2.5 ±0.1 
mm of thickness of 15 × 20 cm2. 
Afterwards, 15 mL of HA solution (30 mg/mL in 0.2 M NaOH), containing the 
corresponding amount of DVS were injected into the 5 × 5 cm2 PEMA templates. 
The template was filled out with the polymeric solution using vacuum. The excess 
of the polymeric solution over the template surfaces was removed and the 
crosslinking reaction was carried out for 24 hours at room temperature. 
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After that, PEMA beads template was removed in a Soxhlet extraction apparatus 
using acetone as solvent. The extraction process was performed for 48 hours. 
Afterwards, HA-DVS scaffolds were swollen in deionized water for the following 
72 hours (the water was replaced every day), freeze-dried and stored in the dark 
under vacuum conditions until use. 
In order to compare HA-DVS scaffolds and bulk polymer networks, different 
compositions of divinyl sulfone-crosslinked hyaluronan polymer networks 
(WI_HA-DVS samples) were prepared (see Table 2. 2). In this case, after the 
reaction time, the post-processes applied were similar to those employed for 
scaffolds .  
 
Table 2. 2. HA-DVS based materials in which water was removed by a phase inversion process. 
Sample group molar ratio HA:DVS Nomenclature 
Nomenclature of 
sample group 
Divinyl sulfone-
crosslinked 
hyaluronan 
scaffolds 
1:0.6 scaff_HA:DVS 1:0.6 
HA-DVS scaffolds 1:0.9 scaff_HA:DVS 1:0.9 
1:1.5 scaff_HA:DVS 1:1.5 
Divinyl sulfone-
crosslinked 
hyaluronan 
polymer networks 
1:0.6 WI_HA:DVS 1:0.6 
WI_HA-DVS 
samples 1:0.9 WI_HA:DVS 1:0.9 
1:1.5 WI_HA:DVS 1:1.5 
 
On the other hand, HA-DVS polymer networks using a HA:DVS molar ratio of 
1:0.9 (lyo_HA:DVS 1:0.9) were prepared  in a similar way than those described 
above, but in this case the water was removed by a freeze-drying process after 
the crosslinking reaction. Then, the dry samples were purified employing similar 
washing steps than those described above and dried by another freeze-drying 
process. These samples were exclusively employed in the degradation study 
described in the corresponding section. 
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2.2.3 Synthesis of methacrylated hyaluronan 
Methacrylated hyaluronan (MeHA) was synthesized by the addition of 
methacrylic anhydride (20-fold excess) to a solution of 50 mg/mL HA in 0.2 M 
NaOH. Briefly, 1.25 g of hyaluronan sodium salt was dissolved in 25 mL of 0.2 M 
NaOH and mixed in a shaker for 24 hours. The solution was then transferred into 
a reactor balloon and stirred for 30 min at 300 rpm under nitrogen atmosphere. 
Afterwards, 10 mL of MA was added dropwise and the reaction was carried out 
in nitrogen atmosphere for 24 hours at room temperature. 
The purification process was aimed to remove remaining methacrylic acid, 
unreacted MA and salts. After the reaction, the solution was precipitated in 
acetone and solved in deionized water three times to remove undesired products. 
The resulting solution was filtered employing nylon fabrics with a mesh size of 
120 µm and the filtered product was dialyzed (MW cutoff 12 kDa) against 
deionized water for 3 days. The MeHA product was frozen at -80 ºC for 4 hours 
and lyophilized for 3 days. Afterwards the dried product was stored in the dark 
under vacuum conditions until use. 
 
2.2.4 Synthesis of poly(methacrylated hyaluronan-co-ethyl acrylate) 
copolymer networks 
The poly(methacrylated hyaluronan-co-ethyl acrylate) copolymer networks, 
poly(MeHA-co-EA) copolymer networks, were obtained by free radical 
copolymerization in a solution of DMF/0.15 M PBS 1/1 (v/v), using different weight 
ratios of MeHA to EA (see Table 2. 3). Constant 5 wt % of crosslinking agent 
(N,N′-methylenebisacrylamide, MBAA) and 1 wt % of initiator (potassium 
persulfate, K2S2O8) with respect to the total weight of monomers (HA monomeric 
unit and EA) were employed. The polymerization reaction was carried out at 60 
ºC for 24 hours. 
After the copolymerization reaction, poly(MeHA-co-EA) copolymer networks were 
unmoulded carefully. In order to remove the low molecular weight substances 
and unreacted monomer from the reaction, copolymer networks were washed 5 
times in acetone/water 1/1 (v/v) for 24 hours each and equilibrated in deionized 
water for 24 hours. Afterwards, poly(MeHA-co-EA) copolymer networks (1-mm 
thickness) were lyophilized and stored under vacuum until use. 
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Table 2. 3. Compositions obtained in the copolymerization of poly(MeHA-co-EA) copolymer 
networks. 
Sample group 
MeHA:EA 
weight 
ratio 
EA 
weight 
fraction 
(WEA) 
Nomenclature Nomenclature of 
sample group 
poly(methacrylated 
hyaluronan-co-
ethyl acrylate) 
copolymer 
networks 
1:0 0 MeHA:PEA 1:0 
poly(MeHA-co-
EA) copolymer 
networks 
1:0.25 0.2 MeHA:PEA 1:0.25 
1:0.5 0.3 MeHA:PEA 1:0.5 
1:1 0.5 MeHA:PEA 1:1 
1:2 0.7 MeHA:PEA 1:2 
1:5 0.8 MeHA:PEA 1:5 
1:10 0.9 MeHA:PEA 1:10 
0:1 1 PEA 
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2.3 Material characterization 
 Fourier transformed infrared spectroscopy (FTIR) 
Attenuated total reflectance Fourier transformed infrared spectroscopy (ATR-
FTIR) spectra of solvent-cast HA-DVS polymer networks, HA film and 
poly(MeHA-co-EA) copolymer networks were recorded by a Thermo Nicolet 
Nexus FTIR, controlled by OMNIC software on a spectrophotometer (FTIR 
Thermo Nicolet Nexus). The different spectra were obtained by averaging 64 
scans in the range of 700-4000 cm-1 with a resolution of 16 cm-1. 
Smart diffuse reflectance Fourier transform infrared spectroscopy (SDR-FTIR) 
spectra of original HA and HA-DVS scaffolds, WI_HA-DVS samples and MeHA 
were recorded by the same spectrophotometer described above. Samples were 
prepared by mixing 1 wt % of sample with potassium bromide. The spectra were 
obtained by averaging 64 scans in the range between 700 and 4000 cm−1 with a 
resolution of 16 cm-1. 
 
 Elemental analysis CHNS 
The atomic content of carbon, hydrogen, nitrogen and sulphur in the solvent-cast 
HA-DVS polymer networks and HA-DVS scaffolds was determined using 
elemental analysis CHNS with an AE1110 CHNS equipment. The method 
consisted in a Dynamic Flash Combustion process: 1 mg of sample is heated at 
1000 ºC with a constant flow of argon stream and the combustion gas mixture is 
driven through an oxidation catalyst (WO3) zone, then though a reduction copper 
catalyst. The combustion and catalytic reactions yield four different final species: 
N2, CO2, H2O and SO2. The gas mixture was eluted and separated by a Porapack 
PQS column and subsequently detected by a thermal conductivity detector 
(TCD). The native HA was employed as negative control of sulphur content and 
each sample was measured by duplicate. 
 
 Nuclear magnetic resonance (1H-NMR) 
The degree of methacrylation was determined by 1H-NMR spectroscopy. The 1H-
NMR spectra were recorded in a Bruker AV-300 at 300 MHz spectrometer. 
Solutions of both original HA and MeHA were prepared at a concentration of 0.3 
% (w/w) using 0.15 M of CaCl2 in D2O (δ 4.69) as solvent and tetramethylsilane 
as internal standard. All the chemical shifts for resonance signals are reported in 
parts per millions (ppm). 
1H-NMR spectrum of methacrylated HA (300 MHz, D2O with 0.15 M CaCl2): δ 
1.86 (m, 3H, -CO-C(CH3)=CH2 belonging to the methacrylate group), 1.93 (m, 
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3H, -NH-CO-CH3 from the HA), and 5.66 and 6.29 (2s, 2H, -CO-C(CH3)=CH2 
belonging to the methacrylate group). Other protons from the HA backbone 
without practical importance are sited at δ 3.25-3.72 (m) and 4.39-4.48 (m). The 
degree of methacrylation (methacrylate groups per HA disaccharide unit) was 
determined comparing the integrated intensities of the methacrylate protons in 
MeHA (δ 1.86, 5.66 and 6.29) and the methyl protons within the HA acetamide 
(δ 1.93). 
 
 Swelling experiments 
The swelling kinetics was determined gravimetrically using an analytical balance 
with precision 10-5 g (METLER TOLEDO). The HA-DVS polymer networks were 
cut in discs of 6 mm of diameter × 1.8 mm of thickness after the crosslinking 
reaction. After drying the discs, swelling kinetics was evaluated by immersing the 
xerogels (dry discs) in different media: controlled pH (3, 7 and 8 at ionic strength 
of 1 M), controlled ionic strengths (0.5, 1 and 2 M at pH 7) and 0.15 M PBS, all 
them at room temperature. Swelling kinetics was evaluated weighing the swollen 
samples at different time points. The swelling ratio was estimated at each time 
according to: 
 
SW = 
ws-wd
wd
                                [Equation 2. 1] 
 
where, SW represent the weight ratio of water to xerogel; wd and ws are the mass 
of xerogel and swollen samples at each time, respectively. Each test was carried 
out by triplicate. 
In addition, the equilibrium water content, EWC, which is the swelling ratio in 
equilibrium, was determined in the solvent-cast HA-DVS polymer networks using 
the different media described above. Moreover, the EWC was determined in the 
WI_HA-DVS samples, HA-DVS scaffolds and poly(MeHA-co-EA) copolymer 
networks immersed in deionized water and 0.15 M PBS. The swollen equilibrium 
of samples was considered reached after three days in immersion. The WI_HA-
DVS samples and HA-DVS scaffolds were cut in cylindrical shape of 6 mm of 
diameter × 2 mm of thickness and poly(MeHA-co-EA) in discs of 6 mm of 
diameter × 1 mm of thickness. Each test was carried out by triplicate. 
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 Volumetric swelling 
The polymer networks in swollen stage undergo changes in their network 
parameters. Therefore, differences on discs geometry and volume by measuring 
thickness and diameter of dry and at equilibrium swollen of solvent-cast HA-DVS 
polymer networks were determined. The employed media were analogous to 
those of the swelling experiments. Each measurement was repeated three times 
for each composition. 
The HA volume fraction (Φ) was determined as follows: 
 
Φ =
Vd
 Vs
=
1
Q                                     [Equation 2. 2] 
 
where, Q is the reciprocal of HA volume fraction; Vd and Vs are the volumes of 
the dry and swollen network, respectively. 
 
On the other hand, Q can be calculated according to: 
 
Q = ρHA-1 + EWC·vH2O
ρHA
-1                  [Equation 2. 3] 
 
where, ρHA is the density of HA experimentally determined and vH2O is the specific 
volume of water (1 cm3/g). 
if the swelling is isotropic, the swollen network will show a deformation respect to 
the dry one with equal stretching ratios: λx = λy = λz = Λ. Therefore, the isotropic 
Q (Qisotropic) can be calculated by: 
 
Qisotropic= dsdd	
3
=Λ
3
                     [Equation 2. 4] 
 
where ds and dd are de diameters of the swollen and dry samples, respectively. 
Similar values between Qisotropic and Q indicate an isotropic swelling of the 
networks. 
 
Materials and methods 
 
- 97 - 
 
 Density 
Density of solvent-cast HA-DVS polymer networks and HA film was determined 
gravimetrically by measuring the weight of dried samples in air and immersed in 
octane according to Equation 2. 5. A Mettler Toledo AX205 balance with a density 
accessory kit with a sensitivity of 10-5 g was used. Density, ρ, was determined as 
follows: 
ρ = ρoctane  wawa-woctane	                        [Equation 2. 5] 
 
where, ρoctane is the density of octane at 25 ºC (0.703 g/cm3); wa and woctane are 
the mass of each sample in air and octane, respectively. 
Measurements were obtained by triplicate for each composition. 
  
 Porosity determination 
Porosity and macroporosity of HA-DVS scaffolds were determined gravimetrically 
by two different procedures. The porosity (large and small pores) was calculated 
by measuring weights of dry scaffolds and the octane filling their interstices, while 
macroporisity (large pores) was determined from scaffolds swollen in water and 
weighting the amount of octane displacing water. In both cases, the octane was 
introduced in the scaffolds applying vacuum.  
Porosity, πp, and macroporosity, πm, can be calculated from the ratio between the 
volume of small pores, Vpores, or large pores, Vmacropores, respectively, and the total 
volume of the sample, Vt, as follows: 
 

/ = Vpores/macroporesVt = Vpores/macroporesVHA + Vpores/macropores                    [Equation 2. 6] 
 
where, each term of the equation can be calculated by: 
 
Vpores = moctane·voctane                        [Equation 2. 7] 
VHA = mHA·ρHA
-1
                             [Equation 2. 8] 
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where, moctane is the mass of the introduced octane, voctane is the specific volume 
of octane (1.422 cm3/g), VHA is the volume of HA in the sample, mHA is the mass 
of dry HA, and ρHA is the density of HA (derived from calculations described 
above). 
All measurements were carried out by triplicate. 
 
 Compression tests 
Compression tests were conducted in a Seiko EXSTAR TMA/ss6000 Dilatometer 
(Seiko Instruments Inc.) in the compression mode. Compression of solvent-cast 
HA-DVS polymer networks was performed at room temperature, under uniaxial 
and unconfined compression and in their equilibrium swollen state in different 
media: three pH (3, 7 and 8) at an ionic strength of 1 M, three ionic strengths (0.5, 
1 and 2 M) at pH 7 and 0.15 M PBS. Besides, compression tests on HA-DVS 
scaffolds, WI_HA-DVS samples and poly(MeHA-co-EA) copolymer networks 
were performed in 0.15 M PBS. Samples (solvent-cast HA-DVS polymer 
networks, HA-DVS scaffolds, WI_HA-DVS samples and poly(MeHA-co-EA) 
copolymer networks) were cylindrical shaped with a diameter of 5-6 mm and the 
height was measured by the apparatus applying a load of 5 mN. Solvent-cast HA-
DVS polymer networks were compressed with forces between 5 and 3500 mN 
and conducted at 200 mN/min. WI_HA-DVS samples, HA-DVS scaffolds and 
poly(MeHA-co-EA) copolymer networks were tested with forces between 5 and 
150 mN and conducted at 5 mN/min. Furthermore, brain tissue from 5 days 
postnatal Wistar rats was tested using similar conditions than those used in the 
HA-DVS scaffolds. Each test was repeated three times. 
Stress-strain curves were obtained for each material conversing the compressed 
thickness, Δe, in strain, ε, and force, F, in tension, σ, respectively, as follows: 
 
σ = 
F
A ; ε = 
∆e
e0
                         [Equation 2.9] 
 
where,  and A are the initial thickness and cross-section of the sample, 
respectively. 
Stress-strain curves permit to determine several parameters, which are related 
with the mechanical properties of a material. The initial modulus, E or E0, was 
obtained using the curve slope at the unitary strain range between 0 and 0.1. A 
modulus at advanced compression, Ef, was calculated in the tension range from 
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3 to 3.5 kPa. The Ef slope was interpolated until section with the strain axis to 
determine a unitary strain at advanced compression, εf. 
 
 Dynamic mechanical thermal analysis (DMTA) 
DMTA analysis of dry poly(MeHA-co-EA) copolymer networks was performed in 
a dilatometer Seiko TMA/SS6000 at a frequency of 1 Hz in the tension mode. The 
temperature dependence from the storage and loss module was recorded in the 
temperature range from -60 to 60 ºC at a rate of 2 ºC/min. Samples tested were 
prismatic (2.5 × 0.5 × 0.1 cm3). 
The storage moduli of each sample was normalized dividing by the storage 
moduli at -60 ºC, E’/E’
-60ºC. This ratio was fitted to the predictions from the 
Takayanagi’s mechanical block model for bi-phasic systems with the aim to 
determine phase distribution in the copolymer networks [360]. The model takes 
into account a disperse phase, of volume fraction φ, working in parallel (deforms 
with the same strain) with a volume fraction of the continuous phase, (1-λ)·(1-φ), 
and both work in series (deform with the same stress) with a volume fraction of 
the continuous phase λ·(1-φ). 
 
 Thermogravimetric analysis (TGA) 
Thermal degradation of solvent-cast HA-DVS polymer networks, HA-DVS 
scaffolds and poly(MeHA-co-EA) copolymer networks was performed using a 
TGA thermogravimetric analyser (TA-Instrument SDT-Q600 system). Samples 
(5–10 mg weight) were placed on the balance and the temperature rose from 
room temperature to 700 ºC at a heating rate of 10 °C/min, under a positive flow 
of nitrogen. The mass of the sample pan was continuously monitored as a 
function of temperature. The assay was performed by duplicate. 
 
 Differential Scanning Calorimetry (DSC) 
Differential scanning calorimetry (DSC) of poly(MeHA-co-EA) copolymer 
networks was performed in a DSC device (Mettler Toledo DSC 823e). 
Temperature of the instrument was calibrated employing indium and zinc. Assays 
were carried out in the temperature range from -80 to 30 ºC at a rate of 10 ºC/min. 
The samples were analysed after the freeze-drying process and after a thermal 
treatment (150 ºC for 4 hours). 
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 Morphological characterization by scanning electron microscopy (SEM). 
The morphology of HA-DVS scaffolds and poly(MeHA-co-EA) copolymer 
networks was analysed using a JEOL JSM 5410 scanning electron microscope 
(SEM), at an accelerating voltage of 10 kV. The cross-sections, obtained by 
cryogenic rupture under liquid nitrogen, and surfaces of the different samples 
were analysed. Samples were mounted on copper stubs and gold coated before 
observation. 
 
 In vitro degradation 
In order to determine the enzymatic degradation of HA in vitro, a solution 
containing hyaluronidase from bovine testes (provided by Aldrich) was employed. 
The degradation was studied on solv_HA:DVS 1:0.9, WI_HA-DVS samples, HA-
DVS scaffolds and on three compositions of poly(MeHA-co-EA) copolymer 
networks (0, 1 and 10) with a diameter of 5 mm. The enzymatic digestion was 
carried out at 37 ºC immersing samples in 1mL 0.15 M PBS containing 10 
units/mL of enzyme and sodium azide 0.05 %. The degradation was achieved at 
different time points and enzymatic solution was replaced every 2 weeks. After 
each time point, the samples were rinsed with deionized water and the enzyme 
in the supernatants was deactivated by boiling each vial into a water bath for 5 
minutes. All samples and supernatants were stored at -20 ºC until 
characterization. The degraded samples were subjected to a freeze-drying 
process before characterization. Each sample was studied by triplicate and 
samples immersed in 0.15 M PBS for 3 and 56 days were taken as controls.  
The weight loss was determined gravimetrically weighting the dry samples before 
and after the enzymatic degradation. The molecular weight distribution of the 
degrading chains contained in the supernatants was determined, fitting the 
fraction of each specie, wi, of molecular weight Mi, by gel permeation 
chromatography (GPC) using a Waters model 1525 equipment. The 
chromatographic device is composed of a binary HPLC pump for gel permeation 
chromatography, an autosampler, a module that includes a column oven and a 
refractive index detector. The column oven consists in four 7.8 mm × 300 mm 
porous bed GPC columns of Ultrahydrogel™, which  are connected in series and 
contain pore sizes of 1000, 500, 250 and 120 µm. 100 µL of supernatant were 
injected each 80 minutes employing a flow of 0.15 M NaCl containing sodium 
azide 0.05 % at 0.8 mL/min. The calibration curve was plotted using PEO/PEG 
standards from 100 to 8.3 × 105 Da and a solution of 1 mg/mL in 0.15 M PBS of 
original HA. Each supernatant was studied by duplicate. On the other hand, the 
effect of degradation over properties and morphology of each sample was studied 
determining EWC in 0.15 M PBS and morphology by SEM and the remaining 
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MeHA component after the degradation was analysed by TGA, as mentioned 
earlier. 
Furthermore, the degree of hydrolysis of original HA in solutions of 0.2 M NaOH 
was determined by GPC. Two HA solutions of 30 and 50 mg/mL in 0.2 M NaOH 
were prepared and shacked for 24 hours. Afterwards, HA solutions were 
neutralized with 0.2 M HCl and the HA concentration was adjusted to 1 mg/mL in 
a final solution of 0.15 M NaCl. Additionally, the molecular weight of the MeHA 
macromer was determined from a solution of 1 mg/mL in 0.15 M NaCl. 
 
 Statistical analyses 
The significant differences of the experimental data were determined by statistical 
analysis using a one-way ANOVA with a Tukey multiple range test by the 
software Statgraphics. The test was performed at 95 % of confidence (p-value < 
0.05). 
The data belonging to a homogeneous group (without significant differences) 
were indicated by a similar numerical value (1’, 2’, 3’…) in the corresponding 
figure. These numerical values correlate the average of the data in an ascendant 
manner and are plotted in the figure considering the relative position of the 
experimental data. 
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2.4 Preparation of materials for cultures and viability assays 
 Preparation of materials and extracts  
First of all, materials (HA-DVS scaffolds, MeHA:PEA 1:1 samples and PEA) were 
conditioned for cell cultures using 70/30 (v/v) ethanol/water mixtures and UV light. 
The disinfection process was performed as follows: samples were washed three 
times in ethanol/water 70/30 (v/v) (two times for 30 minutes and the last one 
overnight); after that, the materials were rehydrated in deionized water; and 
subsequently the water was replaced by Dulbecco’s Phosphate Buffered Saline 
(DPBS) and exposed under UV light for 30 minutes; finally samples were 
incubated in ECBM for 24 hours. 
The extracts, the ECBM medium in contact with materials from the conditioning 
stage described above, were collected for each material. The extracts were 
employed to study the viability and proliferation of SH-SY5Y, U373 and 
hCMEC/D3 cell lines. Besides, the inflammatory effect on the hCMEC/D3 cell line 
as a consequence of being in contact with material extracts was determined. 
 
 Cell cultures 
96-well plates were used to performed cell culture studies, coating wells with 10 
µg/mL fibronectin (FN) overnight before use. SH-SY5Y and hCMEC/D3 cell lines 
at a density of 35000 cells per well were seeded, on the other hand in the case 
of U373 cell line, 15000 cells per well were seeded. All cells populations were 
incubated in ECBM for 48 hours, and afterwards the medium was replaced by the 
corresponding extract and cells were incubated again for 4 and 24 hours. Cell 
viability, proliferation and inflammation were addressed using pure extract and 
three different extract dilutions (1/2, 1/4 and 1/8 v/v). Each experience was 
performed by triplicate. 
 
 Cytotoxicity tests: MTS, lactate dehydrogenase (LDH) release and Crystal 
violet assays 
The cytotoxicity induced on each cell type by the material extracts were 
determined by MTS assay, the lactate dehydrogenase (LDH) release assay and 
the crystal violet staining. The different cell types were cultured for 4 and 24 hours 
in contact with the material extracts and dilutions as described above. Three 
replicates for each medium and cell type were performed. 
The viability of cell cultures in contact with extracts was determined employing a 
3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfopheny)-2H-
tetrazolium (MTS) assay (CellTiter 96 Aqueous One Solution cell proliferation 
Materials and methods 
 
- 103 - 
 
assay kit; Promega). A soluble formazan product was synthesized by 
mitochondrial activity of MTS, and the quantification of this soluble product was 
proportional to living cells. After each culture period, media from 96-well plates 
were removed and stored in new plates, and cells were incubated with MTS 
diluted in ECBM (1:5) for 45 minutes. 100 µL of incubated MTS media was added 
in a new plate and the absorbance was read at 490 nm. Cell populations cultured 
in ECBM for 4 hours were taken as positive control (set as the 100 % of viability) 
and cells cultured in ECBM for 4 hours and incubated with 1 μg/mL of lyase for 
45 minutes were taken as negative control. 
Cell apoptosis or necrosis was quantified by the lactate dehydrogenase (LDH) 
assay (CytoTox 96 non-radioactive cytotoxicity assay; Promega). The LDH is a 
soluble cytosolic enzyme that is released into the culture medium following loss 
of membrane integrity resulting from both apoptosis and necrosis. LDH release 
into the medium was detected using the LDH assay kit as recommended by the 
manufacturer. 50 µL of stored cell cultured medium mentioned above were put in 
a new 96-well plate, 50 µL of substrate from LDH assay kit were added and the 
mixture was incubated for 30 minutes. The reaction was stopped by adding stop 
solution (HCl/H2OS4 mixture) and the absorbance was measured at 490 nm. The 
LDH content of supernatants of cell populations cultured in ECBM for 4 hours 
was employed as negative control and the one of cells cultured in ECBM for 24 
hours and incubated with 1 μg/mL of lyase for 45 minutes were taken as positive 
control (set as the 100 % of apoptosis). 
After the MTS assay, cells were fixed with a methanol/ethanol mixture 2/1 (v/v) 
for 5 minutes and the viability was tested by the crystal violet assay. The crystal 
violet is a triphenylmethane dye (4-[(4-dimethylaminophenyl)-phenyl-methyl]-
N,N-dimethyl-aniline), which has a high affinity for the highly acidic chromatin of 
mitotic cells. The method consisted in adding 100 µL of 0.1 % crystal violet in 
fixed cells and subsequent incubation for 30 minutes. After the incubation period, 
the crystal violet was removed and the plate was rinsed with water and dried 
overnight at room temperature. The next day, 100 µL of 33 % acetic acid were 
added and incubated for 15 minutes at 37 ºC. Afterwards, 90 µL of this solution 
were poured in a new plate and the absorbance was measured at 590 nm. Cell 
populations cultured with ECBM for 4 hours were employed as positive control 
(set as the 100 % of viability) and cells cultured in ECBM for 24 hours and 
incubated with 1 μg/mL of lyase for 45 minutes were taken as negative control. 
 
 Proliferation assay 
Cell proliferation was evaluated by the detection of the Ki-67 protein, exclusively 
detected during the interphase and mitosis of proliferating cells. The different cell 
populations were cultured for 4 and 24 hours in contact with the material extracts 
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and dilutions as described above. Three replicates for each medium and cell type 
were performed.  
First, the fixed cells were permeabilized with 0.1 % Triton-X-100 in PBS for 5 
minutes at room temperature, and, after several rinses, the unspecific sites of 
cells were blocked with a block solution, containing 1 % H2O2, incubated for 1 
hour. Afterwards, cells were incubated with a block solution containing 1 μg/mL 
primary antibody (Ki-67, monoclonal mouse anti-human Ki-67 antigen clone MIB-
1, Dako) for 45 minutes at 37 ºC. After several washing steps, cells were 
incubated in block solution containing secondary antibody, igG1 peroxidase 
(polyclonal rabbit anti-mouse immunoglobulins HRP, Dako), at a dilution 1:400 
for 45 minutes at 37°C. Subsequently, a solution containing 50 mL of 0.1 M citric 
buffer, 20 μL of 30 % H2O2 and an o-Phenylenediamine dihydrochloride tablet 
was added and incubated for 15 minutes at 37 ºC. Finally, 160 µL of this solution 
were added to a new plate containing 50 µL of 3 M HCl and the absorbance was 
measured at 492 nm. The cell populations cultured in ECBM for 4 hours were 
used as positive control (set as the 100 % of proliferation) and cells cultured in 
ECBM for 24 hours and incubated with 1 μg/mL of lyase for 45 minutes were 
taken as negative control. 
 
 Inflammatory assay 
The E-selectin expression was studied with the aim to determine inflammatory 
effects in the hCMEC/D3 cell line exposed to the different extracts for 4 and 24 
hours. The E-selectin is expressed exclusively in endothelial cells and is activated 
by cytokines, playing an important role in the inflammatory process. Three 
replicates for each medium and cell type were performed. 
At the beginning, the fixed cells were blocked by adding a block solution 
containing 1 % H2O2 at 37 ºC for 60 minutes. After blocking, the primary antibody, 
E-selectin (Anti-Human CD62E; eBioscience), was incubated in block solution at 
a dilution 1:2000 for 45 minutes at 37 °C. Afterwards, the secondary antibody, 
anti-mouse IgG biotinylated (RPN 1177; GE Healthcare Life Sciences), was 
incubated in block solution at a dilution 1:1000 for 45 minutes at 37 ºC. The signal 
of E-selectin expression was enhanced adding a biotinylated streptavidin 
complex (GE Healthcare Life Sciences) in the block solution at a dilution 1:1000 
for 60 minutes at 37 ºC. Subsequently, a solution containing 50 mL of 0.1 M citric 
buffer, 20 μL of 30 % H2O2 and an o-Phenylenediamine dihydrochloride tablet 
was added and incubated for 15 minutes at 37 ºC. Finally, the product was 
transferred in a new plate with 3 M HCl and the absorbance was read at 492 nm. 
The cell line line cultured in ECBM containing 1 μg/mL of LPS and incubated for 
4 hours were considered as positive control (set as the 100 % of inflammation) 
and the culture in ECBM was taken as negative control. 
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2.5 Colonization studies on scaffolds 
 Cell seeding on HA-DVS scaffolds 
First of all, HA-DVS scaffolds of 6 mm of diameter × 2 mm of thickness 
(scaff_HA:DVS 1:0.6, scaff_HA:DVS 1:0.9 and scaff_HA:DVS 1:1.5) were 
conditioned following the steps described in section 2.4, next, the scaffolds were 
coated with FN at a concentration of 10 µg/mL before seeding.  
In all the cultures (see Table 2. 4), the ECBM was employed as culture medium 
and the density of each cell population was as follows: U373 at 15000 cells per 
biomaterial, and SH-SY5Y, pBECs and hCMEC/D3 at 35000 cells per 
biomaterial. Each cell seeding was performed covering the materials with 100 μL 
of ECBM containing the corresponding amount of cells and incubating for 4 hours 
before medium replacement or next seeding (in the case of co-cultures and triple-
cultures). 
 
Table 2. 4. Combinations of cell populations for cultures on the HA-DVS scaffolds. 
Culture combination Cell populations employed in each experiment 
Monocultures 
SH-SY5Y 
U373 
hCMEC/D3 
pBEC 
Co-cultures 
SH-SY5Y + hCMEC/D3 
U373 + hCMEC/D3 
SH-SY5Y + pBEC 
U373 + pBEC 
Triple-cultures 
SH-SY5Y + U373 + hCMEC/D3 
SH-SY5Y + U373 + pBEC 
 
In order to determine the optimal HA-DVS scaffold composition for cell 
colonization, each cell population was seeded as monoculture (see Table 2. 4) 
and incubated for 7 days. After culture, each cell population was immunostained 
and fluorescence images were taken (see below). The optimal HA-DVS scaffolds 
for colonization were employed to carry out co-cultures and triple-cultures for 7 
and 14 days (Table 2. 4). Moreover, cultures on 96-well plates were employed as 
controls. In the case of co-cultures, U373 or SH-SY5Y cell lines were first seeded 
and, after incubating 4 hours and removing medium, the corresponding 
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endothelial cell population was seeded. In triple-cultures, U373 and SH-SY5Y cell 
lines were simultaneously seeded and next the corresponding endothelial cell 
population was seeded. The ECBM was replaced every two or three days. 
In addition to cell cultures on HA-DVS scaffolds, the different cell populations 
were seeded as monocultures (described in Table 2. 4) and incubated for 7 days 
onto FN-coated MeHA:PEA 1:0, MeHA:PEA 1:5 and PEA samples using similar 
conditions. 
 
 Immunohistochemistry 
The different cell populations were studied by immunohistochemistry employing 
neuronal, glial and endothelial markers. After each culture, cells were fixed with 
3.7 % paraformaldehyde (Merck, Darmstadt, Germany) at room temperature for 
15 minutes. Cells were then rinsed three times in 0.1 M PBS, and permeabilized 
with 0.2 % Triton-X-100 in 0.1 M PBS for 5 minutes. Afterwards, cells were rinsed, 
and blocked with 1 % of foetal calf serum in 0.1 M PBS (PBSA) at room 
temperature for 1 hour. 
Primary antibodies were diluted in PBSA and incubated at room temperature for 
1 hour. Glial fibrillary acidic protein (GFAP) immunoreactivity was employed for 
U373 cells; however, depending on the culture combination rat anti-GFAP (r-
GFAP, monoclonal rat anti-GFAP; Invitrogen) diluted at 1:200 or mouse anti-
GFAP (m-GFAP, monoclonal mouse anti-GFAP; Sigma) diluted at 1:300 were 
employed. Neuron-specific class III beta-tubulin, mouse anti-Tuj-1 (Tuj-1, 
monoclonal mouse anti-Tuj-1; Millipore) diluted at 1:100 was used as a marker 
for SH-SY5Y cells. Positive cells to the cluster of differentiation 31 were defined 
as endothelial cells; rat anti-pig CD-31 (r-CD-31, monoclonal rat anti-pig CD-31; 
R&Dsystems) diluted at 1:200, and mouse anti-human CD-31 (m-CD-31, 
monoclonal mouse anti-human CD-31; DAKO) diluted at 1:50 were taken as 
markers for pBECs and hCMEC/D3, respectively. After several rinses with PBSA 
to remove unreacted primary antibodies, secondary ones diluted 1:1000 in PBSA 
were incubated at room temperature for one hour. The secondary antibodies 
employed were Alexa Fluor™ goat anti-mouse IgG 546 (A-11030; Invitrogen), 
Alexa Fluor™ goat anti-rat IgG 488 (A-11006; Invitrogen), goat anti-mouse IgG 
488 (A-11029; Invitrogen). In addition, cell nuclei were stained with Hoechst 
diluted in PBS (1:10000) at room temperature for 5 minutes. Fluorescence 
images were recorded using a fluorescence microscope (BZ-900, KEYENCE). 
The presence of each cell population was determined by immunohistochemical 
staining in monocultures and co-cultures, but only endothelial cell populations 
and U373 cell line were stained in triple-cultures (unstained cells were interpreted 
as SH-SY5Y cell line). Antibody incubations were performed in a different way 
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depending on the type of endothelial cells employed in co-cultures and triple-
cultures. Immunohistochemical staining for pBECs co-cultures and triple-cultures 
were performed in a single step; the corresponding two primary antibodies (m-
GFAP or Tuj-1 and r-CD-31) were incubated together, followed by the incubation 
of the two appropriate secondary antibodies. However, the staining process in 
co-cultures and triple-cultures including hCMEC/D3 cell line were performed in 
two steps; m-CD-31 antibody was incubated followed by the incubation of the 
corresponding secondary one, and the process was repeated by incubating the 
r-GFAP or Tuj-1 antibodies followed by the corresponding secondary ones.
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3.1 Crosslinking of hyaluronan with divinyl sulfone 
HA is the major constituent of the ECM in many tissues, and it is continuously 
synthesized by cells and degraded by the hyaluronidase activity. Additionally, HA 
in solution is characterized by its viscoelastic properties with a low consistence. 
The high degradation rate and solubility in physiological media and poor 
mechanical properties suppose a limitation for the use of HA as artificial ECM for 
cell support. For this reason, the scaffolds based on HA are usually derivatives 
thereof using crosslinking or other chemical modifications. HA can be modified 
by a broad range of chemical reactions, but only a few HA derivatives are 
currently employed in clinical applications. For these purposes, one of the most 
employed HA derivatives is the DVS-crosslinked HA. In this section, the formation 
of hyaluronan polymer networks crosslinked with DVS (solvent-cast HA-DVS 
polymer networks) is studied and the resulting hydrogels are characterized. 
 
3.1.1 Crosslinking of hyaluronan with divinyl sulfone 
The crosslinking of HA with DVS was described in section 2.2.1.Therefore, the 
crosslinking reaction was performed in presence of NaOH 0.2 M resulting in a 
solution with pH values between 13 and 14. Furthermore, basic medium provides 
to the HA solution an acceptable viscosity for an easier handling.  
The further addition of DVS into the colourless HA solution becomes it to a 
yellowish solution in a few seconds, showing a rapid homogenization of the 
mixture. In order to select the appropriate HA:DVS molar ratio (referred the molar 
ratio of HA repeat unit to DVS), different amounts of DVS were employed in the 
development of the HA-DVS polymer networks. On the other hand, the 
crosslinking reaction of HA using DVS shows low efficiencies and DVS is usually 
added in molar excess. Thus, in this study DVS was added in amounts below and 
above a theoretical degree of crosslinking of 100 % (HA:DVS molar ratio 1:0.5). 
The HA:DVS molar ratios employed were 1:0.2, 1:0.4, 1:0.6, 1:0.9, 1:1.5, 1:1.8 
and 1:2. After the crosslinking reaction, the HA-DVS polymer networks show in 
general a soft, homogeneous and consistent structure with yellowish tones 
corresponding to the unreacted DVS. However, the HA-DVS polymer networks 
with molar ratios of 1:1.8 and 1:2 gave heterogeneous hydrogels including rigid 
aggregates derived from the self-polymerization of DVS. After the washing 
process, the HA-DVS polymer networks become colourless indicating the 
removal of unreacted DVS, whereas the dried samples become transparent and 
show a vitreous appearance. 
The equilibrium water content, EWC, of the HA-DVS polymer networks in 0.15 M 
PBS was determined (described in section 2.3). The data of EWC in the different 
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HA-DVS polymer networks as function of the molar ratio of DVS to HA is plotted 
in Figure 3. 1. 
 
 
Figure 3. 1. EWC of the HA-DVS polymer networks as function of the molar ratio of DVS to HA. 
Vertical bars show the standard deviation. 
 
Figure 3. 1 shows that the amount of DVS influences in the value of EWC. In 
general, the higher amount of DVS, the lower EWC value, ranging from 120 to 
30. The value of EWC drastically decreases from molar ratios around a 
theoretical degree of crosslinking of 100 % (HA:DVS molar ratio 1:0.5) and such 
value is stabilized for the HA-DVS polymer networks containing larger amounts 
of DVS. However, the HA-DVS polymer network with a HA:DVS molar ratio of 
1:0.2 shows an anomalous lower value than the corresponding one taking into 
account the curve trend. 
On the other hand, the effect of the alkaline medium, employed in the crosslinking 
reaction, on the hydrolysis of HA chains was estimated. In order to corroborate 
this hypothesis, the molecular weight distributions of HA in a solution of 0.2 M 
NaOH and in a solution of 0.15 M NaCl (described in section 2.3) were compared. 
After stirring for 24 hours, the solutions were neutralized (in the case of the 
alkaline medium) and diluted to a final solution of 1 mg/mL in 0.15 M, and then 
both solutions were passed by GPC. 
 
Results 
 
- 113 - 
 
 
Figure 3. 2. Molecular weight distribution of HA chains dissolved in 0.15 M NaCl (solid line) and 0.2 
M NaOH (dashed line). 
 
The molecular weight distribution of HA dissolved 0.15 M NaCl shows an 
asymmetric and narrow curve predominating chains with lower molecular 
weights. However, the HA in 0.2 M NaOH displayed a more symmetrical 
distribution showing a reduction in its molecular weight. Experimental data arise 
that HA dissolved in 0.15 M NaCl shows a weight average molecular weight, Mw, 
of 1.74 × 106 Da with a high polydispersity index, PDI, of 4. Moreover, the HA 
dissolved in alkaline media leads to a high reduction of the Mw (7.25 × 105 Da) 
and the PDI decreases to values of 3.3. 
 
3.1.2 Characterization of crosslinked hyaluronan 
The study of the EWC of the HA-DVS polymer networks with different amount of 
DVS helped to choose three representative compositions with the aim to carry 
out a more complete characterization. The HA-DVS polymer networks showing 
evidences of unreacted chains (molar ratio 1:0.2) and aggregates within the 
hydrogels (molar ratio 1:1.8 and 1:2) were discarded. Therefore, three 
intermediate HA-DVS polymer networks with different HA:DVS molar ratio were 
selected for further studies: 1:0.6, 1:0.9 and 1:1.5. 
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3.1.2.1 Fourier transformed infrared spectroscopy 
In order to determine the new functional groups in the HA-DVS polymer networks 
after the crosslinking reaction, the spectra of pDVS, the HA film and the different 
HA-DVS polymer networks (all them obtained as described in section 2.3) were 
recorded. 
 
 
Figure 3. 3. IR spectra of HA film, HA-DVS polymer networks and pDVS. 
 
The spectrum of unmodified HA film shows a broad absorption band between 
3500 and 3000 cm-1 characteristic of the overlapping of associated O-H and N-H 
stretching vibrations of hydroxyl groups, carboxylic acids and amide groups. The 
multiple peaks in the range from 3000 to 2800 cm-1 are attributed to the sp3-
hybridization in carbons. The broad absorption band at 1600 cm-1 corresponds to 
the superposition of bound C=O groups of amides (Amide 1). The double peak 
between 1500 and 1300 cm-1 is attributed to the N-H bending of amide groups 
(Amide II) and O-H bending in hydroxyls. The intense superposed peaks between 
1200-900 cm-1 correspond to different bond vibrations (stretching of C-O-C, C-O 
and C-O-H, O-H deformation and C=O deformation). 
The spectrum of pDVS is characterized by intense bands between 3000-2800 
cm-1 attributed to C-H stretching and two intense bands in 1290 and 1110 cm-1  
corresponding to S=O asymmetric and symmetric stretching, respectively. 
The spectra of the different HA-DVS polymer networks slightly differ from that of 
the HA film. The broad absorption band between 3500 and 3000 cm-1 becomes 
less intense and two separate peaks at 3690 cm-1 and 3620 cm-1 can be 
appreciated, attributed to stretching vibrations of free O-H. The broad peak at 
1600 cm-1 is not present and the intensity of the peak at 1700 cm-1 is increased. 
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The intense peak of the sulfone symmetric stretching is observed at 1080 cm-1 
superposed to bands of the HA chain. 
 
3.1.2.2 Density 
The densities of the HA film and HA-DVS polymer networks were determined 
employing the Equation 2. 5. Moreover, the specific volume was determined from 
the inverse of the density. In Figure 3. 4 is plotted the density of each sample. 
 
 
Figure 3. 4. Density of the HA film and HA-DVS polymer networks. Vertical bars show the standard 
deviation. 
 
The HA film and the different HA-DVS polymer networks showed no significant 
differences in density, and hence this parameter was taken as the averaged 
values of the different samples (density of 1.575 g/cm3). 
 
3.1.2.3 Swelling experiments 
The swelling degree, SW, of HA-DVS polymer networks immersed in different 
media was evaluated using Equation 2.1, taking the mass of xerogels as 
reference and measuring the weight at different time points until reaching the 
equilibrium. Thereby, the kinetics of swelling was determined and the effect of the 
amount of DVS on the swelling degree was evaluated. In order to achieve the 
influence of pH value and ionic strength in the SW, different media were 
employed. Media with controlled ionic strength and pH were prepared using a 
buffer system, which is able to obtain a wide range of values by altering the 
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amount of each salt. In this study, a single buffer system was chosen with the aim 
of reducing undesirable effects on swelling due to the presence of different ions. 
The composition of each media and the values of ionic strength and pH are 
summarized in Table 3. 1. 
 
Table 3. 1. Salt composition of the buffer systems. 
 
After preparing each solution and after the samples reached the swelling 
equilibrium, the pH in each medium was recorded. Therefore, all the pH 
measurements resulted in values of ± 0.3 with respect to the theoretical ones. 
Additionally, from the kinetics of swelling, the type of transport that governs the 
diffusion process was determined. In first instance, the diffusion was supposed 
to be Fickian, and the kinetics of swelling was plotted using the following equation 
[361]: 
 
Mt
M∞
=k·√t                           [Equation 3.1] 
 
where, Mt and M∞ are the mass of  water in the hydrogel at time t and at swelling 
equilibrium, respectively, and k is a constant defined by the slope of the line from 
the graph obtained from plotting the left hand of the equation as a function of the 
square root of time. 
The following figures display the effect of media with different pH values (3, 7 and 
8) for a constant ionic strength of 1 M on the swelling of the HA-DVS polymer 
networks. Additionally the curves derived from Equation 3.1 are included for each 
medium. 
 
pH at  
25 ºC 
Salt concentration (g/l) to obtain 
buffers with different pH 
KCl (g/l) to obtain different 
ionic strength at different pH 
values 
Na2HPO4· 12H2O H3C6H5O7·H2O 0.5 M 1 M 2 M 
3 14.7 16.7  68.7  
7 58.9 3.7 5.4 42.7 117.3 
8 69.6 0.6  32.9  
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Figure 3. 5. Kinetics of swelling of solv_HA:DVS 1:0.6 samples in media with constant ionic 
strength 1 M and different pH values: 3 (triangle dots), 7 (square dots) and 8 (circle dots). Vertical 
bars show the standard deviation of the experimental data. Inset shows the approximation of 
swelling to a Fickian diffusion at different pH values: 3 (solid line), 7 (dashed line) and 8 (dotted 
line). 
 
 
Figure 3. 6. Kinetics of swelling of solv_HA:DVS 1:0.9 samples in media with constant ionic 
strength 1 M and different pH values: 3 (triangle dots), 7 (square dots) and 8 (circle dots). Vertical 
bars show the standard deviation of the experimental data. Inset shows the approximation of 
swelling to a Fickian diffusion at different pH values: 3 (solid line), 7 (dashed line) and 8 (dotted 
line). 
 
Results 
 
- 118 - 
 
 
Figure 3. 7. Kinetics of swelling of solv_HA:DVS 1:1.5 samples in media with constant ionic 
strength 1 M and different pH values: 3 (triangle dots), 7 (square dots) and 8 (circle dots). Vertical 
bars show the standard deviation of the experimental data. Inset shows the approximation of 
swelling to a Fickian diffusion at different pH values: 3 (solid line), 7 (dashed line) and 8 (dotted 
line). 
 
The swelling at constant ionic strength resulted to have a similar trend (Figure 3. 
5, Figure 3. 6 and Figure 3. 7): the swelling is fast during the first 10 hours and 
becomes asymptotic stable. Moreover, figures evidence that the higher the 
HA:DVS molar ratio, the lower the swelling degree and the earlier stabilization. 
The HA:DVS 1:0.6 samples reach swelling degrees between 30 and 60, the 
HA:DVS 1:0.9 samples range from 35 to 55 and the solv_HA:DVS 1:1.5 samples 
reach swelling degrees between 15 and 30. On the other hand, pH influences the 
swelling degree: the lower the pH value, the lower the swelling reached is. This 
effect is increased in HA-DVS polymer networks with lower DVS amounts. 
However, the swelling degree at pH 7 and 8 show significant differences only for 
solv_HA:DVS 1:0.6 samples. 
The figures below show the effect of media with different ionic strengths (0.5, 1 
and 2 M) at controlled pH of 7 on the swelling degree of the different HA-DVS 
polymer networks. 
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Figure 3. 8. Kinetics of swelling of solv_HA:DVS 1:0.6 samples in media at pH 7 and different ionic 
strengths: 0.5 M (circles), 1 M (squares) and 2 M (triangles). Vertical bars show the standard 
deviation of the experimental data. Inset shows the approximation of swelling to a Fickian diffusion 
at different ionic strengths: 0.5 M (solid line), 1 M (dashed line) and 2 M (dotted line). 
 
 
Figure 3. 9. Kinetics of swelling of solv_HA:DVS 1:0.9 samples in media at pH 7 and different ionic 
strengths: 0.5 M (circles), 1 M (squares) and 2 M (triangles). Vertical bars show the standard 
deviation of the experimental data. Inset shows the approximation of swelling to a Fickian diffusion 
at different ionic strengths: 0.5 M (solid line), 1 M (dashed line) and 2 M (dotted line). 
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Figure 3. 10. Kinetics of swelling of solv_HA:DVS 1:0.1.5 samples in media at pH 7 and different 
ionic strengths: 0.5 M (circles), 1 M (squares) and 2 M (triangles). Vertical bars show the standard 
deviation of the experimental data. Inset shows the approximation of swelling to a Fickian diffusion 
at different ionic strengths: 0.5 M (solid line), 1 M (dashed line) and 2 M (dotted line). 
 
The variation of ionic strength and pH gave similar trends on the swelling kinetics 
of the different HA-DVS polymer networks (Figure 3. 8, Figure 3. 9 and Figure 3. 
10). In addition, as the case of different pH values, the higher molar ratio of DVS 
to HA the lower the swelling degree and the earlier stabilization. At different ionic 
strength, the swelling degree in solv_HA:DVS 1:0.6 samples reaches values 
between 30 and 40, in the solv_HA:DVS 1:0.9 samples from 30 to 50 and in the 
solv_HA:DVS 1:1.5 samples reaches values around 30. On the other hand, the 
lower the ionic strength the higher the swelling degree, this effect is more 
noticeable in the HA-DVS polymer networks with lower DVS amounts. Moreover, 
the different samples showed no significant differences in their swelling degree 
when the media with ionic strength of 1 M and 2 M are compared. 
In order to determine the swelling behaviour of the HA-DVS polymer networks in 
media mimicking the physiological one, the kinetics of swelling in the different 
HA-DVS polymer networks immersed in 0.15 M PBS was determined. The salt 
content of 0.15 M PBS is summarized in Table 3. 2. 
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Table 3. 2. Salt composition of 0.15 M PBS. 
Salt specie Concentration (g/L) 
NaCl 8.0 
KCl 0.2 
Na2HPO4 1.4 
KH2PO4 0.2 
 
The swelling kinetics of the different HA-DVS polymer networks in 0.15 M PBS is 
plotted below: 
 
 
Figure 3. 11. Kinetics of swelling in 0.15 M PBS of the different HA-DVS polymer networks: 
solv_HA:DVS 1:0.6 (circles), solv_HA:DVS 1:0.9 (squares) and solv_HA:DVS 1:1.5 (triangles). 
Vertical bars represent standard deviation of experimental data. 
 
The kinetics of swelling of the HA-DVS polymer networks in 0.15 M PBS arises a 
similar trend than those of samples immersed in other media: the swelling was 
fast during the first 10 hours and became asymptotic stable for longer times. In 
general, the swelling degree of the different samples immersed in 0.15 M PBS 
resulted to be higher than that in other media. Moreover, the HA-DVS polymer 
networks with higher HA:DVS molar ratio show a lower swelling degree. 
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In addition, the equilibrium water content, EWC, of the samples, considered the 
swelling degree after 72 hours in immersion, was determined for each 
composition and medium. In this study, the EWC of samples immersed in 
deionized water was included. 
 
 
Figure 3. 12. Representation of EWC as function of the molar ratio of DVS to HA monomeric unit in 
the different swollen media. (A) Ionic strength at 1 M and different pH values: 8 (circles), 7 (squares) 
and 3 (triangles). (B) Controlled pH 7 and variable ionic strength: 0.5 M (circles), 1 M (squares) and 
2 M (triangles). (C) PBS (circle dots) and water (square dots). Vertical bars show the standard 
deviation of the experimental data. 
 
Figure 3. 12 shows that the amount of DVS added in the crosslinking reaction 
affect the EWC value of the samples in all the media; the higher the amount of 
DVS the lower the EWC value. This effect turns more significant comparing 
solv_HA:DVS 1:1.5 with each other compositions. A higher ionic strength reduces 
EWC values, but this reduction in EWC seems to become stable for ionic 
strengths up 1 M (Figure 3. 12 A). Additionally, the EWC value of the HA-DVS 
polymer networks with larger amounts of DVS is less affected by the ionic 
strength. Contrarily, the higher pH in medium increases the EWC values, 
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observing no significant differences between pH 7 and 8 (Figure 3. 12 B). 
Moreover, the difference in the EWC values between each HA-DVS composition 
remains constant for the different media with variable pH. The swelling of the HA-
DVS polymer networks in 0.15 M PBS and water displayed higher values than 
those in media with controlled pH and ionic strength (Figure 3. 12 C). The EWC 
value in water is significant higher than in 0.15 M PBS and this difference remains 
approximately constant for all the compositions. However, the EWC value in both 
media is stabilized with the amount of DVS. 
On the other hand, the insets in Figure 3. 5 to Figure 3. 11 show curves with 
similar trends for the different HA-DVS polymer networks immersed in the 
different media. At earlier swelling times, the curves show two straight regions: 
the first one at initial times with a lower slope and the second one with a slight 
increment of the slope. In general, these linear regions range between swelling 
ratios of 0 and 0.6, after this point, the curves are asymptotically stabilized until 
the value of 1. 
In a diffusion process governed by a Fickian transport, the swelling depends on 
the square root of time. Therefore, the curves obtained from Equation 3.1 
suggested almost two possible Fickian diffusion transport: the two earlier linear 
regions. In the subsequent study, the first linear region was discarded because 
of the swollen hydrogel at the initial stages showed a transition from a glass state 
to a rubbery-like one. In order to corroborate the Fickian transport in the swollen 
hydrogels, the power law equation was employed: 
 
Mt
M0
=K·tn                                [Equation 3. 2] 
 
where Mt  is the amount of water in the swollen hydrogel at time t, M0 the mass of 
the xerogel, K is the swelling constant, and n is the swelling exponent.  
Therefore, from the logarithmic representation of Equation 3. 2 for Mt/M∞ values 
between 0.2 and 0.6 was determined the swelling exponent, n, which value gives 
the dependence of swelling with time, and hence the type of transport process. 
The n values for the different samples immersed in the different media are shown 
in the following table: 
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Table 3. 3. Values of the swelling power exponent, n, of the HA-DVS polymer networks in the 
different swollen media. 
swelling medium 
swelling power exponent 
solv_HA:DVS 1:0.6 solv_HA:DVS 1:0.9 solv_HA:DVS 1:1.5 
pH 7 and I=0.5 M 0.48 0.53 0.52 
pH 7 and I=1 M 0.50 0.53 0.57 
pH 7 and I=2M 0.58 0.59 0.72 
pH 3 and I=1 M 0.45 0.54 0.50 
pH 8 and I=1 M 0.30 0.47 0.50 
0.15 M PBS 0.47 0.55 0.44 
 
Table 3. 3 shows that diffusion in the swelling of the HA-DVS polymer networks 
is governed, in general, by a Fickian transport (values of n around 0.5). In such 
case of transport, the diffusion coefficient, D, may be determined, fitting the 
swelling ratio, Mt/M∞, between 0.2 and 0.6 as function of the square root of time 
to a straight line: 
 
Mt
M∞
=4 D
π·l2
·√t                             [Equation 3. 3] 
 
where  is the thickness of the hydrogel approximating the swelling phenomena 
as a diffusion process in a thin film. The thickness of the hydrogel was taken as 
the averaged value in the region of Mt/M∞ between 0.2 and 0.6. Therefore, the 
values of the diffusion coefficient, D, in case of Fickian transport were collected 
in the following table: 
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Table 3. 4. Diffusion coefficient in the HA-DVS polymer networks in the different swollen media. 
Swelling media 
Diffusion coefficient (cm2/s × 107) 
solv_HA:DVS 1:0.6 solv_HA:DVS 1:0.9 solv_HA:DVS 1:1.5 
pH 7 and I=0.5 M 3.92 4.23 5.59 
pH 7 and I=1 M 2.81 2.85 5.17 
pH 7 and I=2 M 0.46 2.91 --- 
pH 3 and I=1 M 2.62 2.72 3.19 
pH 8 and I=1 M --- 4.25 1.47 
0.15 M PBS 3.79 4.76 6.88 
 
3.1.2.4 Volumetric swelling  
In order to corroborate the isotropy of swelling, the volumetric swelling in 
equilibrium determined from geometrical measures (Qisotropic) and from 
gravimetric determination (Q) were calculated (see Equation 2. 3 and Equation 
2. 4, respectively).  The hypothesis that in isotropic swelling the HA-DVS polymer 
networks are deformed with similar ratio in all their directions arises that Q and 
Qisotropic should have similar values. The volumetric swelling determined by both 
methods in the different media was evaluated for all the HA-DVS polymer 
networks compositions. 
 
 
Figure 3. 13. Volumetric swelling of solv_HA:DVS 1:0.6 samples immersed in different media 
calculated gravimetrically, Q (black bars), and geometrically, Qisotropic (grey bars). 
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Figure 3. 14. Volumetric swelling of solv_HA:DVS 1:0.9 samples immersed in different media 
calculated gravimetrically, Q (black bars), and geometrically, Qisotropic (grey bars). 
 
 
Figure 3. 15. Volumetric swelling of solv_HA:DVS 1:1.5 samples immersed in different media 
calculated gravimetrically, Q (black bars), and geometrically, Qisotropic (grey bars). 
 
Figures 3.13 to 3.15 show that the volumetric swelling is proportional to the EWC 
values. Therefore, the volumetric swelling shows a similar behaviour of EWC for 
each medium, hence increasing ionic strength, and reducing pH and the DVS 
amount lower volumetric swelling values were obtained. The values of Q and 
Qisotropic arise, in general, an anisotropic swelling. Differences between both 
parameters are increased in media where the swelling degree is higher. 
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3.1.2.5 Determination of the degree of crosslinking 
The degree of crosslinking of the different HA-DVS polymer networks was 
determined by indirect and direct methods. 
The indirect method includes the Flory theory for polymer-solvent systems 
[362,363]. The results derived from the equilibrium water content were employed 
to evaluate the degree of crosslinking. This method is an approximation since it 
requires an isotropic swelling of the hydrogels and not take into account some 
considerations of HA molecules including chains interactions and entanglements. 
The Flory theory for polymeric networks at equilibrium swelling determines that 
the crosslinking density, ρx, may be calculated setting zero the following 
expression: 
 
ln1-Ф2 +Ф2+χФ22+ρxV1Ф0 Ф2Ф0	
1
3
-0.5
Ф2
Ф0
 +V1 2CS*-iФ2VU 	
2
+4CS*2 
[Equation 3. 4] 
 
where, Ф2 and Ф0 are the polymer fractions in the hydrogel at equilibrium swelling 
and after the crosslinking reaction, respectively. V1 is the molar volume of water 
(18 cm3/mol). χ is the Flory polymer-solvent interaction parameter (assumed to 
be 0.473 for low fractions of HA in water and considering that HA and Dextran 
have a similar behaviour [213,364]). CS* is the salt concentration outside the 
hydrogel (assumed zero for pure water). i is the degree of ionization of HA 
(assumed 1 for neutral pH). VU is the molar volume of ionisable groups per HA 
disaccharide unit (250 cm3/mol). 
Additionally, Ф2 and Ф0 may be calculated from the degree of mass swelling, QM, 
at equilibrium swelling and after the crosslinking reaction, respectively, by the 
following expression: 
 
Ф
-1
 = 1+
ρp
ρs
QM-1                      [Equation 3.5] 
 
where ρp and ρs are the densities of the xerogel (1.575 g/cm3 for HA, calculated 
in section 3.1.2.2) and solvent (1 g/cm3 for water), respectively. 
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The molecular weight between crosslinks, , in the different HA-DVS polymer 
networks may be determined from ρx as follows: 
 
M c= 1
ρx·v                                    [Equation 3.6] 
 
where, ̅ is the specific volume of HA (0.635 cm3/g, the inverse of the density 
calculated in section 3.1.2.2). 
Additionally, the number of disaccharide units between crosslinks, d, may be 
determined from  taking into account the molecular weight of the HA 
monomeric unit (400 g/mol). The different parameters derived from the swelling 
experiments in water are collected in Table 3. 5. 
 
Table 3. 5. Parameters determined from the Flory theory for polymer-solvent systems. 
Composition solv_HA:DVS 1:0.6 
solv_HA:DVS 
1:0.9 
solv_HA:DVS 
1:1.5 
QM 97.4 74.5 61.1 
ρx (mol/cm3) 5.8 × 10-4 7.0 × 10-4 8.2 × 10-4 
M c (kDa) 2.7 2.3 1.9 
d 6.9 5.6 4.8 
degree of 
crosslinking (%) 14.6 17.7 20.7 
 
In order to determine the DVS incorporated in the HA-DVS polymer networks, the 
atomic weight fraction of sulphur was determined by elemental analysis CHNS 
(see section 2.3). Taking into account the stoichiometry of the crosslinked 
hyaluronan (see Figure 1. 6) and the atomic mass of each element, the degree 
of crosslinking may be determined, and hence the values of  and  ̅ of the 
different compositions. The atomic content of each element in the samples is 
collected in Table 3. 6. 
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Table 3. 6. Atomic weight fraction of nitrogen, carbon, hydrogen and sulphur. 
Sample 
Atomic weight fraction (in percentage) 
Nitrogen Carbon Hydrogen Sulphur 
native HA 3.2 32.7 9.1  
solv_HA:DVS 1:0.6 2.9 31.8 8.4 0.9 
solv_HA:DVS 1:0.9 2.7 31.9 8.1 1.5 
solv_HA:DVS 1:1.5 2.6 32.3 8.7 2.4 
 
The validity of the method on quantifying the atomic content was achieved 
comparing the relation between the atomic weight of carbon and nitrogen 
determined in the native HA with the stoichiometric ratio of both elements. The 
values of the different parameters of the crosslinking (degree of crosslinking,  
and  ̅) were determined relating the sulphur with both carbon and nitrogen 
contents and taking into account the stoichiometry between them (Table 3. 7). 
 
Table 3. 7. Parameters of the crosslinking of HA with DVS determined by elemental analysis 
CHNS. 
Composition solv_HA:DVS 1:0.6 
solv_HA:DVS 
1:0.9 
solv_HA:DVS 
1:1.5 
M c (Da) 1219.2 752.6 459.7 
d 3.0 1.9 1.1 
degree of crosslinking (%)
 
32.9 53.3 87.2 
 
3.1.2.6 Compression tests 
In order to determine the influence of the degree of crosslinking in the mechanical 
properties of the HA-DVS polymer networks, compression tests were performed. 
The different HA-DVS polymer networks at equilibrium swelling were subjected 
to unconfined compression under immersion in the corresponding medium. 
Moreover, the initial modulus to evaluate the elasticity of the materials was 
determined from the stress-strain curves (Equation 2.9). An initial modulus was 
calculated from the initial slope of the stress-strain curve, until a unitary strain of 
0.1. 
Stress-strain curves of the different HA-DVS polymer networks compositions 
immersed in media with controlled ionic strength and different pH values were 
determined. 
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Figure 3. 16. Stress-strain curves of the HA-DVS polymer networks: A) solv_HA:DVS_1:0.6 
samples, B) solv_HA:DVS_1:0.9 samples and C) solv_HA:DVS_1:1.5 samples. Each composition 
was measured in media with constant ionic strength of 1 M and different pH values: 3 (solid line), 7 
(dashed line) and 8 (dotted line). 
 
For the media with different pH values, the stress-strain curves (Figure 3. 16) 
show a similar trend: an initial and large elastic region, which turns to a vertical 
asymptotic stabilization of the strain at advanced compression. During the 
compression tests, samples reached large unitary strains, between 0.5 and 1, 
without observing the breaking stress in the whole range studied. Moreover, after 
the test, the samples show a slightly deswelling but practically recover their initial 
dimensions after a short time. However, the HA-DVS polymer networks show 
slightly differences depending on their composition. In general, higher amounts 
of DVS lead to a lower elastic region and the stabilization of the strain occurs 
earlier. In addition, the pH of the media affects the compressibility of the samples: 
the higher the value of pH, the larger the elastic region and the reached strains. 
In order to study the effect of ionic strength on mechanical properties, the HA-
DVS polymer networks immersed in media with different ionic strengths at 
constant pH value were conducted under compression. 
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Figure 3. 17. Stress-strain curves of the HA-DVS polymer networks: A) solv_HA:DVS_1:0.6 
samples, B) solv_HA:DVS_1:0.9 samples and C) solv_HA:DVS_1:1.5 samples. Each composition 
was measured in media at  pH value 7 and different ionic strengths: 0.5 M (solid line), 1 M (dashed 
line) and 2 M (dotted line). 
 
The stress-strain curves of the HA-DVS polymer networks swollen in media with 
several ionic strengths (Figure 3. 17) show similar trends than in media with 
different pH (Figure 3. 16). In addition, the increment of crosslinking agent 
reduces the elastic region and the strains reached at advanced compression. 
However, in this case, the effect of ionic strength is lower than the variation on 
the pH, and each HA-DVS composition shows similar mechanical properties 
under compression. 
In order to mimic the behaviour of samples in physiological conditions, HA-DVS 
polymer networks were compressed immersed and in equilibrium of 0.15 M PBS. 
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Figure 3. 18. Stress-strain curves of HA-DVS polymer networks in equilibrium swelling of 0.15 M 
PBS: A) solv_HA:DVS 1:0.6 samples, B) solv_HA:DVS 1:0.9 samples and C) solv_HA:DVS 1:1.5 
samples. 
 
The HA-DVS polymer networks immersed in 0.15 M PBS and subjected to 
compression reached high strains (up 0.6) (Figure 3. 18). Moreover, the stress-
strain curves highlight slight discrepancies in the mechanical behaviour of 
solv_HA:DVS 1:1.5 samples with respect to each other compositions, which show 
softer mechanical properties. 
The stress-strain curves show, in general, non-linear trends due to the change in 
the cross-section during the compression. However, this effect was neglected for 
short compression times, and hence an initial modulus was determined until 
strains of 0.1. In order to compare the elastic properties of the HA-DVS polymer 
networks immersed in the different media, the initial modulus was calculated and 
fitted. 
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Figure 3. 19. Representation of the initial modulus as a function of the molar ratio of DVS to HA 
monomeric unit in samples immersed in different media. A) Media with ionic strength of 1 M and at 
different pH: 3 (circles), 7 (squares) and 8 (triangles). B) Media with constant pH of 7 and different 
ionic strength (2 M (circles), 1 M (squares) and 0.5 M (triangles). C) 0.15 M PBS. Vertical bars show 
the standard deviation of the experimental data. 
 
The samples swollen in different media show an initial modulus, E, comprised 
between 5 and 20 kPa. The increment of crosslinking agent led to slightly higher 
values of E for all the media studied.  These discrepancies are less important 
between media at pH 7 and different ionic strengths (Figure 3. 19 B), but the 
differences increase with the variation of pH at ionic strength of 1 M (Figure 3. 19 
A) and in 0.15 M PBS (Figure 3. 19 C). In the case of media containing different 
ionic strengths, the values of E for the different samples and media are in the 
range of 5 and 10 kPa, showing no significant differences. The E values of the 
different HA-DVS polymer networks show not differences in media with controlled 
ionic strength (1 M) at pH 7 and 8, but this value is significantly increased at pH 
3 for all the compositions.  
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3.1.2.7 Thermogravimetric analysis 
In order to study the thermal stability, the HA-DVS polymer networks were 
conducted on thermogravimetry equipment from room temperature to 700 ºC. 
With the aim to study the effect of the amount of DVS, thermograms of HA-DVS 
polymer networks were compared with those of native HA and pDVS. From the 
weights recorded at each temperature were determined the thermograms of 
remaining weight (%) and the derivative weight loss (%/ ºC). 
 
 
Figure 3. 20. Remaining weight  thermograms obtained for native HA (black solid line), pDVS (black 
dotted line) and the different HA-DVS polymer networks: solv_HA:DVS_1:0.6 (blue line), 
solv_HA:DVS_1:0.9 (red line) and solv_HA:DVS_1:1.5 (green line). The inset shows a detail of the 
thermograms of native HA and the different HA-DVS polymer networks at low temperatures. 
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Figure 3. 21. Derivative weight loss thermograms obtained for native HA (black solid line) and the 
different HA-DVS polymer networks: solv_HA:DVS 1:0.6 (blue line), solv_HA:DVS 1:0.9 (red line) 
and solv_HA:DVS 1:1.5 (green line). The inset shows a detail of the thermograms of native HA and 
pDVS (black dotted line). 
 
First of all, it should be mentioned that the two different stages observed in the 
HA-DVS polymer networks were overlapped at the current rate employed, 10 
ºC/min, thus the rate was reduced to 1 ºC/min from room temperature to 180 ºC 
and the recorded weight was corrected by the data from the calibration at such 
rate. Figure 3. 21 shows two stages of weight loss in native HA and HA-DVS 
polymer networks; an initial weight loss stage in the range between room 
temperature and 180 ºC, and a second one from 200 to 700 ºC.  Focusing the 
attention in the first weight loss stage (inset in Figure 3. 20), it can be observed a 
similar trend between them but a fast weight loss in native HA compared with HA-
DVS polymer networks. Considering the stabilization of this first stage at 180 ºC, 
these samples show similar values of weight loss, 8.8 ±1.9 ºC. The second 
degradation stage of native HA and HA-DVS polymer networks gave similar 
trends with a final continuous degradation over the whole temperature range. 
Therefore the remaining weight at 700 ºC was considered as the residual content, 
which resulted in invariant values for each sample (30.6 ±2.2 %). On the other 
hand, the thermograms of derivative weight loss (Figure 3. 21) revealed 
discrepancies in the maximum rate of weight loss. The maximums observed in 
the thermograms were correlated with the different degradation stages. 
Therefore, native HA shows the highest rate of weight loss (1.6 ±0.2 %/ºC) at 237 
ºC and the HA-DVS polymer networks had lower rates (between the temperature 
range 205 and 235 ºC). Furthermore, the maximum rate of weight loss resulted 
to be higher in the HA-DVS polymer networks containing greater amounts of 
DVS: 0.8 ±0.0 %/ºC in solv_HA:DVS 1:1.5 samples, 0.8 ±0.0 %/ ºC in 
solv_HA:DVS 1:0.9 samples and 0.7 ±0.00 %/ ºC in solv_HA:DVS 1:0.6 samples. 
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Thermograms of pDVS (Figure 3. 20 and Figure 3. 21) evidence some differences 
respect those of the HA-based materials. The thermogram in pDVS shows 
several overlapped degradations stages between 160 ºC and 350 ºC. Focusing 
the attention in the thermograms of derivative weight loss (Figure 3. 21), three 
maximums corresponding to different degradation stages were observed: 0.7 
±0.0 %/ºC at 226 ºC, 0.4 ±0.0 %/ºC at 290 ºC and 3.4 ±0.0 %/ºC at 335 ºC. 
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3.2 Crosslinked hyaluronan scaffolds 
Crosslinked hyaluronan networks and, particularly, HA-DVS polymer networks 
may constitute a good candidate as implants for tissue engineering purposes. 
The goals of employing HA materials are the natural origin of HA, biodegradability 
and stability against aqueous media when crosslinked with DVS. However, the 
HA-DVS polymer networks lack of internal structure to accomplish an adequate 
cell colonization, and hence tissue regeneration. In this section, the process to 
develop HA-DVS scaffolds containing an interconnected porous structure is 
described, as well as their physicochemical characterization. 
 
3.2.1 Preparation of scaffolds 
There is a broad range of possibilities to provide scaffolds with an interconnected 
porous structure. In this case, HA-DVS scaffolds have been developed 
introducing the crosslinking solution into PEMA templates (see section 2.2.2). In 
order to obtain an optimal sintering of PEMA beads, the best operating 
parameters were adjusted and the resulting templates were morphologically 
analysed by SEM. Moreover, a repetitive process in the development of scaffolds 
was accomplished subjecting templates to a quality control. This quality control 
included morphological characterization (Figure 3. 22) and gravimetric 
determination of the porosity within the template interstices (24.1 ±3.9 %). 
 
 
Figure 3. 22. Morphology of the cross-section of PEMA templates obtained by SEM. 
 
The different HA-DVS scaffolds (scaff_HA:DVS 1:0.6, scaff_HA:DVS 1:0.9 and 
scaff_HA:DVS 1:1.5) were obtained injecting the crosslinking solution, containing 
the HA and DVS, in the interstices of the PEMA templates. However, in order to 
reduce the solution viscosity, the concentration of HA for the crosslinking solution 
was reduced to 30 mg/mL (see section 2.2.2).  
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With the aim to determine the hydrolysis of NaOH on HA at such concentration, 
the molecular weight distribution of HA under these conditions was compared 
with the native one using size exclusion chromatography (described in section 
2.3). 
 
 
Figure 3. 23. Molecular weight distribution of HA chains dissolved in 0.15 M NaCl (solid line) and in 
a solution of 0.2 M NaOH for 24 hours (dotted line). 
 
The HA dissolved in 0.2 M NaOH at 30 mg/mL undergoes a considerable 
reduction of its molecular weight from 1.7 × 106 to 8.0 × 105 Da. However, the 
PDI value is reduced from 4 to 3.6 and the molecular weight distribution shows a 
more symmetric trend. 
After removing the PEMA beads and salts, and subsequent freeze-drying 
process, the HA-DVS scaffolds show a fragile structure and a spongy appearance 
suggesting certain porosity thereof. With the aim to ensure the removal of PEMA 
beads, scaff_HA:DVS 1:0.9, solv_HA:DVS 1:0.9 samples and PEMA beads were 
analysed by thermogravimetry. 
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Figure 3. 24. Remaining weight thermograms of PEMA beads (solid line), and solv_HA:DVS 1:0.9 
(dotted line) and scaff_HA:DVS 1:0.9 (dashed-dotted line). 
 
 
Figure 3. 25. Derivative weight loss thermograms of PEMA beads (solid line), and solv_HA:DVS 
1:0.9 (dotted line) and scaff_HA:DVS 1:0.9 samples (dashed-dotted line). 
 
The thermograms of PEMA beads (Figure 3. 24 and Figure 3. 25) resulted in a 
single and pronounced degradation stage in the temperature range between 300 
and 450 ºC with the highest rate of weight loss around 370 ºC. Moreover, the 
residual content in PEMA results in values below 5 % of the initial weight. On the 
contrary, solvent-cast HA-DVS polymer networks and scaffolds show two stages 
of weight loss: the first one between room temperature and 180 ºC and the 
second one in the temperature range between 200 and 700 ºC. Both HA-DVS 
based materials show similar trends in the entire range of temperatures. 
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However, the first weight loss stage in the scaff_HA:DVS 0.9 samples is faster, 
while the second one is retarded with respect to the solv_HA:DVS 1:0.9 samples, 
showing a displacement in the temperature corresponding to the highest 
degradation rate around 25 ºC (225 ºC and 250 ºC for solv_HA:DVS 1:0.9 and 
scaff_HA:DVS 1:0.9 samples, respectively). 
 
3.2.2 Characterization of scaffolds 
3.2.2.1 Fourier transformed infrared spectroscopy 
In order to address the crosslinking reaction on the HA-DVS scaffolds, the spectra 
of pDVS, native HA and the different HA-DVS scaffolds in KBr were obtained 
using a smart diffuse reflectance FTIR device (see section 2.3). 
 
 
Figure 3. 26. IR spectra of native HA powder, the different HA-DVS scaffolds and pDVS. 
 
Figure 3. 26 shows the different spectra of the mentioned samples. The native 
HA spectrum shows a broad absorption band between 3800 and 3000 cm-1 
attributed to the overlapping of different bond vibrations: the O-H stretching of 
hydroxyl and carboxylic acids and the N-H stretching of amides. The multiple 
peaks in the range between 3000 and 2800 cm-1 are characteristic of the C-H 
stretching of sp3-hybridized carbons. The intense double peak between 1700 and 
1500 cm-1 corresponds to the stretching of associated C=O groups within 
carboxylic acids and amide groups (Amide I) and the bending of N-H groups 
(Amide II). The double peak between 1400 and 1380 cm-1 is attributed to the 
amide group. The intense superposed peaks between 1200-900 cm-1 correspond 
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to different bond vibrations (C-O-C, C-O and C-O-H stretching, N-H bending, and 
O-H and C=O deformation). 
The pDVS spectrum is characterized by intense bands between 3000-2800 cm-1 
attributed to C-H stretching in sp3-hybridized carbons and the two intense bands 
in 1290 cm-1 and 1110 cm-1  corresponding to the S=O asymmetric and symmetric 
stretching, respectively. 
The spectra of the HA-DVS scaffolds show similar characteristic bands than 
those of native HA, but new bands appeared and some native ones were 
significantly different. The intense overlapped bands between 1700 and 1500 cm-
1
 correspond to the C=O stretching of carboxylic acids and amides (Amide I), and 
the N-H bending of amide groups (Amide II), all them are characterized by the 
superposition of three bands showing a symmetric shape. The intense peak of 
the sulfone symmetric stretching is observed at 1080 cm-1 superposed to 
characteristic bands of HA, and this band turns more intense with increasing the 
DVS content. Moreover, the S=O asymmetric stretching appears in the spectra 
of HA-DVS scaffolds as a low-intensity band. 
 
3.2.2.2 Sulphur content and degree of crosslinking 
Similarly to the HA-DVS polymer networks, the HA-DVS scaffolds were analysed 
by elemental analysis with the aim to determine the sulphur content (Table 3. 8), 
and hence the degree of crosslinking was estimate taking into account the 
stoichiometry of the crosslinking of HA with DVS (Figure 1. 6). 
 
Table 3. 8. Atomic weight fraction of nitrogen, carbon, hydrogen and sulphur in the HA-DVS 
scaffolds and native HA. 
Sample 
Atomic weight fraction (in percentage) 
Nitrogen Carbon Hydrogen sulphur 
native HA 3.2 32.7 9.1 0.0 
scaff_HA:DVS 1:0.6 2.9 32.4 8.0 0.6 
scaff_HA:DVS 1:0.9 2.9 32.1 8.4 0.9 
scaff_HA:DVS 1:1.5 2.7 32.4 8.5 1.7 
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The sulphur content resulted in higher values in the HA-DVS scaffolds with higher 
amounts of DVS. Therefore, the sulphur content was compared with the carbon 
and nitrogen content and, taking into account the stoichiometry of the crosslinking 
of HA with DVS, the different parameters of the crosslinking (degree of 
crosslinking, M c and d) were determined (Table 3. 9). 
 
Table 3. 9. Parameters of the HA crosslinked scaffolds with DVS determined by elemental analysis. 
Composition scaff_HA:DVS 1:0.6 
scaff_HA:DVS 
1:0.9 
scaff_HA:DVS 
1:1.5 
degree of crosslinking (%)
 
18.4 20.9 42.6 
M c (kDa) 2.2 1.9 0.9 
d 5.4 4.8 2.3 
 
The parameters collected in Table 3. 9 show that the higher contents of DVS 
increase the degree of crosslinking in the HA-DVS scaffolds, and hence the HA 
molecules contain a lower molecular weight and disaccharide units between 
crosslinks. 
 
3.2.2.3 Morphological characterization 
The morphology of the different HA-DVS scaffolds was evaluated by SEM with 
the aim to assess their adequate interconnected porous structure. At the 
beginning, the HA-DVS scaffolds were swollen in deionized water until the 
equilibrium swelling (3 days). Then, the different scaffolds were subjected to a 
freeze-drying process and a posterior cryofracture obtaining their vertical cross-
section. 
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Figure 3. 27. Images of the inner structure in the different HA-DVS scaffolds obtained by SEM. 
 
The internal structure (Figure 3. 27) and surface (data not shown) between the 
different scaffolds showed no significant differences: in all the cases HA-DVS 
scaffolds showed a highly interconnected and porous structure along their vertical 
cross-section. The porosity due to the PEMA beads was eclipsed by the sheet-
like structure of the bulk material. The thickness of these sheets was measured 
by imageJ software resulting in sizes below 5 μm. Moreover, the inner walls of 
the scaffolds resulted to be uniform without displaying microporosity. On the other 
hand, the interconnection between pores resulted to be spherical and oval with 
variable sizes showing no significant differences between compositions: 76.7 
±20.9 μm in scaff_HA:DVS 1:0.6, 76.0 ±22.1 μm in scaff_HA:DVS 1:0.9 and 82.8 
±25.7 μm in scaff_HA:DVS 1:1.5. 
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3.2.2.4 Porosity 
In order to obtain the macroporosity (large pores) due to the PEMA template and 
the microporosity (small pores) in the bulk material due to the freeze-drying 
process, the porosity of the different HA-DVS scaffolds was determined by 
different methods (see section 2.3). 
 
 
Figure 3. 28. Porosity due to large pores (black bars) and including large and small pores (grey 
bars) in the different HA-DVS scaffolds. The horizontal dashed line shows the averaged porosity 
between samples and method. 
 
Figure 3. 28 shows that the HA-DVS scaffolds contain a very high porosity with 
no significant differences between compositions. Moreover, the porosity due to 
large and small pores resulted in similar values for each composition, except for 
the scaff_HA:DVS 1:1.5 sample. Despite the discrepancies found in the 
scaff_HA:DVS 1:1.5 composition, the porosity value (99.0 ±0.1 %) was 
considered similar for all the compositions and the effect of large and small pores 
in such value was neglected. 
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3.2.2.5 Swelling experiments 
In order to compare the swelling on scaffolds and polymer networks, WI_HA-DVS 
samples were subjected to similar washing and drying processes (see section 
2.2.2). The EWC values of the different materials immersed in 0.15 M PBS and 
deionized water for 3 days were determined (see section 2.3). 
 
 
Figure 3. 29. The EWC value of HA-DVS scaffolds (solid lines) and WI_HA-DVS samples (dashed 
lines) in immersion of 0.15 M PBS (squares) and de-ionized water (circles). Inset shows a zoom of 
the EWC value in WI_HA-DVS samples. Vertical bars represent the standard deviation of each 
experience. 
 
As can be observed in Figure 3. 29, the swelling degree in each media resulted 
much higher on HA-DVS scaffolds (EWC values ranging from 65 to 80) than in 
WI_HA-DVS samples (EWC values ranging from 5 to 11). In general, the EWC 
of the HA-DVS scaffolds resulted in higher values when immersed in 0.15 M PBS 
than those obtained for deionized water. Moreover, the compositions with lower 
amounts of DVS displayed higher EWC values; however, these discrepancies 
showed no significant differences. On the contrary, the EWC in WI_HA-DVS 
samples showed higher values when immersed in deionized water (values 
ranging from 9 to 11) than those determined for 0.15 M PBS (values around 5). 
In the case of WI_HA-DVS samples, differences in swelling depending on the 
immersed medium showed significant differences. However, as the case of HA-
DVS scaffolds, the EWC values between the different WI_HA-DVS samples 
resulted to be similar in both media. 
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3.2.2.6 Compression tests 
Compression tests of HA-DVS scaffolds and WI_HA-DVS samples at equilibrium 
swelling of 0.15 M PBS were conducted with the aim to compare the mechanical 
properties of the HA-DVS bulk material and scaffolds (see section 2.3). In order 
to determine the compatibility of the materials for future brain implants from the 
point of view of their mechanical properties, compression tests of brain tissue of 
postnatal rats were conducted in a similar way. 
  
 
Figure 3. 30. Stress-strain curves of the different WI_HA:DVS compositions (red lines) 
(WI_HA:DVS 1:0.6 (dotted line), WI_HA:DVS 1:0.9 (dashed line) and WI_HA:DVS 1:1.5 (solid line)), 
brain tissue (dashed black line) and HA-DVS scaffolds (blue lines) (scaff_HA:DVS 1:0.6 (dotted 
line), scaff_HA:DVS 1:0.9 (dashed line) and scaff_HA:DVS 1:1.5 (solid line)). Samples were 
measured at equilibrium swelling in 0.15 M PBS. 
 
Figure 3. 30 shows similar trends for the stress-strain curves of the different 
materials; an initial and relative long elastic zone and after a densification region 
a second elastic region, in which the stress increases faster without noticeable 
increasing of strain. In the case of the brain tissue, the curve does not show a 
clearly identifiable densification region. The stress-strain curves of HA-DVS 
scaffolds evidence a very high first elastic region, reaching great strains (up to 
0.8) in the stress range studied. In the Figure 3. 30 can be observed that 
scaff_HA:DVS 1:0.6 and scaff_HA:DVS 1:0.9 samples show similar curves 
reaching strains near 1, while the scaff_HA:DVS 1:1.5 sample shows a relative 
less soft behaviour reaching a strain near 0.8. Moreover, the brain tissue shows 
a less soft behaviour than all the scaffolds compositions, showing a more similar 
behaviour with respect to the scaff_HA:DVS 1:1.5 sample. On the other hand, the 
stress-strain curves of WI_HA-DVS samples show a shorter first elastic region 
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and the stress in the second elastic region increases faster compared with that 
observed in the HA-DVS scaffolds. Therefore, the WI_HA-DVS samples under 
compression reached lower strains in the range studied compared with scaffolds: 
values around 0.4 for WI_HA:DVS 1:1.5, 0.5 for WI_HA:DVS 1:0.9 and 0.8 for 
WI_HA:DVS 1:0.6. The WI_HA:DVS 1:0.6 sample shows a similar initial slope to 
those of scaff_HA:DVS 1:0.6 and scaff_HA:DVS 1:0.9 samples, but it resulted in 
a faster increasing of stress along the second elastic region. 
In order to compare the mechanical properties of the different materials and brain 
tissue, different parameters were calculated from the stress strain curves: the 
initial modulus (E0), final modulus (Ef) and final strain (εf). The E0 value was 
determined from the initial slope from strains between 0 and 0.1. The Ef  value 
was determined from the slope in the region compressing stresses between 3 
and 3.5 kPa and from the intersection of this slope with the strain axis was defined 
the εf value. 
 
 
Figure 3. 31. Parameters of WI_HA-DVS samples (circles), HA-DVS scaffolds (squares) and rat 
brain (horizontal solid line) obtained from the compression tests. A) Initial modulus, B) final modulus 
and C) final strain. 
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With respect to the initial modulus (Figure 3. 31-A), the scaffolds show values in 
the range between 2 and 4 kPa, while this modulus is slightly higher for WI_HA-
DVS samples showing values from 2 to 8 kPa. These differences between 
samples become significant with increasing the DVS content. However, in both 
materials, the value of E0 slightly increases in samples with higher amounts of 
DVS. Moreover, the different HA-DVS scaffolds show smaller initial modulus 
values than brain tissue (4.8 ±0.4 kPa) arising more similar values with 
scaff_HA:DVS 1:1.5 samples (4.0 ±0.0 kPa). 
The Figure 3. 31-B shows that the Ef values of HA-DVS scaffolds (from 14 to 35 
kPa) resulted lower than that of WI_HA-DVS samples (from 7 to 14 kPa). The Ef 
values resulted in a different trend compared with that of the initial modulus: the 
higher the molar ratio of DVS to HA in the samples, the lower the Ef values. 
However, differences in Ef in the scaffolds resulted to not be significant between 
compositions, while WI_HA-DVS samples showed different Ef values only for 
WI_HA:DVS 1:1.5 samples. In this case, brain tissue showed lower values of Ef 
(5.1 ±0.4 kPa) than the different materials, and differences between the values of 
initial modulus and Ef resulted to be minimal. On the other hand, the εf revealed 
in general higher values in scaffolds ranging from 0.6 to 0.7 in scaff_HA:DVS 
1:0.6 and scaff_HA:DVS 1:0.9 samples and values from 0.3 to 0.5 in 
scaff_HA:DVS 1:1.5 samples. In the case of WI_HA-DVS samples the values of 
εf resulted to have a maximum in WI_HA:DVS 1:0.6 samples (0.7) with a 
significant decreasing in WI_HA:DVS 1:0.9 and WI_HA:DVS 1:1.5 samples (0.25 
and 0.16, respectively). 
 
3.2.2.7 Thermogravimetric analysis 
In order to assess the thermal degradation stages, the different HA-DVS scaffolds 
were subjected to a thermogravimetric analysis from room temperature to 700 ºC 
(see section 2.3). Additionally, the native HA was conducted in similar conditions 
with the aim to compare its thermal stability with that of the scaffolds. 
Thermogravimetric analyses allow obtaining two different thermograms showing 
the remaining weight and the derivative weight loss as functions of the 
temperature. 
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Figure 3. 32. Remaining weight thermograms of the native HA (solid line) and the different HA-DVS 
scaffolds: scaff_HA:DVS 1:0.6 (dashed line), scaff_HA:DVS 1:0.9 (dashed-dotted line) and 
scaff_HA:DVS 1:1.5 (dotted line). 
 
 
Figure 3. 33. Derivative weight loss thermograms of the native HA (solid line) and the different HA-
DVS scaffolds: scaff_HA:DVS 1:0.6 (dashed line), scaff_HA:DVS 1:0.9 (dashed-dotted line) and 
scaff_HA:DVS 1:1.5 (dotted line). 
 
Figure 3. 32 and Figure 3. 33 show that the different materials and native HA yield 
two differentiated stages of weight loss; the first one occurs in the temperature 
range between room temperature and 180 ºC, and the second one from 225 ºC 
to the final temperature recorded (700 ºC). As can be observed in the 
thermograms, some differences were evidenced between native HA and HA-DVS 
scaffolds; however, differences between HA-DVS scaffolds compositions 
resulted to be non-significant different and could be neglected. Therefore, the 
Results 
 
- 150 - 
 
thermal parameters of the HA-DVS scaffolds were averaged between the 
different compositions. In the first weight loss stage, the different HA-DVS 
scaffolds and native HA show similar trends, however, at the end of this first 
stage, native HA shows lower weight loss (8.1 ±0.6 %) than the different HA-DVS 
scaffolds (13.0 ±1.7 %). 
In the second degradation stage, the thermograms of native HA and HA-DVS 
scaffolds give similar trends showing continuity in the loss of weight at 700 ºC. 
The percentage of residual species, determined from the remaining weight at 700 
ºC, gave similar values in the different HA-DVS scaffolds (22.9 ±2.4 %), while this 
value resulted in higher values in native HA (31.7 ±4.0 %). 
On the other hand, the thermograms of derivative weight loss (Figure 3. 33) arise 
discrepancies in the rate of weight loss between the HA-DVS scaffolds and native 
HA. The maximum degradation rate corresponding to the first stage of 
degradation shows no significant differences between the HA-DVS scaffolds and 
native HA, showing an averaged value of 0.2 ±0.0 %/ºC. However, in the second 
degradation stage, a noticeable difference between the maximum degradation 
rate of native HA (1.6 ±0.2 %/ºC) and HA-DVS scaffolds (1.0 ±0.2 %/ºC) can be 
observed. 
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3.3 Poly(methacrylated-co-ethyl acrylate) copolymer networks 
The methacrylated HA macromer, MeHA, was synthesized by the esterification 
reaction between native HA and MA. In order to tailor the swelling degree, 
mechanical properties and degradability, the MeHA macromer was 
copolymerized with EA obtaining semi-degradable copolymers. The EA was 
chosen as monomer because of the biostable nature of PEA polymer networks 
possess relative low mechanical properties and low swelling ratios compared with 
other similar polymers, which make it attractive on obtaining materials with 
controllable properties for soft tissue engineering, and particularly for neural 
regeneration purposes. 
 
3.3.1 Methacrylated hyaluronan macromer 
3.3.1.1 Synthesis of methacrylated hyaluronan macromer 
In order to obtain poly(MeHA-co-EA) copolymer networks, HA was modified 
leading to chains with vinyl groups (described in section 2.2.3). Therefore, 
methacrylated hyaluronan (MeHA) was synthesized by adding 20-fold excess of 
methacrylic anhydride (MA) to a solution of HA in 0.2 M NaOH. The excess of 
MA is required due to the low efficiency of this reaction in aqueous solutions. 
Moreover, the basic media prevents the formation of excessive methacrylic acid 
along the reaction. The MA was added dropwise in the HA solution under 
vigorous stirring due to the low solubility of this reagent in aqueous media and 
avoiding phase separation as possible. 
After the reaction, the impure product resulted in a white, viscous and 
homogenous solution. During the purification process, and particularly in the 
precipitation with acetone, the product became a solid and white paste hindering 
its posterior solubility in water. However, the subsequent purification steps 
removed the insoluble components of the product. After the freeze-drying 
process, the product showed a white powdery appearance similar to the native 
HA. The reaction yield, amount of product obtained with respect to the initial HA 
employed, was calculated from three different batches resulting in an averaged 
value of 56.6 ± 6.9 %. 
In order to determine changes in the molecular weight, the MeHA product and 
native HA were dissolved in 0.15 M NaCl at a concentration of 1 mg/mL, and 
these solutions were passed through gel permeation columns (see section 2.3). 
The different parameters (Mw, Mn and PDI) and the molecular weight distribution 
of native and modified HA were determined similarly to those presented in 
sections 3.1.1 and 3.2.1. 
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Figure 3. 34. Molecular weight distribution of HA (solid line) and MeHA (dashed line). 
 
The Figure 3. 34 shows the differences of the molecular weight distribution 
between native HA and MeHA. The native HA resulted in a Mw value of 1.74 MDa 
with a PDI value of 4. However, the MeHA product resulted in higher Mw (2.48 
MDa) and PDI (13.3) values. 
 
3.3.1.2 Fourier transformed infrared spectroscopy 
In order to assess the methacrylation of HA, the spectra of native HA and MeHA 
powders were obtained by FTIR spectroscopy (see section 2.3). The MeHA 
spectrum was compared with that of native HA. 
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Figure 3. 35. IR spectra of native HA powder and MeHA. 
 
The characteristic IR absorption bands of native HA were described in section 
3.2.2.1. The broad band between 3600-3000 cm-1 is attributed to the O-H and N-
H stretching of associated hydroxyls in acids and amides, respectively. The 
multiple peaks in the range 3000-2800 cm-1 are characteristic of the C-H 
stretching. The overlapped bands between 1800 and 1600 cm-1 correspond to 
C=O stretching of carboxylic acids and amides (Amide I) and N-H bending of 
amide groups (Amide II). The peak at 1400 cm-1 is attributed to the C-N stretching. 
The intense overlapped peaks between 1200-900 cm-1 correspond to other bond 
vibrations (C-O-C, C-O and C-O-H stretching, N-H bending, and O-H and C=O 
deformation). 
On the other hand, the spectrum of MeHA powder (Figure 3. 35) shows 
similarities with that of the native HA. However, with a detailed study of both 
spectra small differences may be appreciated. The broad band between 3600 
and 2400 cm-1 revealed maximums at different frequencies in native HA (3100 
cm-1) and MeHA (3300 cm-1), and the band of 3600 cm-1 corresponding to free O-
H stretching becomes less intense. The overlapped bands between 1800 and 
1600 cm-1 present different shapes; in the case of native HA the bands 
corresponding to the C=O stretching of carboxylic acids and amides shows an 
asymmetric distribution, while these bands in the MeHA resulted in a higher 
symmetry showing an intense peak centred at 1600 cm-1. The intense overlapped 
peaks between 1200-900 cm-1 show an increase of the intensity at 1000 cm-1, 
which is attributed with the C=C-H bending. 
 
 
Results 
 
- 154 - 
 
3.3.1.3 Determination of the degree of methacrylation 
In order to assess the efficiency of methacrylation and quantify the degree of 
methacrylation of the MeHA macromer, the 1H-NMR spectra of native HA and 
MeHA were compared. The 1H-NMR spectrum of MeHA was obtained from a 
homogeneous mixture of powder from three different batches. 
 
 
Figure 3. 36. 1H-NMR spectrum of HA (A) and MeHA (B). The arrows show the characteristic peaks 
of methacrylate groups. 
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The 1H-NMR spectrum (Figure 3. 36) of native HA revealed signals at three 
different regions. The first one between 1 and 2 ppm shows an intense singlet 
associated with the three protons of the methyl group in acetamide. The second 
region lies between 3 and 4 ppm and contains a complex pattern that is 
associated with several protons of the HA backbone. Finally, the third region 
comprised between 4 and 4.5 ppm shows two peaks overlapped with the intense 
D2O signal, and these peaks are attributed to hydrogens in the HA backbone that 
are close to electronegative groups (ether linkages). On the other hand, the 
MeHA spectrum revealed three new bands attributed to the methacrylate group: 
at 6.10 and 5.60 ppm associated with the protons within the vinyl group and at 
1.85 ppm attributed to the three protons in the allyl group. 
The degree of methacrylation (methacrylate groups per HA disaccharide unit) 
was determined comparing the relative integrated intensities of the five 
methacrylate protons in MeHA (peaks at 6.10, 5.60 and 1.85 ppm) and the three 
methyl protons within the HA acetamide (peak at 1.93 ppm), resulting in a value 
of 12.5 %. 
 
3.3.2 Synthesis of poly(methacrylated-co-ethyl acrylate) copolymer 
networks 
After addressing the methacrylation of HA, the macromer was employed in the 
copolymerization reaction of MeHA and EA with the aim to obtain poly(MeHA-co-
EA) copolymer networks. In order to evaluate differences in the mechanical 
properties and the stability of the poly(MeHA-co-EA) copolymer networks, 
copolymerization was carried out using different weight ratios of MeHA to EA, 
including the homopolymer networks (see Table 2. 3). Due to the different polarity 
of both components, monomers were dissolved in a mixture of solvents 
(DMF/0.15 M PBS, 1/1 (v/v)). Therefore, salts in the polymer solutions were 
added with the aim of decreasing the viscosity of MeHA. In addition, the low 
solubility of both monomers in the solution limited the monomeric concentration, 
and the copolymerization reactions were carried out as very dilute ones. In order 
to assess the reaction of the macromer and monomer chains, MBAA (5 % with 
respect to the amount of MeHA and/or EA in the copolymerization reaction) was 
added as crosslinking agent and the reaction was performed with a considerable 
amount of thermal initiator (1 % with respect to the amount of MeHA and/or EA 
in the copolymerization reaction). 
After the thermal copolymerization, the poly(MeHA-co-EA) copolymer networks 
showed a homogeneous, whitish and soft appearance. During the washing steps 
the poly(MeHA-co-EA) compositions with larger amounts of MeHA lead to a 
transparent hydrogel, while the ones with larger amounts of EA resulted to give 
a whitish colour. After the purification and freeze-drying process, the xerogels 
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where characterized by different techniques with the aim to determine the 
composition and phase distribution of both components.  
 
3.3.2.1 Fourier transformed infrared spectroscopy 
In order to assess the incorporation of polymerized MeHA and PEA in the 
poly(MeHA-co-EA) copolymer networks, each composition was chemically 
studied by Fourier transformed infrared spectroscopy (FTIR) (see section 2.3). In 
order to determine variations in the infrared bands due to the different chemical 
groups of each component, spectra of different copolymer networks and those of 
the homopolymer networks were recorded. 
 
 
 Figure 3. 37. IR spectra of the different poly(MeHA-co-EA) copolymer and homopolymer 
networks. 
 
Figure 3. 37 shows that the spectrum of MeHA:PEA 1:0 samples contains a broad 
band between 3800-2800 cm-1 attributed to different bond vibrations: associated 
O-H stretching of hydroxyl groups and associated N-H stretching of amide 
groups. The bands in the range between 3000 and 2800 cm-1 are characteristic 
of C-H stretching in sp3-hybridized carbons. The broad band between 1700 and 
1500 cm-1 corresponds to the overlapping of the C=O stretching within the 
carboxylate and amide (Amide I), and the N-H bending of amide groups (Amide 
II). The peak at 1400 cm-1 is characteristic of the C-N stretching of amide groups. 
The intense superposed peaks between 1200-900 cm-1 correspond to several 
bond vibrations (C-O-C, C-O and C-O-H stretching, N-H bending, and O-H and 
C=O deformation). 
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The PEA spectrum shows a broad absorbance band centred at 3400 cm-1 with 
low intensity attributed to N-H groups of the crosslinking agent, MBAA, and O-H 
stretching of bound water. The overlapping of multiple peaks between 3000 and 
2800 cm-1 is associated with the C-H stretching in sp3-hybridized carbons. The 
intense peak at 1735 cm-1 is attributed to free C=O stretching of ester groups and 
a lower peak at 1660 cm-1 is associated to the carbonyls of the MBBA (Amide I). 
Multiple bands in the region from 1000 to 1200 cm-1 are attributed to C-O-H and 
C-O stretching. 
 
The different intermediate compositions of poly(MeHA-co-EA) copolymer 
networks show characteristic bands belonging to groups of the homopolymer 
networks. Therefore, larger amounts of MeHA in the copolymer networks resulted 
in changes in the spectra, such as a more intense band between 3000 cm-1 and 
2800 cm-1 , between 1600 cm-1 and 1500 cm-1 and the peaks around 1400 cm-1 
and 1000 cm-1. Moreover, the increase of MeHA in the copolymer networks 
provokes a major overlapping of different bands and peaks. Moreover, as can be 
observed in Figure 3. 37, the intense peak at 1735 cm-1 corresponding to the C=O 
stretching and the overlapped bands centred at 1600 cm-1 are attributed to 
carboxylates, Amide I and Amide II remain independent for all the intermediated 
compositions studied. However, bands at 1660 cm-1 attributed to the carbonyl 
stretching of the MBBA are overlapped with the ones at 1600 cm-1 corresponding 
to the Amide I of the MeHA component. 
 
3.3.2.2 Swelling experiments 
In order to determine the influence of the nominal PEA weight fraction (WEA) on 
swelling, the EWC of the different poly(MeHA-co-EA) copolymer networks and 
PEA was evaluated (see section 2.3). The EWC was studied on samples after 3 
days immersed in 0.15 M PBS with the aim to mimic the swelling in physiological 
conditions and shield electrostatic interactions because of the anionic nature of 
HA and hence MeHA. 
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Figure 3. 38. The equilibrium water content of the different poly(MeHA-co-EA) copolymer networks 
as function of WEA. 
 
The Figure 3. 38 shows that the EWC value significantly decreases for higher 
weight fractions of EA. The MeHA homopolymer resulted in a value of EWC of 
94.7 ±1.8, and small increments in the EA content (WEA = 0.2) halve such value 
(49.4 ±1.2). Moreover, greater WEA produces a continuous reduction of the EWC 
value. However, the reduction of the EWC values turns stable in samples with 
WEA beyond 0.7 until reaching values of 4.8 ±0.5 in samples with the higher 
content of EA. The PEA homopolymer resulted in a value of 0.07 ±0.02. 
 
3.3.2.3 Compression tests 
In order to determine the influence of the EA to MeHA weight ratio on the 
mechanical properties of the copolymer networks, the samples were studied 
under unconfined compression. The compression was conducted on the different 
samples at equilibrium swelling in 0.15 M PBS. From the compression tests, the 
stress-strain curves were determined employing Equation 2. 9. Additionally, the 
stress-strain curves were used to calculate the mechanical parameters of the 
different copolymer networks: initial modulus, E0, final modulus, Ef, and final 
strain, εf. 
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Figure 3. 39. Stress-strain curves of the different poly(MeHA-co-EA) copolymer networks. The 
study was conducted with samples swollen in 0.15 M PBS to equilibrium. 
 
Figure 3. 39 shows the mechanical behaviour of the different compositions of 
poly(MeHA-co-EA) copolymer networks. In the figure, it can be observed that all 
the compositions had a similar mechanical behaviour under compression, and 
the stress-strain curves had a similar trend: an initial linear stage and, after a 
small transition region, the curves display a vertical asymptotic behaviour at 
advanced compression. However, significant differences were found when 
changing the composition: samples with higher amounts of MeHA widen the 
linear region and, hence the vertical asymptote was shown at greater strains. 
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Figure 3. 40. Parameters of the poly(MeHA-co-EA) copolymer networks obtained from the stress-
strain curves: A) Initial modulus, B) final modulus and C) final strain. 
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Figure 3. 40 shows the parameters determined from the stress-strain curves from 
the compositions plotted in Figure 3. 39. The determined parameters showed 
differences depending on the nominal PEA, weight ratio of EA to MeHA in the 
copolymer networks. 
The E0 value (Figure 3. 40 A) was found to be in the range between 0.5 and 2.5 
kPa in the different samples. This modulus increased faster its value from 0.7 kPa 
in samples with EA weight fractions of 0.5 until reaching values of 1.4 kPa in 
samples with EA weight fractions of 0.3. Moreover, this value of E0 became stable 
in samples with higher content of EA. However, the value of E0 increases 
significantly with respect to each other composition (2.1 kPa) in the copolymer 
network with the highest content of EA. 
The Ef value (Figure 3. 40 B), which is related with the strain when the vertical 
asymptote is reached, shows a different trend between the different samples than 
for the E0 values. Moreover, Ef had relative higher values than E0 and resulted to 
be in the range from 15 to 37 kPa. Therefore, the trend of the Ef showed 
decreasing values in compositions with higher EA weight fractions. However, in 
samples with the highest weight fraction of EA, the Ef value seemed to reach a 
stable behaviour. 
The εf values (Figure 3. 40 C) in the different copolymer networks resulted to have 
decreasing values (from 0.75 to 0.5) with respect to the EA weight fraction. 
Therefore, the εf value was significantly reduced in samples with higher amounts 
of EA, (WEA between 0.83 and 0.91). Therefore, the samples with larger amounts 
of EA reached lower strains under the load range studied. 
 
3.3.2.4 Morphological characterization 
In order to determine the macroscopic integration of both components within the 
poly(MeHA-co-EA) copolymer networks and the structural changes between 
compositions, the inner morphology of different compositions was analysed by 
scanning electron microscopy (section 2.3). 
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Figure 3. 41. Cross-section of MeHA:PEA 1:0 (A), MeHA:PEA 1:0.5 (B), MeHA:PEA 1:1 (C), 
MeHA:PEA 1:5 (D), MeHA:PEA 1:10 (E) copolymer networks, and PEA homopolymer (F). Scale bar 
600 μm. 
 
Figure 3. 41 displays the inner structure in the different copolymer networks and 
PEA homopolymer network. The MeHA:PEA 1:0 sample showed a porous 
structure with a sheet-like shape. The PEA homopolymer network shows a flat 
non-porous structure. The different copolymer networks show continuous porous 
flat structures with circular porous with different sizes. However, this structure 
becomes more closed with increasing WEA. Therefore, the MeHA:PEA 1:10 
sample showed a closed and unstructured inner matrix. 
 
3.3.2.5 Thermogravimetric analysis 
In order to determine the thermal stability and degradation stages, the different 
poly(MeHA-co-EA) copolymer networks were analysed by thermogravimetry  
from room temperature to 700 ºC (see section 2.3). Moreover, the thermal 
degradation of the intermediate copolymers were compared with the MeHA:PEA 
1:0 and PEA samples with the aim of investigating some change in thermal 
behaviour due to the incorporation of both polymers. From the thermogravimetric 
analyses, the corresponding thermograms of remaining weight and derivative 
weight loss as functions of the temperature were obtained. Additionally, 
thermograms were employed to calculate some thermal parameters including 
maximum rate of weight loss in each weight loss stage, weight remaining after 
each stage and residual content at 700 ºC. 
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Figure 3. 42. Remaining weight (A) and derivative weight loss (B) thermograms of the different 
poly(MeHA-co-EA) copolymer networks: MeHA:PEA 1:0 (black line), MeHA:PEA 1:0.5 (green line), 
MeHA:PEA 1:1 (blue line), MeHA:PEA 1:2 (orange line), MeHA:PEA 1:5 (cyan line), MeHA:PEA 
1:10 (purple line) and PEA (red line). The inset in “A” shows a detail of the thermograms at low 
temperatures. The Inset in “B” shows the maximum rate of weight loss between 200 and 300 ºC 
(red circles) and between 300 ºC and 500 ºC (blue circles) as function of WEA. 
 
As can be observed in Figure 3. 42, the thermograms of the homopolymers, 
MeHA:PEA 1:0 and PEA samples, revealed two and one degradation stages, 
respectively. The thermogram of the MeHA:PEA 1:0 sample showed a first weight 
loss step from room temperature to 180 ºC and a second one from 200 ºC until 
the final temperature recorded. The thermogram of the PEA homopolymer 
network contains a unique degradation stage from 220 ºC to 500 ºC. The 
thermograms of the intermediate poly(MeHA-co-EA) copolymer networks 
resulted to have three different degradation stages, and each one is located in 
the temperature range of those corresponding to the homopolymers: the two early 
weight loss stages were assumed to the MeHA component and the last one to 
the PEA matrix. However, in Figure 3. 42, it can be observed that the second 
weight loss stage is overlapped with the third one. On the other hand, the 
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homopolymer networks resulted to have a residual content of 23.2 % in the 
MeHA:PEA 1:0 sample and 3.1 % in PEA homopolymer, whereas the 
intermediate copolymer networks showed residual contents with values between 
those corresponding to the homopolymer networks (see Table 3. 10). 
At the first weight loss stage, in samples containing MeHA, the different materials 
show similar trends. However, in general, the lower the amounts of MeHA in the 
samples, the lower the maximum rate of weight loss and weight loss at the end 
of such stage (see Table 3. 10). Moreover, the maximum rate of weight loss in 
the intermediate compositions (46 ºC) is reached at earlier temperatures than that 
of the MeHA homopolymer network (72 ºC). 
In the second stage of degradation, in the samples containing MeHA, it can be 
observed as the weight loss is higher in the MeHA:PEA 1:0 samples and it 
becomes lower in samples with larger amounts of EA. Moreover, the maximum 
degradation rate appears at similar temperature for all the mentioned samples, 
but the higher the amounts of MeHA, the lower the maximum weight loss rate 
(see Table 3. 10). The PEA homopolymer network did not reveal any degradation 
stage corresponding to this temperature range. 
The third degradation stage was found in samples containing PEA. In this case, 
decreasing the EA content in the poly(MeHA-co-EA) copolymer networks 
resulted in a relative lower weight loss in this stage. PEA homopolymer networks 
resulted to have a higher maximum degradation rate than the intermediate 
compositions (see Table 3. 10). Moreover, larger amounts of MeHA in the 
samples resulted in lower degradation rates. In the case of poly(MeHA-co-EA) 
copolymer networks, such maximum was displaced to lower temperatures with 
increasing the MeHA content in the samples. 
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Table 3. 10. Parameters determined from the TGA thermograms of different poly(MeHA-co-EA) 
copolymer networks. 
Copolymer 
network 
composition 
Remaining 
weight after 
the first 
stage (%) 
Maximum rate of 
weight loss in 
the second stage 
Maximum rate 
of weight loss 
in the third 
stage 
Residual 
content 
(%) 
MeHA:PEA 1:0 86.9 1.2 0.0 23.2 
MeHA:PEA 1:1 92.1 0.5 0.6 17.9 
MeHA:PEA 1:2 94.8 0.4 1.0 14.6 
MeHA:PEA 1:5 97.7 0.2 1.4 5.2 
MeHA:PEA 1:10 98.9 0.1 1.8 10.2 
PEA 99.7 ---- 2.0 3.1 
 
3.3.2.6 Differential scanning calorimetry 
In order to determine thermal transitions in the different poly(MeHA-co-EA) 
copolymer networks, different compositions of such copolymers and the 
homopolymer networks were analysed by differential scanning calorimetry 
(DSC). The analysis was conducted in the temperature range between -60 ºC 
and 30 ºC and was performed for samples after the freeze-drying process and 
after an additional drying (see section 2.3) with the aim of removing possible 
bound water. The analysis of homopolymer and copolymer networks was 
performed with the aim of observing some changes in thermal transitions due to 
the incorporation of both components. From the DSC analyses, the 
corresponding thermograms, from the normalization of the recorded heat flow by 
the mass of the sample and the rate of heating, were obtained. Additionally, 
thermograms were employed to determine the glass transition temperature by 
the inflexion point method (Table 3. 11). 
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Figure 3. 43. DSC scans of the different poly(MeHA-co-EA) copolymer networks after the freeze-
drying (A) and an additional drying step (B). 
 
The DSC thermograms after the freeze-drying process (Figure 3. 43-A) and after 
additional drying (Figure 3. 43-B) showed analogous trends. The thermograms of 
each composition show a main transition corresponding to the glass transition, in 
samples after the freeze-drying process (Tg1) and after the additional drying (Tg2) 
(see Table 3. 11). 
Figure 3. 43-A shows the DSC thermograms of the homopolymer networks 
(MeHA:PEA 1:0 and PEA) and different compositions of the poly(MeHA-co-EA) 
copolymer networks after the freeze-drying process. The vitreous transition (Tg1) 
in the PEA homopolymer network and in the different poly(MeHA:PEA) copolymer 
networks was displayed at different temperatures. Therefore, PEA showed the 
glass transition around -1.5 ºC, while those in the different copolymer networks 
was displaced to lower temperatures, around -10 ºC, (see Table 3. 12). Moreover, 
among the different copolymer networks, the glass transition was observed at 
similar temperatures, but its amplitude was reduced with increasing the MeHA 
content. In the case of MeHA:PEA 1:0 sample the glass transition was not 
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observed. In the thermograms of samples containing MeHA, a change in the heat 
flow was observed at 5 ºC until the final temperature recorded. This phenomenon 
yields an endothermic change and its intensity is more significant in samples with 
higher amounts of MeHA. 
Figure 3. 43-B shows the thermograms of the different samples after the 
additional drying process. In this case, the endothermic change from 5 ºC to 30 
ºC in samples containing MeHA was not observed. On the other hand, the glass 
transition process (Tg2) occurs at similar temperatures than in the series without 
additional drying process. Therefore, PEA homopolymers had the glass transition 
process at 1.2 ºC, while the copolymer networks show a displacement to lower 
temperatures (around -10 ºC). However, the increment of MeHA content yields to 
a reduction in the change of the heat flow intensity through the glass transition.  
Considering that PEA constitutes a completely amorphous phase in all the 
compositions, the experimental PEA content in them was estimated from the 
change in the normalized heat flow through the glass transition. Therefore, the 
experimental PEA fraction in each copolymer network was determined from the 
ratio between the change in the normalized heat flow of each composition and 
the one of the PEA homopolymer (Table 3. 11). The experimental PEA content 
was also obtained from the thermograms of the samples after the freeze-drying 
process (WPEA1) and the ones after the additional drying process (WPEA2). The 
experimental PEA content determined from both sample groups was compared 
with the nominal one, referred as the EA weight fraction (WEA) employed in the 
copolymerization reaction. 
 
Table 3. 11. Temperature of glass transition and PEA weight fraction in the copolymer networks. 
WEA 0 0.3 0.5 0.7 0.8 0.9 1 
Tg1 ( ºC) --- -8.91 -9.06 -10.73 -10.19 -10.79 -1.46 
Tg2 ( ºC) --- -12.56 -7.72 -10.39 -9.68 -9.69 1.22 
WPEA1 0.00 0.33 0.30 0.43 0.61 0.81 1.00 
WPEA2 0.00 0.23 0.24 0.48 0.60 0.86 1.00 
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3.3.2.7 Dynamic mechanical thermal analysis 
Dynamic mechanical thermal analysis (DMTA) of the different homopolymer and 
copolymer networks were performed with the aim of evaluating variations in the 
mechanical properties in the temperature range from -60 ºC to 60 ºC (see section 
2.3). Therefore, those changes in mechanical properties are related with 
transitions in the motion of the polymer chains of both components due to 
temperature variations. These differences were measured by DMTA recording 
the variation of the storage and loss modulus (E’ and E’’, respectively) as function 
of the temperature. Moreover, the ratio between E’’ and E’ (tan δ), which 
constitutes a loss factor, was employed as an estimation of the viscoelastic 
behaviour. 
 
 
Figure 3. 44. Dynamic-mechanical properties of the different poly(MeHA-co-EA) copolymer 
networks: MeHA:PEA 1:0 (blue line), MeHA:PEA 1:1 (red line), MeHA:PEA 1:2 (green line), 
MeHA:PEA 1:5 (cyan line), MeHA:PEA 1:10 (purple line), and PEA (orange line). (A) Thermograms 
of E’/E’
-60 ºC. (B) Thermograms of the loss tangent, tan δ, the arrow indicates the axis for PEA 
homopolymer network. Inset in “A” shows the value of E’/E’
-60 ºC at 60 ºC as function of the WEA. 
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Figure 3. 44-A shows the variation in the storage modulus as function of the 
temperature for different copolymers and both homopolymer networks. In 
general, the samples show the principal mechanical-dynamical relaxation from -
30 ºC to 50 ºC increasing its amplitude for samples with higher weight fractions 
of EA. However, this transition was not observed for MeHA:PEA 1:0 and 
MeHA:PEA 1:1 samples. Therefore, this transition was attributed to the glass 
transition of the PEA homopolymer network. At temperatures below the principal 
transition (-30 ºC), the PEA homopolymer network shows the highest storage 
modulus value (around 2 × 109 Pa), whereas this modulus for copolymer and 
MeHA homopolymer networks resulted in much lower values (between 1 × 107 
and 2 × 108). Moreover, this value of modulus decreased for copolymer networks 
with lower amounts of EA. In the region of temperatures above the transition, the 
storage modulus values evidenced a different behaviour. In this case, the PEA 
homopolymer network resulted in lower modulus values (around 4 × 105 Pa), 
while the copolymer and the MeHA homopolymer networks displayed slightly 
higher values (between 9 × 106 and 1.6 × 107 Pa). Taking into account the 
representation of Figure 3. 44 where the storage modulus is showed as the ratio 
between E’ at each temperature and E’ at -60º, a reduction in such ratio can be 
appreciated for samples containing larger amounts of EA at temperatures above 
the main transition. This observation is clearly displayed in the inset of Figure 3. 
44. 
Figure 3. 44-B shows the loss tangent, tan δ, as function of the temperature. The 
PEA homopolymer network resulted to show the highest loss tangent value (2.8) 
and copolymer networks showed much lower values (from 0.34 to 0.08), 
decreasing such value in samples with a lower weight fraction of EA.  Despite the 
observed changes in the loss tangent of the MeHA:PEA 1:0 and MeHA:PEA 1:1 
samples, their respective maximums were not well defined and were not taken 
into account. The maximum of the loss tangent is manifested at 2.2 ºC, whereas 
the corresponding ones of the copolymer networks was displaced to lower 
temperatures (between -1 and -5  ºC); however, the higher the EA weight fraction, 
the lower the temperature at which appeared the maximum. 
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3.4 Enzymatic degradation 
In order to somehow predict their behaviour in physiological conditions, 
enzymatic degradation of the different HA-based materials (solv_HA:DVS 1:0.9 
samples, HA-DVS scaffolds and poly(MeHA-co-EA) copolymer networks) was 
carried out in buffer medium consisting in 0.15 M PBS containing 10 units/mL of 
hyaluronidase at 37 ºC (see section 2.3). The employed hyaluronidase is a 
mammal endo-β-N-acetylhexosaminidase (PH-20) which possesses hydrolase 
activity, yielding as final products small oligosaccharides. The biodegradation of 
the HA-based materials and its effects were assessed analysing changes in some 
parameters at different degradation times: weight loss, equilibrium water content, 
morphology of degraded samples and molecular weight distribution of by-
products. 
 
3.4.1 Determination of weight loss 
The weight loss of the different samples after the enzymatic degradation was 
evaluated by comparing the remaining weight at different time points (up to 56 
days) with the initial one. In this study, the effect of enzymatic digestion on the 
weight loss of HA-DVS scaffolds and poly(MeHA-co-EA) copolymer networks 
was evaluated separately. The degradation of the solv_HA:DVS 1:0.9 samples 
and HA-DVS scaffolds was compared. In order to determine some hydrolysis due 
to the effect of 0.15 M PBS, samples swollen at equilibrium for 3 and 56 days 
were taken as controls. 
 
 
Figure 3. 45. Percentage of weight loss of solv_HA:DVS 1:0.9 (circles) and HA-DVS scaffolds: 
scaff_HA:DVS 1:0.6 (asterisks), scaff_HA:DVS 1:0.9 (squares) and scaff_HA:DVS 1:1.5 
(diamonds), at different degradation times. 
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.  
Figure 3. 46. Weight loss at different degradation times of poly(MeHA-co-EA) polymer networks: 
MeHA:PEA 1:0 (asterisks), MeHA:PEA 1:1 (squares) and MeHA:PEA 1:10 (circles). 
 
Figure 3. 45 and Figure 3. 46 display significant differences in terms of the effect 
of hyaluronidase in the weight loss depending on the type of sample. Therefore, 
the solv_HA:DVS 1:0.9 materials show the highest digestion rates yielding to a 
complete degradation after 3 days. Moreover, the degradation of these samples 
can be clearly observed after 6 hours in the enzymatic solution. The different 
samples immersed in 0.15 M PBS for 3 and 56 days showed around 2 % of weight 
loss. 
The exposition of the different HA-DVS scaffolds to hyaluronidase (Figure 3. 45) 
resulted in a non-significant effect in terms of their weight loss along the studied 
period (in most cases weight loss resulted below 15 %). Moreover, the weight 
losses of these materials subjected to the degradation process and controls 
(samples immersed in 0.15 M PBS) resulted in similar values (in all cases the 
weight loss was below 15 %). 
The enzymatic degradation of poly(MeHA-co-EA) copolymer networks (Figure 3. 
46) was found to depend on the EA weight fraction employed in the 
copolymerization reaction. The MeHA:PEA 1:0 samples suffer complete weight 
loss between 14 and 28 days and the degradation is observed after one day in 
the enzymatic solution. However, the MeHA:PEA 1:1 and MeHA:PEA 1:10 
samples are only partially digested, reaching weight losses below 60 % and 15 
%, respectively, after 52 days of enzymatic degradation. Moreover, the weight 
loss of the poly(MeHA-co-EA) copolymer networks in 0.15 M PBS in equilibrium 
at 3 and 56 days represents values below 7 %. 
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3.4.2 Determination of equilibrium water content 
In order to evaluate the effect of enzymatic degradation on swelling, the 
equilibrium water content, EWC, of the different HA-based materials was 
evaluated after the enzymatic degradation. The swelling in a solution of 0.15 M 
PBS is employed with the aim to shield electrostatic repulsions due to HA 
moieties. Additionally, the EWC value at different times was compared with that 
of controls after 3 and 56 days in 0.15 M PBS. 
 
 
Figure 3. 47. Equilibrium water content of solv_HA:DVS 1:0.9 (blue bars) and HA-DVS scaffolds: 
scaff_HA:DVS 1:0.6 (red bars), scaff_HA:DVS 1:0.9 (green bars) and scaff_HA:DVS 1:1.5 (purple 
bars), immersed in 0.15 M PBS at different degradation times. The two first groups represent 
samples immersed in 0.15 M PBS without enzyme (time is shown in brackets). Vertical bars show 
the standard deviation. 
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Figure 3. 48. Equilibrium water content of solv_HA:DVS 1:0.9 (blue bars) and poly(MeHA-co-EA) 
copolymer networks: MeHA:PEA 1:0 (red bars), MeHA:PEA 1:1 (green bars) and MeHA:PEA 1:10 
(purple bars), immersed in 0.15 M PBS at different degradation times. The two first groups 
represent samples immersed in 0.15 M PBS without enzyme (time is shown in brackets). Vertical 
bars show the standard deviation. 
 
Figure 3. 47 and Figure 3. 48 show the variation of the EWC value in the different 
samples after different times of enzymatic digestion. After the degradation time, 
each sample was freeze-dried and swollen in 0.15 M PBS for 3 days, taking 
samples non-exposed to the enzyme and immersed in 0.15 M PBS for 3 and 56 
days as controls. In Figure 3. 47, the effect of degradation on the EWC values in 
the different HA-DVS scaffolds and the solv_HA:DVS 1:0.9 sample was 
compared. In the meanwhile, In Figure 3. 48, the effect of degradation on the 
EWC values in the different poly(MeHA-co-PEA) copolymer networks and the 
solv_HA:DVS 1:0.9 sample was compared   
The EWC value of the solv_HA:DVS 1:0.9 samples was increased along the 
incubation time in the enzymatic solution, ranging between values from 40 to 100 
(no significant differences was found between both controls). In the case of HA-
DVS scaffolds, the equilibrium water content value resulted in no variations 
comparing samples after the different degradation times and controls. Moreover, 
differences in the water content were not significant between different 
compositions. The evolution of the EWC value in the different poly(MeHA-co-EA) 
copolymer networks during enzymatic digestion was found to depend on 
chemical composition. The MeHA:PEA 1:0 sample showed a reduction in the 
equilibrium water content from the initial time and after one day incubated with 
the enzyme; after this time the water content seemed to stabilize between values 
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from 50 to 60 and finally the value significantly increased after reaching a value 
of 125. Differences between both controls resulted to be not significant. The 
MeHA:PEA 1:1 and MeHA:PEA 1:10 samples resulted in a slight reduction of the 
equilibrium water content with increasing the degradation time, but differences 
resulted not significant. 
 
3.4.3 Morphological characterization 
In order to determine any change in the structure, the vertical sections of the  HA-
DVS scaffolds and poly(MeHA-co-EA) copolymer networks were analysed by 
SEM. The effect of degradation on the different samples was addressed 
comparing the control materials (at equilibrium swelling for 3 days) with the ones 
after the enzymatic degradation. Therefore, samples after 56 days in the 
enzymatic solution were taken as the degraded ones, except for the MeHA:PEA 
1:0 sample, in which case the degraded sample was analysed after 14 days in 
the enzymatic solution because it was completely degraded for longer times (see 
Figure 3. 45).  
In the following figures, the effect of the enzyme on the morphology of the 
different HA-DVS scaffolds is addressed comparing the internal structure of the 
scaffolds before the enzymatic digestion (Figure 3. 49) and after 56 days in a 
solution containing hyaluronidase (Figure 3. 50). 
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Figure 3. 49. Scanning electron microscopy of the inner structure of the HA-DVS scaffolds: 
scaff_HA:DVS 1:0.6 (A-B), scaff_HA:DVS 1:0.9 (C-D) and scaff_HA:DVS 1:1.5 (E-F). The images of 
the samples were taken before the enzymatic solution. 
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Figure 3. 50. Scanning electron microscopy of the inner structure of the HA-DVS scaffolds 
(scaff_HA:DVS 1:0.6 (A-B), scaff_HA:DVS 1:0.9 (C-D) and scaff_HA:DVS 1:1.5 (E-F)) immersed for 
56 days in the solution containing enzyme. 
 
The internal structure of the HA-DVS scaffolds, before the enzymatic degradation 
(Figure 3. 49) and after 56 days immersed in the solution containing 
hyaluronidase (Figure 3. 50) resulted in no evidence of degradation for the 
different compositions, in terms of morphological changes. 
In the following figures, the effect of the enzyme on the morphology of three 
different poly(MeHA-co-PEA) copolymer networks is determined comparing their 
internal structure before the enzymatic digestion (Figure 3. 51) and after 56 days 
in a solution containing hyaluronidase (Figure 3. 52). 
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Figure 3. 51. Scanning electron microscopy of the inner structure of the poly(MeHA-co-EA) 
copolymer networks: MeHA:PEA 1:0 (A-B), MeHA:PEA 1:1 (C-D) and MeHA:PEA 1:10 (E-F). The 
images of the samples were taken before the enzymatic digestion. Insets show roughness of the 
inner structures for each composition at high magnification (scale bar 10 μm). 
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Figure 3. 52. Scanning electron microscopy of the inner structure of the poly(MeHA-co-EA) 
copolymer networks: MeHA:PEA 1:0 (A-B), MeHA:PEA 1:1 (C-D) and MeHA:PEA 1:10 (E-F). The 
images of each composition were taken for the last time point at which samples in the enzymatic 
solution were observed. Insets show roughness of the inner structures for each composition at high 
magnification (scale bar 10 μm). 
 
Before the enzymatic degradation, the poly(MeHA-co-EA) copolymer networks 
showed different internal morphologies depending on the composition thereof 
(Figure 3. 51). The MeHA:PEA 1:0 sample displayed interconnected pores 
forming a sheet-like structure, which surface presented certain roughness. The 
MeHA:PEA 1:1 samples showed an interconnected structure forming sheets 
crossed by circular porous with different sizes. In this case, the roughness of the 
sheets resulted to be similar to that of the MeHA:PEA 1:0 sample. The 
MeHA:PEA 1:10 samples showed a collapsed and unstructured inner matrix 
distributed in agglomerates. 
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The internal structure of the degraded poly(MeHA-co-EA) copolymer networks 
(Figure 3. 52) showed some changes respect to the non-degraded ones.  The 
MeHA:PEA 1:0 sample showed a collapsed structured losing its interconnected 
structure, but its roughness seems to not be affected by the enzyme activity. The 
degradation in the MeHA:PEA 1:1 sample yielded a closer internal structure and 
the increasing of the roughness of the internal walls, however, its original internal 
porous structure was also observed. On the contrary, the effect of the enzyme on 
the MeHA:PEA 1:10 sample gave an unstructured internal matrix more open with 
respect to the non-degraded one. The roughness of this copolymer network 
resulted similar to that of the original non-degraded sample. 
 
3.4.4 Determination of by-products 
In order to determine the molecular weight distribution of by-products produced 
during the enzymatic degradation, the supernatants of the samples were 
collected at different time points and were analysed by gel permeation 
chromatography (see section 2.3). The HA solutions are usually passed through 
a chromatographic columns using fluxes with ionic strengths higher than 1M with 
the aim to shield electrostatic repulsions. Therefore, the supernatants were 
analysed using a flux of 0.15 M NaCl, which also possesses similar ionic strength 
than the medium employed in the enzymatic solution (0.15 M PBS). 
The methodology employed to determine the molecular weight of degraded HA 
chains was carried out using a calibration curve obtained from narrow standards 
of poly(ethylene oxide)/poly(ethyl glycol) (PEO/PEG). However, the elution 
volume (directly proportional to the retention time) of a molecule depends on its 
molecular weight, as well its hydrodynamic volume, and hence differences in the 
hydrodynamic volume between the polymer employed as standard and the HA 
should be taken into account. For this reason, the calibration curve calculated 
from the PEO/PEG narrow standards was reformulated using the Mark-Houwink-
Sakurada equations, which relate the intrinsic viscosity and molecular weight 
using the equation [η] = k·Mα (described in section 1.2.2). Moreover, the 
molecular weight and the intrinsic viscosity of two components in a determined 
solvent may be related using the equation: 
 
Mw1!η1"= Mw2!η2"                   [Equation 3.7] 
 
therefore, combining both equations the molecular weight of a component from 
the known one of other component may be calculated by their constants, k and 
α, as follows: 
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lnM2=
1
1+α2
·ln
k1
k2
+
1+α1
1+α2
·lnM1                    [Equation 3.8] 
 
the constants k and α for PEO/PEG and HA are collected in Table 3. 12. These 
constants were compiled from previous works, in which they were obtained under 
similar conditions than the employed in the present work. 
 
Table 3. 12. Values of the constants k and α for HA and PEO/PEG. 
Component Range of molecular 
weight (kDa) α k (mL/g) 
HA (1) 
below 102 1.06 1.29  × 10-3 
from 102 to 103 0.78 3.39 × 10-2 
above 103 0.60 3. 95 × 10-1 
PEO/PEG (2) from 3 × 103 to 7 × 105 0.82 0.64 × 10-2 
(1) Data from [131] 
(2) Data from [345] 
 
The variation of k and α with molecular weight should be taken into account: HA 
constants vary depending on the molecular weight range of the polymer chain, 
while the PEO/PEG ones show similar values in the range of molecular weights 
studied. This fact was considered in the determination of the calibration curve 
and the posterior analysis of supernatants. 
Additionally, in order to not dismiss characteristic peaks of HA chains, the 
different media employed (0.15 M PBS and 0.15 M NaCl containing 0.05 % of 
sodium azide), and the enzyme in 0.15 M PBS containing 0.05 % of sodium azide 
at time 0 and after 56 days were also passed through the chromatographic 
columns. The enzyme at the employed concentration was not detected and salts 
from the different media appeared at times up 46 minutes. Therefore, the 
analysed peaks were limited to times below 46 minutes. 
Taking into account all the considerations mentioned above, the supernatants of 
the different samples (solv_HA:DVS 1:0.9 sample, HA-DVS scaffolds and the 
poly(MeHA-co-EA) copolymer networks) were analysed by chromatography. For 
each injection, the chromatographic device proportioned raw signals with 
arbitrary units of the refractive index as a function of the retention time. After the 
normalization of the refractive index signals, the onset and offset of the detected 
peaks were determined and the region limited by them was integrated. From the 
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integration of the corresponding peaks, the fraction (wi) of each specie with 
molecular weight (Mi) was determined, and hence the molecular weight 
distribution was plotted. Therefore, the weight average molecular weight (Mw), 
the number average molecular weight (Mn) and the polydispersity index (PDI) 
were determined using the following equations: 
 
Mw = # Mi·wi
i
       													[Equation 3.9] 
Mn = 
1
∑ wi/Mii
           							  		[Equation 3.10] 
PDI = 
Mw
Mn
                										 [Equation 3.11] 
 
The following figure shows the molecular weight distribution of the by-products 
produced through the degrading solv_HA:DVS 1:0.9 sample at different time 
points: 
 
 
Figure 3. 53. Molecular weight distribution of degraded HA chains in the solv_HA:DVS 1:0.9 sample 
at different times: 6 hours (blue line), 1 day (green line) and 3 days (red line). Inset shows the 
molecular weight distribution after 56 days of enzymatic digestion. 
 
The supernatants of the HA-DVS scaffolds studied by chromatography showed 
no traces of by-products due to enzymatic degradation in the range of times 
studied. However, the by-products of the degradation in solv_HA:DVS 1:0.9 
samples (Figure 3. 53) were observed after 6 hours of enzymatic digestion. The 
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molecular weight distribution of by-products of the net-HA:DVS 1:0.9 sample after 
6 hours and 3 days of enzymatic digestion resulted to be a markedly asymmetry. 
However, this asymmetry on the molecular weight distribution was slightly 
decreased for relative short incubation times (between 6 hours and 3 days). Even, 
this asymmetry was drastically reduced for much longer times of enzymatic 
degradation, up to 56 days (inset in Figure 3. 53). Moreover, all the parameters 
obtained from the chromatography (Mw, Mn and PDI) were significantly 
decreased for longer incubation periods (Table 3. 13). 
 
Table 3. 13. Mw, Mn and PDI of the by-products obtained in the enzymatic degradation of the 
solv_HA:DVS 1:0.9 sample at different incubation times. 
Incubation time Mw (kDa) Mn (kDa) PDI 
6 hours 47.3 ±3.9 14.0 ±0.2 3.4 ±0.2 
24 hours 40.2 ±1.5 13.0 ±0.0 3.1 ±0.1 
3 days 28.8 ±0.6 10.9 ±0.2 2.7 ±0.1 
56 days 4.0 ±0.0 3.1 ±0.0 1.3 ±0.0 
 
A more detailed study of the molecular weight distribution of the by-products in 
the degrading solv_HA:DVS 1:0.9 samples after 56 days (inset in Figure 3. 53) 
revealed different maximums with molecular weights of 2.9, 2.5, 2.0 and 1.6 kDa. 
Therefore, taking into account the molecular weight of the disaccharide unit of HA 
(401 Da, including the sodium ion), these maximums correspond to HA 
oligosaccharides between 8- and 14-mer (4 and 7 disaccharide units, 
respectively). 
The following figure shows the molecular weight distribution of the by-products 
produced through the degradation process of three different poly(MeHA-co-EA) 
copolymer networks at different time points: 
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Figure 3. 54. Molecular weight distribution of degraded HA chains in MeHA:PEA 1:0 (A), 
MeHA:PEA 1:1 (B) and MeHA:PEA 1:10 (C) at different degradation times: 3 days (blue line), 7 
days (green line), 28 days (purple line) and 56 days (red line). Insets show the parameters Mw, Mn 
and PDI for each composition at different degradation times. Vertical bars show the standard 
deviation. 
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Figure 3. 54 shows the molecular weight distribution of the by-products obtained 
in the enzymatic degradation of MeHA:PEA 1:0, MeHA:PEA 1:1 and MeHA:PEA 
1:10 samples. In general, the molecular weight distribution resulted to be 
asymmetric for all the samples, but this asymmetry (PDI values slightly higher 
than 1) was drastically reduced for incubation times up 7 days, at which time the 
PDI was found with values around near 1. However, in the MeHA:PEA 1:0 sample 
it can be observed a small fraction of by-products with Mw higher than 4 kDa for 
all the incubation times studied. With respect to the Mw values, the different 
compositions reached values between 3 and 4 kDa for incubation times below 7 
days, however that value was significantly decreased around 2 kDa at 28 days. 
A detailed study of the molecular weight distribution shows that the different 
poly(MeHA-co-EA) copolymer networks displayed several peaks with molecular 
weights between 1 and 3 kDa. These maximums found in the molecular weight 
distribution displayed molecular weights around 1.6, 2.0 and 2.4 kDa, 
corresponding to HA oligosaccharides between 8- and 12-mer (4 and 6 
disaccharide units, respectively). Moreover, another maximum in the molecular 
weight distribution was found with a value around 3 kDa, which corresponds with 
HA oligosaccharides between 14- and 16-mer (7 and 8 disaccharide units, 
respectively), for shorter degradation times (below 7 days). 
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3.5 Cell cultures 
Viability assays and cell cultures were performed in the HA-DVS scaffolds and 
poly(MeHA-co-EA) copolymer networks with the aim of determining some 
biological characteristics. The cell viability was addressed by different assays 
using extracts prepared from the materials (see section 2.4). Moreover, HA-DVS 
scaffolds were seeded with different cell populations as described in section 2.5. 
 
3.5.1 Viability assays 
The viability of hCMEC/D3, U373 and SH-SY5Y cell lines was evaluated by 
seeding the different cells in 96-well plates, previously coated with fibronectin. 
After culturing cells for 48 hours in ECBM medium, the cells were exposed to the 
extracts prepared from the different materials (see section 2.4). Due to the similar 
chemistry employed between compositions, these assays were carried out 
employing the extract of a representative composition for each material group: 
scaff_HA:DVS 1:0.9 and MeHA:PEA 1:1. The effect of the different extracts on 
cell viability was studied by different methods: cytotoxicity by the MTS and crystal 
violet assays, apoptosis by the LDH release assay, proliferation by the Ki-67 
assay and inflammatory effects by the expression of E-selectin. 
 
Cytotoxicity 
The cytotoxic effect of the extracts, obtained from the biomaterials, on the 
different cell lines were determined by different methods: MTS, crystal violet and 
LDH release assay. The MTS and crystal violet are methods employed to 
determine live cells by indirect methods, whereas the LDH release assay is a 
measure of apoptotic cells. In the case of MTS and crystal violet assays, the 
different cell lines exposed to ECBM for 4 hours were set as the 100 % viability 
with the aim to determine the effect of culture time in this value. 
The viability of the different cell populations exposed to the different material 
extracts and measured by the MTS assay is displayed in the following figure: 
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Figure 3. 55. Cell viability of U373/D3 (a), SH-SY5Y (b) and hCMEC/D3 (c) cell lines after exposure 
to the material extracts for 4 and 24 hours: ECBM (purple), scaff_HA:DVS 1:0.9 (red), MeHA:PEA 
1:1 (green) and lysed cells (cyan). Viability was measured by the MTS assay, with cells cultured in 
pure ECBM for 4 hours being set to 100 % of viability. Vertical bars show the standard deviation of 
each independent experiment. 
 
The MTS assay (Figure 3. 55) showed that cells were viable at 4 and 24 hours 
for both material groups since the viability resulted to be up the 80 % of the 
control. The viability of U373 and SH-SY5Y cells after 2 days of exposition to the 
biomaterial extract increased with respect to the control. However, the viability of 
hCMEC/D3 decreased after 24 hours, but the values resulted acceptable. 
Moreover, lysed cells displayed values of viability below 40 % with respect to the 
control. The cells cultured with ECMB increased their viability after 24 hours with 
respect to culture times of 4 hours. 
The viability of the different cell populations exposed to the different material 
extracts and measured by the crystal violet assay is shown in the following figure: 
 
 
Figure 3. 56. Cell viability of U373/D3 (a), SH-SY5Y (b) and hCMEC/D3 (c) cell lines after exposure 
to the material extracts for 4 and 24 hours: ECBM (purple), scaff_HA:DVS 1:0.9 (red), MeHA:PEA 
1:1 (green) and lysed cells (cyan). Viability was measured by the crystal violet assay, with cells 
cultured in pure ECBM for 4 hours being set to 100 % of viability. Vertical bars show the standard 
deviation of each independent experiment. 
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Figure 3. 56 shows the cell viability measured by the crystal violet assay. The 
viability determined by this method resulted in similar results than those 
employing the MTS assay. However, in this case, all the cell lines increased their 
viability with respect to the corresponding controls when they were cultured in the 
different biomaterial extracts. As expected, the viability of lysed cells resulted in 
values below 40 % of viability with respect to the control. 
The apoptosis of the different cell populations exposed to the different material 
extracts and addressed from the determination of the LDH released by cells is 
shown in the following figure: 
 
 
Figure 3. 57. LDH release in U373/D3 (a), SH-SY5Y (b) and hCMEC/D3 (c) cell lines after 
exposure to the material extracts for 4 and 24 hours: ECBM (purple), scaff_HA:DVS 1:0.9 (red), 
MeHA:PEA 1:1 (green) and lysed cells (cyan). Cell apoptosis was measured by the LDH release 
assay, with lysed cells after culture for 24 hours being set to 100 % of apoptosis. Vertical bars show 
the standard deviation of each independent experiment. 
 
As can be observed in Figure 3. 57, the release of LDH by cells exposed to the 
different media resulted in values below 50 % (taking as controls cells exposed 
to ECMB for 4 and 24 hours). After 4 hours of culture, the different cell lines 
showed a percentage of LDH release below 40 %, whereas this percentage 
slightly increase after 24 hours. In the case of U373 and SH-SY5Y cell lines, the 
LDH release of cells exposed to the material extracts was lower with respect to 
cells cultured in ECBM. Oppositely, the hCMEC/D3 cell line displayed a LDH 
release when exposed to the different extracts and ECBM higher than the other 
cell lines. This effect was increased for hCMEC/D3 cultured for 24 hours. 
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Proliferation 
In order to determine the effect of the material extracts on cell proliferation, the 
amount of nuclear Ki-67 was quantified. In this case, cultures in ECBM after 4 
hours were set as the 100 % of the proliferation with the aim of determining 
changes induced by the culture time. The effect of material extracts on the 
proliferation of the different cell populations is shown in the following figure: 
 
 
Figure 3. 58. Cell proliferation of U373 (a), SH-SY5Y (b) and hCMEC/D3 (c) after exposure to the 
material extracts for 4 and 24 hours: ECBM (purple), scaff_HA:DVS 1:0.9 (red), MeHA:PEA 1:1 
(green) and lysed cells (cyan). Proliferation was measured by the ki-67 assay, with cells cultured in 
pure ECBM for 4 hours being set to 100 % of proliferation. Vertical bars show the standard deviation 
of each independent experiment. 
 
Figure 3. 58 shows that cell proliferation was increased after 24 hours in culture 
for all cell lines and exposure media, including ECBM. This increment on 
proliferation resulted to be significant for U373 cell line exposed to all the 
mentioned media, SH-SY5Y cell line exposed to the different extracts of materials 
and hCMEC/D3 cell line in ECBM. In the case of lysed cells, the proliferation 
value was below 30 % with respect to the control. 
 
Inflammation 
In order to determine the inflammatory effect of extracts obtained from the 
biomaterials on the hCMEC/D3 cell line, the E-selectin expression was evaluated 
by a CAM-EIA assay. The hCMEC/D3 cell line was exposed for 4 hours to both 
material extracts, ECBM was used as negative control and ECBM containing 1 
μg/mL of LPS was employed as positive control (set as 100 % of inflammation). 
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Figure 3. 59. Inflammation processes on hCMEC/D3 cell line exposed to the material extracts for 4 
hours. Inflammation was measured determining the expression of E-selectin using a CAM-EIA 
assay, with cells cultured in ECBM containing 1 μg/mL of LPS for 4 hours being set to 100 % of 
inflammation. Vertical bars show the standard deviation. 
 
Figure 3. 59 shows the inflammatory effects of the different extracts and media 
employed as controls on the hCMEC/D3 cell line. The expression of E-selectin in 
the hCMEC/D3 cell line resulted in values below 15 % with respect to cells 
stimulated with 1 μg/mL of LPS. 
 
3.5.2 Cultures of cell populations on scaffolds 
Influence of the degree of crosslinking on the initial cell colonization 
In order to determine the influence of the HA:DVS molar ratio on the initial cell 
colonization, the U373, SH-SY5Y and hCMEC/D3 cell lines were seeded on the 
different HA-DVS scaffolds. The different cultures were carried out up 7 days and 
the bottom of 96-well plates were taken as controls with the aim to assess the 
health of the cultured cells.  
The culture of each cell type (U373 (Figure 3. 60), SH-SY5Y (Figure 3. 61) and 
hCMEC/D3 (Figure 3. 62)) on the different HA-DVS scaffolds and controls is 
shown in the following figures:  
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Figure 3. 60. GFAP expression (green fluorescence) by U373 cell line cultured on scaff_HA:DVS 
1:0.6 (A, B and C), scaff_HA:DVS 1:0.9 (D, E and F) and scaff_HA:DVS 1:1.5 (G, H and I), and 96-
well plates (J, K and L) for 7 days. Cell nuclei were stained in blue with Hoechst. 
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Figure 3. 61. Tuj-1 expression (red fluorescence) by SH-SY5Y cell line cultured on scaff_HA:DVS 
1:0.6 (A, and B), scaff_HA:DVS 1:0.9 (C, D and E) and scaff_HA:DVS 1:1.5 (F, G and H), and 96-
well plates (I, J and K) for 7 days. Cell nuclei were stained in blue with Hoechst. 
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Figure 3. 62. CD-31 expression (green fluorescence) by hCMEC/D3 cell line cultured on 
scaff_HA:DVS 1:0.6 (A, B and C), scaff_HA:DVS 1:0.9 (D, E and F) and scaff_HA:DVS 1:1.5 (G, H 
and I), and 96-well plates (J, K and L) for 7 days. Cell nuclei were stained in blue with Hoechst. 
 
In general, the HA-DVS scaffolds showed a low cell colonization of the different 
cell types (U373, SH-SY5Y and hCMEC/D3 cell lines) and cells were observed 
on top of the scaffolds with some cell ingrowth in the adjacent layers. The different 
monocultures show that the initial cell colonization is clearly influenced by the 
amount of DVS; all cell types were more abundant in the scaff_HA:DVS 1:1.5 
samples. The U373 and SH-SY5Y cells were distributed as isolated clusters, 
whereas the hCMEC/D3 cells in the scaff_HA:DVS 1:1.5 samples were arranged 
in a uniform and continuous layer surrounding the pores. 
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The U373 cells cultured on the 96-well plates displayed an orientated and 
elongated shape. Despite the low colonization in the HA-DVS scaffolds, this 
elongated shape was observed in the different scaffolds, showing longer 
processes when they are cultured in scaffolds with higher amounts of DVS. On 
the contrary, the SH-SY5Y cells formed clusters in both 96-well plates and the 
different scaffolds, showing some short processes. The hCMEC/D3 cells cultured 
on p-96 well plates were distributed as a disordered monolayer, while its culture 
on the scaff_HA:DVS 1:1.5 samples evoked a distribution on the porous 
structure, showing cell-cell connections through cell processes. 
 
 
Figure 3. 63. CD-31 expression (green fluorescence) by pBECs primary cell line cultured on 
scaff_HA:DVS 1:1.5 (a, b and c) and 96-well plates (d, e and f) for 7 days. Cell nuclei were stained 
in blue with Hoechst. 
 
Aimed by the results by the previous cultures, the primary endothelial cells, 
pBECs, were cultured on the scaff_HA:DVS 1:1.5 samples, taking cultures on 96-
well plates as control to address the health of cells. The culture of pBECs on the 
96-well plates gave rise to the formation of a monolayer where cells formed a 
closely structure. However, as the case of hCMEC/D3 cells, the pBECs cultured 
on the scaff_HA:DVS 1:1.5 samples resulted to have a uniform colonization on 
top of the materials showing some degree of ingrowth into the scaffolds. 
 
Co-cultures and triple-cultures 
The endothelial cells in brain tissue are arranged forming a unique structure, the 
BBB, whose phenotypic maintenance is influenced by the interaction of 
endothelial cells with astrocytes and neurons among other cell types. Therefore, 
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these three types of cells were employed in co-cultures and triple-cultures with 
the aim to study their synergistic effects on the initial colonization of the HA-DVS 
scaffolds. After choosing the scaff_HA:DVS 1:1.5 samples as those with the best 
chemistry in terms of monocultures behaviour, co-cultures and triple-cultures 
were performed on these scaffolds (described in section 2.5). The different co-
cultures and triple-cultures on the scaffolds were carried out with the aim to study 
the behaviour of cells, which are typical of brain tissue (endothelial, glial and 
neural cells). 
  
 
Figure 3. 64. Immunofluorescence analysis on co-cultures of hCMEC/D3 and U373 (A, B and C), 
hCMEC/D3 and SH-SY5Y (D, E and F) and triple-cultures of hCMEC/D3, U373 and SH-SY5Y (G, H 
and I). Cells were cultured on scaff_HA:DVS 1:1.5 samples (left and central columns) and 96-well 
plates (right column) for 7 days. hCMEC/D3 were stained against CD-31 expression (red 
fluorescence), U373 were stained against GFAP expression (green fluorescence) and SH-SY5Y 
were stained against Tuj-1 expression (green fluorescence). Cell nuclei were stained in blue with 
Hoechst. 
 
In general, the initial cell colonization of the scaffolds by the hCMEC/D3 cells in 
co-cultures and triple-cultures after 7 days resulted more significant than the 
colonization observed by astrocytes and neurons (Figure 3. 64). The hCMEC/D3 
cells resulted to cover few layers of the scaffolds showing cells attached onto 
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their inner porous surfaces. On the contrary, the U373 cell line showed that these 
cells remained isolated in both co-cultures and triple-cultures. The presence of 
SH-SY5Y cells in the co-cultures is slightly higher compared with co-cultured 
U373, but these cells are forming individual clusters. However, the hCMEC/D3 
co-cultured with the SH-SY5Y cells and in triple-cultures resulted in a uniform 
layer showing a dense distribution of cells.  
The co-cultures and triple-cultures in the 96-well plates evidenced similar 
structures between endothelial cells with U373 and SH-SY5Y cells. The 
hCMEC/D3 cells formed dense layers of cells and delimited by the U373 and SH-
SY5Y cells yielding to heterogeneous cultures and some degree of structuration 
between cell groups. 
 
 
Figure 3. 65. Immunofluorescence analysis on co-cultures of pBECs and U373 (A, B and C), 
pBECs and SH-SY5Y (D, E and F) and triple-cultures of pBECs, U373 and SH-SY5Y (G, H and I). 
Cells were cultured on scaff_HA:DVS 1:1.5 samples (left and central columns) and 96-well plates 
(right column) for 7 days. The pBECs primary cells were stained against CD-31 expression (green 
fluorescence), U373 were stained against GFAP expression (red fluorescence) and SH-SY5Y were 
stained against Tuj-1 expression (red fluorescence). Cell nuclei were stained in blue with Hoechst. 
 
The primary cells, pBECs, in co-cultures and triple-cultures resulted to give more 
dense populations surrounding the pores of the scaffolds (Figure 3. 65). As in 
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cultures with hCMEC/D3 cells, the co-cultures and triple-cultures of U373 with 
pBECs on the scaffolds resulted in a low expression of these astrocyte-like cells. 
On other hand, the structures formed by U373 and pBECs resulted to be similar 
than those observed using the hCMEC/D3 cells; both cells types form 
heterogeneous structures limited by themselves. However, the SH-SY5Y cells 
co-cultured with pBECs yielded to a homogeneous distribution of both cell types, 
even observing the formation of a uniform layer of pBECs in the case of co-
cultures in 96-well plates. 
After 14 days of culture, the different co-cultures and triple-cultures using the 
hCMEC/D3 cell line and the pBECs primary cells displayed similar results than at 
7 days (Figure 3. 66). However, the different endothelial cells increased their 
density within the scaffolds, but this effect was not observed for U373 and SH-
SY5Y populations. 
 
 
Figure 3. 66. Immunofluorescence analysis on co-cultures of hCMEC/D3 and U373 (a) pBECs and 
U373 (b), hCMEC/D3 and SH-SY5Y (c), pBECs and SH-SY5Y (d), and triple-cultures of 
hCMEC/D3, U373 and SH-SY5Y (e) and pBECs, U373 and SH-SY5Y (f). Cells were cultured on 
scaff_HA:DVS 1:1.5 samples for 14 days. The pBECs primary cells and hCMEC/D3 were stained 
against CD-31 expression, U373 were stained against GFAP expression and SH-SY5Y were 
stained against Tuj-1 expression. Cell nuclei were stained in blue with Hoechst. The SH-SY5Y cell 
line was unstained in triple-cultures.
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The properties of HA and its nature as component of the ECM within multiple 
tissues have encouraged researchers to employ it for many tissue engineering 
purposes. In the past decades, the research of HA has found some clinical 
applications: temporal substitute of the synovial fluid in osteoarthritic joints, 
protective fluid against minor surgeries (ophthalmologic surgery), anti-adherence 
in some surgeries and as a dermal filler in aesthetic surgery [261,365]. However, 
the direct application of HA solutions is limited in tissue engineering since HA 
shows a high bioresorption within the body because of its high solubility, a low 
mechanical properties in its use as transient artificial ECM in regenerating tissues 
and an high biodegradability due to the presence of enzymes and chemicals 
within the body. Moreover, HA with high molecular weight is usually preferred to 
the one of low molecular weight because of its lower inflammatory effects and 
longer residence times. However, the HA with low molecular weight possesses 
some beneficial effects such as angiogenic activity helping the transport of 
nutrients in the regenerating tissue. Taking into account this duality, implants 
based on HA with high molecular weight with controlled biodegradability and 
insolubility in the physiological medium are usually preferred. 
From the past few decades to present, many researchers have focused on 
developing new HA based materials with the aim of expanding the applications 
for tissue engineering. In this sense, a wide range of HA derivatives have been 
developed obtaining insoluble materials in physiological conditions with tailored 
degradability, mechanical properties and swelling degree. Therefore, a broad 
range of HA derivatives have been developed employing different chemistries 
and physical methods. The most common modified HA products are the ones 
obtained by crosslinking reactions (DVS-, glutaraldehyde- and BDDE-
crosslinked); even these HA derivatives are the most common employed in 
several clinical applications [197]. 
In the present work, HA has been modified with the aim of developing polymer 
networks for soft tissue engineering, particularly for central nervous system 
regeneration in brain damages such as traumatic brain injury and stroke. Here 
two different strategies have been employed: the crosslinking of HA with DVS 
(HA-DVS polymer networks) and the copolymerization of a HA derivative, MeHA, 
with EA (poly(MeHA-co-EA) copolymer networks). These HA-based materials 
have been developed to increase the molecular weight of HA single chains, and 
improve and grant a control over mechanical properties, residence time in the 
physiological environment, degradation rate, and swelling degree. Additionally, 
these HA derivatives have been employed to develop structured materials for 
their use as artificial ECM for cells in the regenerating tissue. Therefore, the 
materials were subjected to a preliminary biologically characterization in vitro 
employing different cells belonging to the brain tissue (astrocytes, neurons and 
endothelial cells). 
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On the other hand, the methacrylated HA, MeHA, allows its copolymerization with 
other monomers. In this case, MeHA has been copolymerized with EA to obtain 
semi-biodegradable copolymers combining the properties of HA and PEA. 
Therefore, the copolymers are expected to possess the biological properties of 
HA and the good mechanical properties and cell compatibility of PEA. Besides, 
different compositions of these copolymers may result in materials with tuneable 
mechanical properties and swelling degrees, provide structural stability during the 
regenerative process and improve the initial colonization of glial, neural and 
endothelial cells belonging to the brain tissue. 
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4.1 Crosslinking of hyaluronan with divinyl sulfone 
The divinyl sulfone-crosslinked hyaluronan, HA-DVS, (known as hylan) has been 
widely employed with the aim to develop HA-based hydrogels for tissue 
engineering applications. Moreover, this material is currently employed in some 
clinical applications [219]. In the present work HA-DVS polymer networks have 
been developed focusing the attention on their further use as artificial ECM for 
brain tissue engineering. In the current section is discussed the characterization 
of the HA-DVS polymer networks, in which water removal was performed by a 
solvent-casting process. 
The HA-DVS crosslinking was evaluated as a method to obtain insoluble 
hydrogels based on HA as a principal component. The crosslinking reaction of 
HA with DVS requires alkaline aqueous media (above 12) since vinyl groups of 
DVS are firstly activated by hydroxyl ions and hydroxyls of HA must be 
deprotonated. It is widely accepted that this reaction occurs principally by the 
unique primary hydroxyl within the N-acetyl-ᴅ-glucosamine moiety due to the 
steric hindrance of the molecule. Therefore, the crosslinking yields an ether bond 
between two HA disaccharides by one molecule of DVS (see Figure 1. 6). The 
steric hindrance of HA molecule together the high viscosity and low concentration 
of the HA solutions yield to very low efficiencies of reaction. For this reason, the 
crosslinking with DVS is commonly carried out employing a DVS excess. 
In order to determine the effect of DVS in the final properties of the hydrogel, 
different amounts of DVS were employed to carry out the crosslinking of HA. 
Therefore, the appropriate amounts of DVS in the development of the HA-DVS 
polymer networks were addressed by using a broad range of molar ratios of HA 
monomeric unit to DVS (HA:DVS molar ratio) from 1:0.2 to 1:2. Then, the 
resulting hydrogels were swollen in 0.15 M PBS until reaching the equilibrium 
swelling (after 3 days in immersion) and the equilibrium water content, EWC, was 
evaluated with the aim to choose three representative compositions of the HA-
DVS polymer networks for further studies. The fitting of the EWC values for the 
different HA-DVS polymer networks (Figure 3. 1) shows a clear reduction of water 
in the inner network due to larger amounts of crosslinking density. However, 
extreme HA:DVS molar ratios gave anomalous results. The HA-DVS polymer 
networks with a molar ratio 1:0.2 yielded unexpected low EWC values, because 
of the inefficiency of the reaction and a partial solubility of the uncrosslinked HA 
chains. On the other hand, high HA:DVS molar ratios (above 1:1.5) resulted in 
heterogeneous hydrogels due to the self-polymerization of divinyl sulfone 
molecules. For this reason, the HA:DVS molar ratios selected were the 
intermediate ones: 1:0.6, 1:0.9 and 1:1.5. 
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The HA molecule is subjected to spontaneous hydrolysis in aqueous media by 
the nucleophilic attack of water molecules on carbon forming the glycosidic 
bonds. However, the hydrolysis rate is increased under extreme pH values, both 
acid and alkaline [138]. The hydrolysis produces a reduction of the molecular 
weight of HA chains that may produce inflammatory effects and some alterations 
in the crosslinking reaction. Therefore, the effect of the alkaline medium, 
employed in the crosslinking reaction, on the molecular weight of HA was studied 
by chromatography (Figure 3. 2 and Figure 3. 23). The results evidence a 
reduction in the molecular weight during the solubilisation of HA in the alkaline 
medium, halving its value with respect to the original one. However, the molecular 
weight distribution shows a more symmetric fashion after mixing with alkaline 
medium, suggesting that the reduction of the molecular weight occurs in a 
random fashion. Moreover, the reduction in the molecular weight resulted to be 
to be independent of the concentration of HA in the alkaline solution. Despite the 
reduction of the molecular weight, the values between 700- 800 kDa, which may 
be considered as HA chains of high molecular weight [189]. On the other hand, 
alkaline medium may yield other undesirable reactions within the HA chains, 
including the deacetylation of the acetylamide moiety [138]. However, spectra 
recorded from thin films of the different HA-DVS polymer networks (Figure 3. 3) 
showed no evidence of primary amine formation, since the double peak with 
maximums around 3300 and 3100 cm-1 associated to the N-H stretching of this 
group was not present, and hence these secondary reactions were discarded. 
The crosslinking reaction with DVS is considered complete after a few hours; 
however, in the present work, the reactions were carried out for 24 hours. After 
the crosslinking reaction, hydrogels are formed because samples show a soft but 
consistent appearance. Moreover, the subsequent purification processes do not 
produce visible disaggregation of the samples. The spectra of the HA-DVS 
polymer networks showed the incorporation of sulfone groups in the hydrogels 
(Figure 3. 3). The sulfone characteristic asymmetric and symmetric stretching 
appears in the self-polymerized DVS (pDVS) at wavenumbers of 1290 cm-1 and 
1110 cm-1, respectively. In the case of the HA-DVS polymer networks these 
bands clearly appeared, but they are displaced to lower wavenumbers and, in the 
case of the S=O symmetric stretching, the band was overlapped with 
characteristic peaks of HA. Moreover, the elemental analysis (atomic weight 
fraction of carbon, nitrogen, hydrogen and sulphur collected in Table 3. 6) 
corroborated the presence of sulphurs in the samples, even this method shows 
an increment of the sulphur content when the DVS is increased during the 
crosslinking reaction. 
The swelling of crosslinked hydrogels, both neutral and polyelectrolytes, are 
governed by the interaction of the solvent-polymer system and the elastic 
properties of the crosslinked networks, which are correlated with the incorporated 
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crosslinks. However, in the case of polyelectrolyte hydrogels, the presence of 
ionisable groups noticeably influences the swelling process. Therefore, the 
change in free energy in swollen polyelectrolytes is defined by three components: 
mixing of pure solvent with the unstrained polymer network (free energy of 
mixing), conformational changes of the gel structure (elastic free energy) , and 
the gradient of ions in the hydrogel and in the external solution (ionic free energy) 
[362]. The change in free energy (∂∆G/∂V) can be expressed in terms of the 
osmotic pressure (π) at which the hydrogels are subjected in the swelling process 
as follows: 
 
- %∂∆G
∂V &
n,T 
= π = πmix+ πel+ πion                       [Equation 4.1] 
 
where, πmix, πel and πion are the osmotic pressure in the hydrogel due to the mixing 
with the solvent, changes in the configuration and the gradient of ions between 
the electrolyte and the polymer network, respectively. 
At equilibrium swelling, π in the equation is set equal to 0 and each term 
contributing to the osmotic pressure can be estimated:  πmix from the Flory-
Huggins theory, πel from the rubber-elasticity theory and πion by the Donnan 
equilibrium [362,363]. Therefore, the combination of all these terms, taking into 
account several assumptions, gives an expression as that described in Equation 
3. 4 allowing the estimation of the molecular weight between crosslinking points. 
Polysaccharide chains, as the case of HA, are characterized by presenting 
interactions in aqueous media that are usually not taken into account when these 
equations are employed [366] including entanglements and hydrogen bonding. 
Additionally, hydrogels derived from polysaccharides are sensitive to the 
purification and drying processes  behind the crosslinking reaction [221], leading 
to chains interactions and entanglements, which may alter the results obtained 
from these equations. The HA molecule shows a rigid structure in aqueous 
environments at neutral pH due to hydrogen bonding formation mediated by 
water molecules, and hence its hydrodynamic volume show high values giving a 
low motility of chains and solutions with very high viscosity, even at low 
concentrations [135]. However, the increment in pH of the media, such as the 
case of the alkaline solutions employed in the crosslinking solution, yields to a 
reduction of the hydrodynamic volume with a higher motility of chains, which is 
reflected in a dramatic reduction of the viscosity. This fact may not be explained 
only by the addition of ions and indicates that the rupture of hydrogen bonds due 
to the ionization of hydroxyls influences in such reduction of the hydrodynamic 
volume in the HA molecule. 
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In order to discard the possible effect of entanglements on the swelling of the 
hydrogels, the HA-DVS polymer networks were obtained and purified by a 
determined process (described in section 2.2.1). Therefore, during the dissolution 
in 0.2 M NaOH and after the crosslinking reaction, the chains of hyaluronan 
remain contracted and hence forming entanglements. The volume increment 
observed in the samples in the posterior washing steps in the water/acetone 
mixture suggested that the water environment allow the rearrangement of chains 
in an extended fashion, whereas acetone limits the formation of hydrogen bonds 
in the molecules. The purification finished by washing steps in pure de-ionized 
water, and after that a soft drying at 40 ºC with the aim to maintain the chains 
without producing entanglements. Taking into account all these considerations, 
the effect of the crosslinking agent, ionic strength and pH on the swelling process, 
and the determination of the crosslinking degree using the above-mentioned 
equations was addressed discarding chain entanglements. The higher HA:DVS 
molar ratios yielded a reduction in the equilibrium water content values in the 
hydrogels for all the media studied (Figure 3. 12), even for much higher DVS 
amounts that those for a theoretical degree of substitution of 100 %, suggesting 
the incorporation of additional crosslinks.  
According to the swelling experiments, the effect of pH resulted in a higher water 
uptake for relative more alkaline media (Figure 3. 5, Figure 3. 6, Figure 3. 7  
Figure 3. 12-A). Discrepancies between pH of 7 and 8 resulted not significant due 
to their similar values. However, the swelling of hydrogels in acidic medium, at 
pH 3, resulted in lower swelling degrees. This fact can be explained by the degree 
of hydrolysis of the carboxylic acids within the HA disaccharides since these 
groups possess a pKa value around 3.2, and more acid pH values yield a lower 
degree of ionization decreasing chains repulsions. However, several studies 
have determined that at ionic strengths up to the physiological one (around 0.1 
M) the charges within the HA molecule are shielded and the electrostatic effects 
on swelling resulted to be modest [135]. In this work, the effect of pH on the 
swelling of the hydrogels was performed at a constant ionic strength of 1 M, 
discarding changes in the swelling degree due to charge repulsions. Therefore, 
the higher swelling found at pH values of 7 and 8 is explained by the rupture of 
hydrogen bonds between HA chains directly bonded or mediated by water 
molecules, due to the ionization of hydroxyls within the HA and the increment of 
hydroxyl ions in the media. These results suggest that hydrogen bonds restricts 
the free swelling of the network acting in a similar way than the crosslinks.  
Moreover, the effect of the pH seems to not be influenced by the HA:DVS molar 
ratio (Figure 3. 12-A), suggesting that hydrogen bonding is independent of the 
degree of crosslinking. 
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On the other hand, the effect of ionic strength in the swelling of the HA-DVS 
polymer networks (Figure 3. 8,  Figure 3. 9, Figure 3. 10 and Figure 3. 12 B) is in 
agreement with the effect predicted by the Donnan equilibrium over the osmotic 
pressure due to ionic contributions: 
 
πion=RT· 'i·c2z -γ·cs * - cs,                          [Equation 4.2] 
 
where, R is the gas constant, T the temperature, i the degree of ionization 
multiplied by the valence of the ionisable groups, c2 is the polymer concentration, 
z the valence of the ions in the polymer network, γ = (γ++γ-)  the sum of the 
valences of the dissociating salt, cs*  and cs are the concentration of salt in the 
electrolyte and in the polymer network, respectively. 
From the Equation 4.2 it can be deduced that the lower swelling degree in 
hydrogels immersed in media with higher ionic strengths is produced by the 
reduction of the osmotic pressure in the network. However, the equilibrium water 
content of hydrogels for ionic strengths of 1 M and 2 M resulted in no significant 
differences, suggesting that for relative high ionic strengths the effect on swelling 
is limited. Contrarily to the effect of pH on swelling, the ionic strength seems to 
have an effect dependent with the HA:DVS molar ratio: the lower the crosslinking 
agent, the lower the discrepancies in swelling degree. This observation may be 
related to the higher degree of crosslinking points within the polymer networks 
and subsequent reduction of the mesh size yielding to a restriction on swelling. 
The effect of electrostatic repulsions on swelling can be estimated comparing the 
water uptake of the hydrogels at equilibrium swelling in water and in 0.15 M PBS 
(Figure 3. 11 and Figure 3. 12-C). Therefore, the swelling degrees of the 
hydrogels in de-ionized water resulted in equilibrium water content values much 
higher than hydrogels immersed in 0.15 M PBS. This fact can be explained 
because of the absence of ionic species and a complete ionization of carboxylic 
acids in de-ionized water yielding to repulsions between chains. Additionally, in 
the inner lattices of the HA polymer networks are always present ionic species 
due to the ionization of carboxylic acids. This phenomenon produces a difference 
of osmotic pressure between the interior and exterior of the network, which is 
neutralized with ions from the external media. In the case of swelling in water, the 
absence of ions leads to greater increments of the water uptake to maintain the 
equilibrium conditions. 
In the first instance, the diffusion of electrolyte in the HA-DVS polymer networks 
was supposed to follow a Fickian transport. This assumption implies that water 
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diffusing in the hydrogels is dependent with the square root of time (Equation 3. 
1) when the water uptake is less than the 60 % of that in the equilibrium swelling. 
Moreover, this supposition was corroborated by the power law equation 
(Equation 3. 2) which determines the dependence of diffusion with time. 
Therefore, in general, the swelling exponents determined from this equation 
resulted in values close to 0.5 (Table 3. 3), for swellings ratios between 20 % and 
60 % with respect to that at equilibrium, corroborating the Fickian diffusion. 
However, the diffusion process resulted to be lower for swellings less than 20 %, 
as can be observed in insets in Figure 3. 5  to Figure 3. 11. This phenomenon is 
explained because the xerogels show a glassy state and the swelling process 
produces a transition from the glassy to a relaxed rubbery state, consequently, 
during the transition the water uptake is governed by the relaxation of the 
network. A similar effect is observed in hydrogels with higher contents of DVS, in 
which the swelling exponent increases, even values up 0.5 were found. 
Therefore, increasing the crosslinks, the water uptake shifts to a higher control 
due to the relaxation of the polymer chains. Surprisingly, the diffusion coefficient, 
which shows values between 4 × 10-8 and 6.9 × 10-7 cm2/s, typical of HA 
hydrogels [367,368], results in higher values for compositions with larger 
amounts of DVS. 
The degree of crosslinking in the HA-DVS polymer networks is usually estimated 
employing equations derived from the Flory-Rehner theory. However, many 
studies discard the contribution of ions in the osmotic pressure of the polymer 
networks [213]. From the results of swelling described above, it is derived that 
the polyelectrolyte nature of HA takes an important role in the swelling behaviour 
and must be considered. Therefore, in the present work, the crosslinking density 
was estimated considering all the terms contributing to the osmotic pressure 
within the networks (Equation 3. 4). On the other hand, these equations are 
commonly applied for hydrogels in which the posterior purification and drying 
processes are not taken into account [366]. In this work, the degree of 
crosslinking was determined from the HA-DVS polymer networks with the aim to 
discard false crosslinks related with chain entanglements. In any case, these 
equations were used under certain common hypothesis including the assumption 
of isotropic swelling, even though that is not the case of the HA-DVS polymer 
networks (Figure 3. 13 to Figure 3. 15). Taking into account all these 
considerations, calculations from these equations arise higher degree of 
crosslinking when higher DVS quantities are employed (Table 3. 5). Despite the 
DVS is introduced in molar excess in all the cases, the degree of crosslinking 
results in very low values (14.6, 17.7 and 20.7 % for HA:DVS molar ratios of 1:0.6, 
1:0.9 and 1:1.5, respectively). Although this method overestimates the water 
content, due to the water retained in the cavities of the imperfect network, the 
degree of crosslinking is in agree with the determination of the molecular weight 
after enzymatic degradation (Figure 3. 53 and Table 3. 13). On the other hand, 
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the determination of sulphur content, and hence the crosslinked degree 
calculated from the data of the elemental analysis yielded higher values (32.9, 
53.3 and 87.2 % for HA:DVS molar ratios of 1:0.6, 1:0.9 and 1:1.5, respectively) 
(Table 3. 7) than those predicted by the equations derived from the Flory-Rehner 
theory. Despite the fact that DVS is assumed to react principally by the primary 
hydroxyls, this method might overestimate the degree of crosslinking since some 
DVS might be included forming ineffective chains incorporated or interpenetrated 
in the bulk polymer networks. However, the possible ineffective DVS chains lack 
of double bonds since the infrared spectra of the HA-DVS polymer networks do 
not show these characteristic bands on the left of 3000 cm-1 (Figure 3. 3). 
Therefore, possible undesirable effects of vinyl groups in a biological environment 
are discarded. In any case, the low degree of crosslinking determined by both 
methods evidences the inefficacy of the reaction between HA and DVS. 
The HA-DVS polymer networks show low mechanical properties, which are in 
agreement with similar studied hydrogels [73,238]. Additionally, the mechanical 
properties of the HA-DVS polymer networks can be tailored using different 
amounts of DVS, because increasing the DVS content produces a slight 
improvement of the mechanical properties of the hydrogels (Figure 3. 16 to Figure 
3. 19). Similar observations were found in crosslinked HA with DVS [369], as well 
as using other crosslinking methods [73,238]. The different HA-DVS polymer 
networks subjected under unconfined compression show two characteristic 
regions typical of hydrogels: the first one corresponds to the elastic region 
extending until strains around 0.2, and the subsequent stage corresponds to the 
densification and collapse of the structure. The large elastic region appears 
because of the compression of lattices contained in the polymer networks and 
the displacement of water from themselves. The densification region is produced 
due to the collapse of the lattices, and hence the compression is applied in the 
bulk material containing lower amounts of water. Moreover, the elastic region is 
increased and the initial modulus takes lower values in hydrogels containing 
lower amounts of DVS, suggesting that the content of crosslinks increases the 
rigidity of the polymer networks. This fact is corroborated because of the higher 
contents of DVS yield to lower reached strains for a similar stress. On the other 
hand, the mechanical properties of the different HA-DVS polymer networks are 
clearly influenced by the swelling medium. These results are in agreement with 
the results from the swelling studies since, in general, the higher the water 
uptake, the lower the mechanical properties, due to the reduction in the 
contraction of the lattices formed between crosslinks. 
As can be observed in the thermal degradation, after the purification and drying 
processes of the different HA-DVS polymer networks and the native HA, some 
water remains in the samples because of the lyophilisation process does not 
remove the bound water within the HA chains [370]. The water desorption 
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process is produced until 180 ºC, suggesting that the water is bonded to the HA 
chains. Moreover, the desorption process is slower in the native HA than in the 
HA-DVS polymer networks because native HA is in a lyophilized power form and 
the different HA-DVS polymer networks show a glassy contracted conformation 
giving a lower diffusion of water molecules. The addition of DVS does not produce 
significant changes in water content and degradation. On the other hand, the 
degradation of HA and HA-DVS chains starts at temperatures around 200 ºC 
leading to similar residues contents at 700 ºC, because of the major proportion in 
weight of HA with respect to DVS. However, the addition of DVS alters the 
maximal degradation rate, decreasing and displacing it to lower temperatures, 
due to the presence of  a degradation step of self-polymerized DVS (pDVS) at 
lower temperatures than that corresponding to the HA. Contrarily, the maximum 
degradation rate between the HA-DVS polymer networks is reached faster with 
increasing the DVS content, suggesting a synergistic effect of the degradation 
stages in the pDVS sample and the HA-DVS polymer networks (inset in Figure 
3. 21). 
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4.2 Crosslinked hyaluronan scaffolds 
The crosslinking of HA with different amounts of DVS allow the development of 
materials with soft tuneable mechanical properties maintaining high degrees of 
diffusion in aqueous environments. These properties together with the large 
clinical applications previously reported using these hydrogels encouraged us to 
consider the HA-DVS polymer networks as a good candidate in the development 
of scaffolds for brain tissue engineering. Moreover, the use of diverse DVS 
amounts suggests the possibility to obtain scaffolds with different mechanical 
properties and study this effect on cells from the CNS environment. HA scaffolds 
have been widely studied employing DVS and other crosslinking agents for soft 
tissue engineering, even central nervous system. The methods usually employed 
to develop HA based scaffolds are diverse including electrospinning [304], 
freeze-drying processes [278], particulate leaching [295]… One of the most 
important requisites in scaffold fabrication as artificial ECM for tissue engineering 
includes accomplishing an inner structure able to allow cell ingrowth, cell 
communication and diffusion of nutrients. In some cases, the techniques 
employed in developing scaffolds yield structures with small spaces for cell 
ingrowth and in many cases, the control over the size and interconnectivity of this 
inner structure shows a low reproducibility. In the present work, the development 
of HA-DVS scaffolds was carried out by a template technique with the aim to get 
a control over pore size and interconnectivity developing a repetitive method in 
the batch-to-batch production. 
First of all, the optimal process in the fabrication of the PEMA templates 
(described in 2.2.2) was achieved by studying their microscopic morphology in 
order to stablish the more adequate conditions in the compression and sintering 
of PEMA beads. The conditions selected gave templates with not excessive 
deformation of the PEMA beads, maintaining an adequate interconnection 
between themselves and leaving space enough to the filling with the crosslinking 
solution (Figure 3. 22). In order to ensure the correct filling of the PEMA 
templates, the crosslinking solution was prepared with a lower HA concentration 
with respect to the HA-DVS polymer networks without no significant effect on the 
HA molecular weight after exposing to the alkaline medium (Figure 3. 23). The 
correct crosslinking of the HA with DVS was suggested by the integrity of the 
materials observed during the purification process and corroborated by the 
posterior analysis of the dry HA-DVS scaffolds by SEM (Figure 3. 27). 
Additionally, different properties on PEMA templates and HA-DVS scaffolds were 
evaluated with the aim to ensure repetitively in the batch-to-batch production. 
These parameters and studies include the determination of the thickness in 
PEMA templates between the compression and sintering stages, the analysis of 
the porosity in the interstices of the templates, thermogravimetric analysis of the 
HA-DVS scaffolds to ensure the elimination of residual PEMA (Figure 3. 24), 
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microscopic imaging by SEM  and compression tests on the final scaffolds 
(described in the following). These parameters and studies resulted to be similar 
between scaffolds obtained in different batches, and hence the fabrication of the 
HA-DVS scaffolds was considered repetitive. 
In addition to the observed integrity of the HA-DVS scaffolds during the fabrication 
and purification processes, the effectiveness of the crosslinking was achieved 
from the IR spectra (Figure 3. 26) and posterior elemental analysis (Table 3. 8). 
The infrared spectra of the different HA-DVS scaffolds compared with that of 
native HA showed sulfone groups, and the posterior elemental analysis confirms 
the presence of sulphur content. With respect to the infrared spectra, increasing 
DVS content resulted in a higher absorption band attributed to the symmetric 
stretching of sulfone groups (at wavenumber of 1080 cm-1). The band 
corresponding to the asymmetric stretching of sulfone groups (wavenumber of 
1290 cm-1) is presented but its relation with the DVS amount is not clearly 
observed. Moreover, the effective crosslinking between HA and DVS is 
corroborated comparing the relative intensity of the peaks at 1100 cm-1 
(stretching of the ether groups) and at 1600 cm-1 of the different HA-DVS 
scaffolds and the native HA. Therefore, the intensity of the band corresponding 
to the ether groups is more intense in the HA-DVS scaffolds than in the native 
HA, corroborating the ether formation and hence the adequate crosslinking of HA 
with DVS. On the other hand, the determination of the degree of crosslinking 
derived from the elemental analysis yielded lower values (18.4, 20.9 and 42.6 for 
HA:DVS molar ratios of 1:0.6, 1:0.9 and 1:1.5, respectively) than those 
corresponding to the solv_HA-DVS polymer networks. This fact suggests that the 
effectiveness of the crosslinking between the interstices of the PEMA templates 
is altered. 
The morphological characterization of the different HA-DVS scaffolds (Figure 3. 
27) and the thermogravimetric analysis (Figure 3. 25) resulted in no evidences of 
PEMA residues. The content of DVS seems not to alter the morphology of the 
scaffolds, which resulted in an interconnected porous inner structure where the 
HA walls form a sheet-like structure typical of scaffolds based on polysaccharides 
[279]. The interconnections in the inner surface resulted in sizes ranging from 60 
to 100 μm, suggesting their adequate dimensions to permit cell ingrowth [371]. 
The porosity due to the sintered beads was estimated to have a maximum value 
of 75 %; however, the porosity determined by gravimetric measurements resulted 
in higher values, around 99 %. This fact is explained because HA chains are 
contracted during the washing process in acetone, the subsequent swelling and 
freeze process can produce additional pores in the size range of those to the 
PEMA template itself, due to the growth of ice nuclei during the freeze process 
[278]. The different HA-DVS scaffolds showed similar porosity taking into account 
the effect of small and large pores together and only the large pores, suggesting 
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the lack of micro- and nano-porosity due to the removal of solvent  (Figure 3. 28). 
Additionally, the walls of the inner surface of HA-DVS scaffolds observed by SEM 
(Figure 3. 27) showed a bulk material with absence of micro- and nano- porosity. 
This closed structure of the bulk material suggests that the drastic immersion of 
the crosslinked HA in acetone yields to a contraction of the molecules suggesting 
stable entanglements between chains. 
In order to compare the properties of HA-DVS scaffolds with HA in bulk, HA-DVS 
polymer networks (WI_HA-DVS samples) were developed and purified using 
similar conditions than those of the HA-DVS scaffolds. Despite the differences in 
HA concentration in the crosslinking solution, the much lower swelling degree on 
WI_HA-DVS samples (inset in Figure 3. 29) than on solv_HA:DVS samples 
(Figure 3. 12 C) corroborated the influence of post-treatments in the final swelling 
of the hydrogel. Therefore, the establishment of interactions and entanglements 
between HA chains due to the drastic transition of hydrogels from a conformation 
containing contracted and entangled chains (after the crosslinking reaction using 
alkaline medium) to a non-aqueous environment (such as the case of acetone 
immersion) was corroborated. In spite of the reduction in the swelling degree 
observed in the polymer networks with higher contents of DVS, the equilibrium 
water content values of the WI_HA-DVS samples immersed in water and 0.15 M 
PBS evidence no significant differences, suggesting an important influence of the 
entanglements in their swelling behaviour. On the other hand, the HA-DVS 
scaffolds resulted in a much higher water uptake compared with the lyophilized 
WI_HA-DVS samples and differences between media and compositions resulted 
to be not significant when the salt weight is taken into account. The much higher 
water uptake by the HA-DVS scaffolds respect to the non-structured hydrogels 
can be explained because of its high porosity (around 99 %). However, taking 
into account the porosity and determining the water uptake by the bulk HA 
contained in the HA-DVS scaffolds, the values of EWC resulted much lower than 
in the WI_HA-DVS samples, suggesting that the material structure have an 
important effect on swelling. 
The principal advantage of employing hydrogels against other polymeric systems 
is their similar mechanical properties with respect to brain tissue [73]. Moreover, 
several works have demonstrated that hydrogels with closer mechanical 
properties to those of the brain tissue favour the differentiation of NPCs to neural 
lineages against glial ones, and enhance neurite extension in neural cell lines 
[75]. For this reason, the different HA-DVS scaffolds were conducted to 
compression tests and the parameters derived from them were compared with 
those of the brain tissue. The HA-DVS scaffolds under compression showed a 
typical behaviour of hydrated hydrogels with open-mesh structures, resulting in a 
very large first elastic region and after densification zone a second elastic region 
at advanced strains, above values of 0.7 (Figure 3. 30) [280]. The large elastic 
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region is due to the compression of the lattices and the effect of water 
displacement from the inner hydrogel, while in the densification region the 
compression is applied in the bulk HA, containing some remaining water, due to 
the collapse of the pores and displacement of water from HA. The content of DVS 
on the HA-DVS scaffolds yielded appreciable changes, which become more 
evident for the scaff_HA:DVS 1:1.5 samples, indicating an effect of the degree of 
crosslinking on the mechanical properties of the scaffolds. The module and final 
strain (Figure 3. 31) determined from the compression tests corroborated that the 
higher amounts of DVS increase their rigidity, since the scaff_HA:DVS 1:1.5 
samples resulted in higher initial modulus values and lower final strains indicating 
a less soft behaviour. However, the different compositions showed similar values 
in the parameters obtained from the compression tests, and the scaffolds are 
considered such as soft materials. Moreover, the result of the comparation of HA-
DVS scaffolds with brain tissue is that both have similar mechanical properties, 
suggesting that HA-DVS scaffolds are good candidates for brain tissue 
engineering from the point of view of their mechanical properties. As it was 
expected, bulk materials corresponding to the WI_HA-DVS samples resulted in 
higher mechanical properties than HA-DVS scaffolds. These materials showed a 
shorter elastic region and the densification was more pronounced, and it 
appeared at lower strains. This fact is explained by the lack of pores within 
WI_HA-DVS samples. 
Such as other HA-DVS based materials, the HA-DVS scaffolds resulted in a 
similar thermal degradation, showing a first stage associated to the desorption of 
water and a principal degradation step starting at 200 ºC and extending through 
all the temperature range (Figure 3. 32 and Figure 3. 33). Despite the similar 
behaviour of HA-DVS scaffolds and native HA submitted to thermal degradation, 
some differences were appreciated. As can be observed in the first stage of 
weight loss, the HA-DVS scaffolds gave higher amounts of bound water; such 
fact can be explained by the increment of specific surface because of their 
porosity. Moreover, the principal degradation stage yielded lower degradation 
rates and percentage of residues at 700 ºC than native HA, suggesting that the 
DVS content reduces, both degradation rate and residual content, which is in 
agreement with the thermal degradation observed in the thermograms of pDVS 
(Figure 3. 20 and inset in Figure 3. 21). 
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4.3 Poly(MeHA-co-EA) copolymer networks 
Previous studies have reported that the HA based biomaterials, and particularly 
the DVS crosslinked ones, possess low resistance against the degradation 
mechanisms found at physiological conditions [222,372]. In order to obtain 
hydrogels with longer residence times and tuneable properties, poly(MeHA-co-
EA) copolymer networks were developed. The incorporation of ethyl acrylate in 
the polymer networks was performed with the aim to obtain semi-biodegradable 
block copolymers, providing the presence of artificial ECM through the 
regenerative process. Moreover, the incorporation of EA allows to modulate 
several properties within the hydrogels including mechanical properties and 
swelling degree. 
Poly(methacrylates) and poly(acrylates) have been widely employed and 
investigated for a wide range of tissue engineering applications, even some of 
them have found clinical applications [349]. In particular, poly(ethyl acrylate) 
networks constitutes a less explored system for tissue engineering applications, 
but few studies have demonstrated their good biological properties, in terms of 
cell colonization, including good biocompatibility with the brain tissue even 
showing infiltration of neural and glial cells [49]. Moreover, the poly(ethyl acrylate) 
networks show softer mechanical properties compared with other 
poly(methacrylates) and poly(acrylates), suggesting it as a more adequate 
polymer for soft tissue engineering. Additionally, the polymerized ethyl acrylate is 
a relatively hydrophophic material [353], suggesting that the use of different 
amounts of ethyl acrylate in the copolymerization with HA can be useful in 
modulating the swelling degree of the resulting hydrogels. 
However, the copolymerization of ethyl acrylate cannot be successfully 
performed directly with native HA, and it needs to be previously chemically 
modified. Despite the wide range of possible chemical modifications within the 
HA molecule, in the present work, the HA has been esterified using anhydride 
methacrylic giving methacrylate hyaluronan (MeHA) (see Figure 1. 7-A). This 
chemistry incorporates methacrylate groups, mainly by the primary hydroxyls of 
the N-acetyl glucosamine subunit within the HA. Therefore, this HA derivative 
possesses vinyl groups, which are able to carry out polymerization reactions, and 
hence the copolymerization with ethyl acrylate (see Figure 1. 7-B). This chemistry 
has been employed by other authors with the aim to copolymerize HA and other 
synthetic polymers  and functionalize HA chains [241]. 
The HA derivative, MeHA, has been previously synthesized in both, aqueous and 
organic media [373]. However, the reaction in an aqueous medium possesses a 
difficult control, because the pH must be maintained at higher values with the aim 
to avoid the formation of methacrylic acid, which reduces the degree of 
methacrylation. This fact together the inherent properties of HA in solution, high 
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viscosity and molecular hindrance, and the phase separation between aqueous 
medium and anhydride methacrylic produce in general low methacrylation 
degrees. In order to provide an adequate degree of methacrylation, the reaction 
was carried out employing a HA solution in 0.2 M NaOH with the aim to reduce 
HA viscosity and ensure high pH values avoiding excessive methacrylic acid 
formation. Moreover, the anhydride methacrylic reagent was added dropwise in 
excess with the aim to obtain an adequate degree of functionalization and reduce 
phase separation, as suggested in previous works [73,238]. After the reaction 
time, the pH falls down to values of 3 indicating the inevitable formation of 
methacrylic acid as by-product. However, after the purification processes, the pH 
taken values around neutrality, even the analysis of the macromer by 
chromatography, infrared spectroscopy and nuclear magnetic resonance showed 
non-remaining methacrylic acid. However, as in the case of WI_HA-DVS 
samples, the precipitation of MeHA in acetone during the purification steps 
yielded chain entanglements, which effect can be observed by the decrease of 
the solubility in water. Additionally, the posterior analysis of MeHA macromer by 
chromatography resulted in weight average molecular weights around 2.5 MDa , 
much higher than the native HA (Figure 3. 34) , which is only explained by the 
formation of entanglements. 
On the other hand, the functionalization of HA chains was addressed by Fourier 
transformed infrared spectroscopy and nuclear magnetic resonance. The MeHA 
spectra obtained by FTIR did not show the characteristic bands of vinyl groups 
because of the presence of broad bands corresponding to the associated O-H 
stretching of carboxylic acids, hydroxyls and associated N-H bonds of the amide 
groups (Figure 3. 35). However, comparing the spectra of native HA and MeHA, 
the band around 1000 cm-1 increased its relative intensity with respect to peaks 
associated with unmodified groups (N-H stretching), suggesting an increment of 
the C-O-C stretching and hence the formation of ester groups. Additionally, the 
posterior nuclear magnetic resonance of purified MeHA showed peaks at 6.1, 5.6 
and 1.85 ppm (Figure 3. 36) indicating the presence of methacrylate groups as 
previous works [73,212]. Therefore, from the 1H-NMR spectrum of MeHA, the 
degree of methacrylation was determined, resulting to be a value of 12.5 %, which 
is comparable with that obtained by other authors employing similar conditions 
[238]. 
Once the functionalization of HA was determined, the MeHA was copolymerized 
with different amounts of ethyl acrylate with the aim to obtain semi-biodegradable 
copolymers with tuneable properties and resistance against enzymatic 
degradation. The amounts of EA employed in the copolymerization were chosen 
in agreement with the solubility of EA itself in the reacting solution employed. 
Therefore, the reaction was performed in a solvent mixture of 0.15 M PBS and 
DMF using a low concentration of MeHA because of the high viscosity of MeHA 
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solutions and the entanglements between chains. On the one hand, the use of 
0.15 M PBS reduces the viscosity of MeHA and, on the other hand, the use of 
DMF increases the solubility of EA and reduces the entanglements between 
MeHA chains, due to its intrinsic nature as strong hydrogen bonding acceptor 
decreasing the interactions between chains [374,375]. Additionally, the 
incorporation of DMF increases the solubility of ethyl acrylate, which shows a 
reduced solubility in aqueous medium. On the other hand, the incorporation of 
crosslinking agent, N,N'-methylenebisacrylamide, was aimed to ensure the 
crosslinking between methacrylate groups within the MeHA and/or the ethyl 
acrylate networks, since the high viscosity and the low degree of methacrylation 
of MeHA poses a handicap to obtain an adequate poly(MeHA-co-EA) copolymer 
network. Therefore, during the mixture of all the reagents (monomer, macromer, 
crosslinking agent and initiator) in the polymerization solution, phase separation 
and MeHA entanglement was not observed for the different compositions. 
Despite the relative low degree of methacrylation obtained in the production of 
MeHA, its copolymerization with EA employing MBAA as crosslinking agent was 
accomplished for all the compositions. After the copolymerization reaction, the 
different poly(MeHA-co-EA) copolymer networks resulted to be continuous and 
soft samples, without observing segregation of material during the purification 
processes. However, the copolymer networks with larger amounts of EA (above 
MeHA:EA weight ratios of 1:2) resulted to have an opaque aspect with a lower 
consistence, suggesting some phase separation. This fact can be explained 
because of the largest MeHA:EA weight ratios (1:5 and 1:10) are in the limit of 
phase separation for the mixture of solvents employed in the copolymerization 
reaction. Moreover, during the copolymerization reaction, the new forming 
networks (the growing chains of polymerized EA and MeHA) decreases their 
solubility in the solvent mixture. 
The copolymerization of both components and their presence in the different 
copolymer networks was addressed by FTIR. The spectra of the copolymer 
networks showed the characteristic absorption bands of PEA and MeHA 
homopolymer networks. Therefore, the copolymer networks with higher content 
of MeHA gave a more intense band at 1000 cm-1 due to the major presence of C-
O-C groups within the MeHA molecule with respect to the EA one. In this way, 
the broad band from 3600 to 2500 cm-1, attributed to associated N-H and O-H 
stretching vibrations, resulted more intense and narrow in samples containing 
MeHA because this molecule contains larger amounts of these groups and 
includes bound water. The copolymer networks show multiple peaks in the range 
between 1800 cm-1 and 1600 cm-1, associated with a unique vibration, the 
stretching of C=O, whose intensity depends on the amount of EA or MeHA 
employed in the copolymerization reaction. The band at 1735 cm-1 in the PEA 
homopolymer and the different copolymer networks, corresponding to free C=O 
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groups, appears at the same wavenumber suggesting that PEA and MeHA 
chains lack of hydrogen interactions at the molecular level. However, the use of 
MBAA could slightly increase the interaction between the PEA and MeHA 
networks since the characteristic bands of associated carbonyls in Amide I and 
carboxylates within the MeHA and MBAA molecules were displayed as 
overlapped bands around 1600 cm-1. On the other hand, the IR spectra suggest 
that the PEA chains are forming a network without hydrogen bonding association, 
whereas the MeHA and MBBA chains in the copolymer networks may form 
interactions by hydrogen bonds. These observations suggest the lack of 
interactions between MeHA and PEA networks at the molecular level induced by 
hydrogen bonds. However, the incorporation of MBAA may slightly increase the 
interaction between both components due to hydrogen bonding between the 
crosslinking agent and the MeHA molecules, and hence this fact could indicate a 
low miscibility between PEA and MeHA networks mediated by MBBA. 
The copolymerization yields copolymer networks with a hydrogel-like behaviour 
for all the compositions studied. Therefore, all the compositions showed a high 
water uptake under immersion in 0.15 M PBS, even considering that PEA 
homopolymer networks are relatively hydrophophic (Figure 3. 38). However, the 
swelling degree is drastically reduced when MeHA homopolymer networks are 
compared with the copolymer ones, even in those in which low amounts of EA 
were employed. Therefore, the MeHA homopolymer networks show a very high 
equilibrium water content (values around 100); while in the copolymer networks 
using EA weight fractions of 0.2 this value is drastically reduced (values around 
50). Moreover, the incorporation of higher amounts of EA produces a continuous 
reduction on the swelling degree until an apparent stabilization. However, the 
EWC reached values slightly higher than that characteristic of PEA homopolymer 
networks (EWC values below 0.1) [353]. This fact may be explained because of 
the high water uptake of the MeHA component and the additional porosity 
produced in the freeze-drying process, and hence water could be incorporated in 
the inner porous structure. 
On the other hand, the copolymerization including greater contents of EA yielded 
hydrogels with less soft mechanical properties, including the copolymers 
networks containing highest EA contents, which are considered as not consistent 
ones (Figure 3. 39). The different copolymers showed soft mechanical properties 
when compressed, displaying the typical behaviour of hydrogels open-lattice 
structures. The copolymer networks display a large elastic region and, after a 
transition region, they undergo a densification, and a second elastic region is 
observed where the compression is applied over the bulk material due to the 
displacement of water and the collapse of pores. The first elastic region is 
characterized by a high strain rate when the applied stress is small, while the 
second one is characterized by a limited change in strain increasing the applied 
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stress. However, the first elastic region becomes narrower with increasing the EA 
content in the copolymer networks, and hence the densification region is reached 
at lower strains. Therefore, this behaviour in copolymer networks with higher 
amounts of EA is translated to the parameters determined from the stress-strain 
curves: the initial elastic modulus take higher values, the final strain is slightly 
lower and the final modulus decreases (Figure 3. 40). However, the stress-strain 
curves and the initial modulus, reaching values between 0.5 and 2.5 kPa, display 
a behaviour typical of hydrogels, even the copolymer networks with higher 
content of EA (weight fractions above 0.9) resulted in a very soft behaviour. This 
fact suggests discrepancies in the formation of the PEA networks due to the 
possible low solubility during the copolymerization reaction, formation of internal 
porosity during the freeze-drying process and a predominance of MeHA networks 
over the mechanical properties of the copolymer networks. Despite the 
differences in the synthesis and purification of MeHA homopolymer networks with 
respect other authors, their soft mechanical properties are in agreement with 
previous works [73,238]. 
The macroscopic images of the cross-sections in the different copolymer 
networks (Figure 3. 41) evidence changes in the inner structure by varying the 
composition of EA respect to MeHA. Therefore, the MeHA homopolymer 
displayed pores with a sheet shape, whereas lower amounts of EA produces 
inner structures with spherical pores. However, copolymers with high contents of 
EA lead to the collapse of the internal pores giving disordered internal structures. 
Therefore, the swelling degree and compression of the copolymers networks are 
clearly influenced by the presence of this internal structure. Moreover, from the 
macroscopic study arises that the copolymer networks may be obtained with 
tuneable topography varying the EA content in the copolymerization reaction. 
Besides, the copolymerization of MeHA and EA can be carried out into the 
interstices of the PEMA templates, in a similar way that the process described in 
section 2.2.2. In this process, it is possible to obtain scaffolds based on 
poly(MeHA-co-EA) copolymer networks, and hence a method to develop 
scaffolds with a controlled porosity and pore size (Figure 4. 1). These scaffolds 
display interconnected pores with an average diameter of 204.4 ±51.8 μm and 
interconnections with a diameter of 78.7 ±20.3 μm. 
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Figure 4. 1. Cross-section in the scaffolds obtained from the MeHA:PEA 1:10 composition. 
 
The methacrylation of HA and subsequent crosslinking using MBAA did not 
significantly alter the thermal degradation of the HA derivative with respect to the 
native HA, as is observed comparing the thermograms of native HA (Figure 3. 
20) and MeHA homopolymer networks (Figure 3. 42). This fact can be explained 
by the low degree of functionalization and the big size of the HA chains and its 
disaccharide unit, and hence the MeHA molecules are considered as a big one. 
Moreover, the MeHA homopolymer networks resulted to content similar bound 
water than other developed HA-DVS based materials, indicating a low influence 
of the employed crosslinking agents and modification in the ability of MeHA to 
associate with water molecules. On the other hand, the incorporation of higher 
contents of EA yielded to a drastic reduction of bound water because of the 
relative more hydrophobic domains of the EA molecule. In addition to the stage 
of water desorption, the thermograms of the poly(MeHA-co-EA) copolymer 
networks showed two differentiated degradation stages corresponding to each 
component. This behaviour under thermal degradation is typical of block 
copolymers [376]. However, a possible low interaction between both components 
in the copolymer networks cannot be achieved by thermogravimetry because of 
the degradation of MeHA continues in the whole temperature range studied 
altering that corresponding to the PEA phase (inset in Figure 3. 42 B). 
In order to determine the interaction between both components, MeHA and PEA, 
the different copolymer networks were characterized by differential scanning 
calorimetry. The thermograms of the copolymer networks showed a vitreous 
transition associated to the amorphous PEA phase (Figure 3. 43 and Figure 3. 
44). However, the vitreous transition in the PEA homopolymer networks occurs 
at higher temperatures than in the copolymer networks. Moreover, the 
temperature of glass transition was independent of the EA content in the different 
copolymer networks, suggesting that PEA and MeHA phases interact at least in 
some degree. After desorption of bound water, the temperatures of glass 
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transition took relative higher values than those in samples containing bound 
water. However, the glass transition in PEA homopolymer networks was 
displayed at higher temperatures than those of the copolymer networks, 
corroborating that MeHA network interacts with the PEA one, and hence some 
degree of interaction occurs between both phases. Additionally, the lack of 
displacement of the vitreous transition between the different copolymer networks 
implies that MeHA does not have an influence on the thermal properties of the 
PEA network. 
Due to the conditions employed in the copolymerization reaction, a quantity of the 
EA employed was expected to not being involved in the formation of the PEA 
network. Taking into account this hypothesis, the real PEA content in the different 
copolymer networks, considering the bound water as part of the MeHA 
homopolymer network, was determined by different methods: from calorimetry of 
both dried and water-containing samples (Table 3. 11), and from the residues 
determined from the thermogravimetric analysis (Table 3. 10). 
 
 
Figure 4. 2. WPEA in each copolymer network as function of WEA employed in the copolymerization 
reaction. The weight fraction was determined from the DSC thermograms in networks containing 
bound water (squares), from the DSC thermograms after drying the samples (circles) and from the 
residues determined by TGA (diamonds). Dotted line represents the theoretical WPEA in each 
copolymer network. 
 
Therefore, the experimental PEA content resulted in lower values than expected, 
considering that the total amount of EA forms efficient networks (Figure 4. 2). The 
real PEA content and the expected one resulted in more discrepant values for 
intermediate compositions, suggesting that MeHA could have an effect on the 
formation of the PEA network for such compositions. The PEA content for each 
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composition resulted, generally, in similar values independently of the method 
employed in its determination, and hence its value was supposed the average of 
those calculated by each method (Table 4. 1). Additionally, the similarity of the 
calculated PEA content, independently of the method used (from TGA and DSC 
analysis), asserts that the change in thermal properties of the copolymer 
networks is exclusively due to  the amorphous PEA network. 
 
Table 4. 1. Weight fraction of EA employed in the copolymerization reaction and the real weight 
fraction of PEA in each copolymer network. 
WEA 0.33 0.50 0.67 0.83 0.91 
WPEA 0.28 ±0.07 0.27 ±0.03 0.45 ±0.03 0.72 ±0.17 0.77 ±0.11 
 
The copolymer networks were measured by dynamic analysis at 1 Hz in the 
temperature range between -60 ºC and 60 ºC and showed a main, α, relaxation 
process between -30 ºC and 50 ºC (Figure 3. 45). A drastic drop in the elastic 
modulus characterizes the transition from the glassy to the rubbery state derived 
from the amorphous PEA component. The intensity on the reduction of the elastic 
modulus resulted to be dependent with the weight fraction of PEA contained in 
the copolymer network. Moreover, this transition was observed in the tan δ 
thermograms, which contain a maximum indicating the loss of mechanical 
properties around the α relaxation process. However, the copolymers 
synthesized with lower EA weight fractions (WEA of 0.33) do not register this 
transition stage, suggesting that the PEA matrix does not have an influence on 
their mechanical properties, and hence the PEA may be presented as a non-
continuous phase for this composition forming aggregates or isolated chains 
included or linked to a continuous matrix of MeHA. The PEA homopolymer 
networks attained the higher elastic modulus in the glassy state with values 
around 2 GPa, which are typical of PEA in such state [377]. However, the different 
copolymer networks displayed lower values of elastic modulus in this region with 
increasing the MeHA fraction, suggesting that in the glassy state the PEA network 
governs the mechanical properties. After the α relaxation process, the elastic 
modulus of the PEA homopolymer network is drastically reduced to values 
around 0.4 MPa at 50 ºC, as expected for PEA networks [377]. However, the 
different copolymer networks and the MeHA homopolymer networks attained 
similar values in the rubbery state, between 10 and 15 MPa, but the rate between 
the modulus at the rubbery and the glassy state, E’/E’
-60 ºC, resulted to be 
dependent with the EA content showing higher values for lower EA contents. This 
observation suggests that after the main relaxation process, the copolymer 
networks have a more similar behaviour with the MeHA homopolymer networks, 
but the EA content decreases the mechanical properties of the copolymer 
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networks. The copolymerization of EA with MeHA produces a displacement of 
the α relaxation to lower temperatures compared with the PEA homopolymer 
network, as can be observed in the thermograms of E’/E’
-60 ºC and tan δ, indicating 
some interaction between MeHA and PEA chains. However, as in the case of the 
DSC thermograms, this α relaxation is not displaced with the EA content in the 
different copolymer networks indicating that the interaction between both kinds of 
networks is in any case minimal. This minimal interaction may be due to the 
reaction during the polymerization process of methacrylate groups of MeHA with 
the crosslinking agent (MBAA) and PEA chains. On the other hand, the E’/E’
-60 ºC 
and tan δ thermograms do not display secondary transitions associated with PEA 
chains, observing a stabilization of both, E’/E’
-60 ºC and tan δ, for temperatures 
above the α relaxation. However, the tan δ thermograms of the copolymer and 
MeHA homopolymer networks showed an increment of losing mechanical 
properties that can be attributed to the desorption of water at temperatures above 
20 ºC. The results of the dynamic-mechanical thermograms displayed that the 
mechanical response of copolymers in the dry state is influenced by the PEA 
content at physiological temperatures. This observation is in consonance with 
those results reported in the compression tests, where the mechanical properties 
of the swollen copolymer networks resulted to be dependent with the PEA weight 
fraction. 
Due to the nature of MeHA, the procedure employed in the copolymerization and 
the results showed above, the MeHA homopolymer network is considered to be 
as a continuous phase, at least in compositions with lower amounts of EA. On 
the other hand, the growing PEA network during the copolymerization is 
supposed to be associated in some degree with the MeHA one, but the phase 
distribution of the PEA networks for each copolymer composition is not well 
understood. In order to address the phase distribution, the logarithmic value at 
60 ºC of the ratio between E’ at each temperature and at -60 ºC in the different 
poly(MeHA-co-EA) copolymer networks was fitted to a Takayanagi’s model for 
bi-phasic systems [378], considering disperse phase both components, MeHA 
and PEA, respectively. 
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Figure 4. 3. Fitting of the experimental E’ values from the dynamical-mechanical assay to the 
Takayanagi’s model for bi-phasic systems, taking the data as the absolute value of the logarithmic 
value at 60 ºC of the ratio between E’ at each temperature and at -60 ºC in the different poly(MeHA-
co-EA) copolymer networks. The approximation to the Takayanagi’s model considering the PEA 
(solid lines) and  MeHA (dashed lines) as the components in the disperse phase, respectively, with 
different λ values are fitted. Inset shows the Takayanagi’s block model in series. 
 
Figure 4. 3 reveals that the elastic modulus at 60 ºC in the copolymer networks 
may be predicted by the Takayanagi’s model. The data fitted to the Takayanagi’s 
block model, considering as disperse phase both components, arise similar 
conclusions: the λ fraction in the different copolymer and homopolymer networks 
resulted in small values, and it was slightly increased in the sample with the 
largest PEA weight fraction (WPEA of 0.77). These observations indicate that 
disperse and continuous phases within the copolymer networks are disposed in 
a parallel arrangement. However, the copolymer network with the lowest WPEA, 
0.27, may consist in a continuous MeHA phase including isolated PEA chains, 
since it is characterized by a modulus similar to the MeHA homopolymer network 
and some deviation from the values predicted by the model. Additionally, the 
experimental elastic modulus of the copolymer network with the largest WPEA, 
0.77, is slightly higher than the predicted for a bi-phasic system without λ fraction 
suggesting the formation of aggregates.  
Taking into account the different analysis above described, the copolymer 
networks are composed of two different phases, which coincide with each 
component, and owing a low interaction degree at the molecular level. Moreover, 
the copolymers showed mechanical properties more similar to the MeHA 
homopolymer networks indicating that MeHA governs the properties of the 
copolymer networks. However, the intermediate copolymers contain a parallel 
arrangement of the phase structure indicating co-continuity, except for the 
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extreme compositions: high MeHA weight fractions lead to isolated PEA chains 
and the composition with larger PEA content slightly turns the co-continuity of 
phases to an aggregate-like structure. 
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4.4 Enzymatic degradation 
In the biological environment, there are multiple factors involved in degrading HA: 
free radicals, hydrolysis mediated by water molecules and enzymes. However, 
the most prevalent degradation mechanism of HA in the biological environment 
is due to the enzymatic degradation catalysed by hyaluronidases [145,153]. 
Moreover, the enzymatic activity of hyaluronidases is increased because their 
synthesis is up-regulated in certain pathologies, including the CNS ones, yielding 
higher concentrations of enzyme in the physiological fluids, and hence the 
degradation of HA chains is faster [154]. 
The study of the enzymatic degradation induced by hyaluronidase activity was 
performed with the aim of mimicking the biological environment, understanding 
that in the biological environment, and in particular in the damaged brain tissue, 
the degradation of HA is mediated by multiple factors, which synergistic effect 
cannot be taking into account in an in vitro model. Taking into account this 
limitation, the study of the enzymatic degradation in the HA-based materials is 
aimed to estimate the residence time and integrity of the materials when 
subjected to degradation. Moreover, the biodegradation of HA chains is an 
important matter to promote certain biological functions. Therefore, the HA 
fragments containing between 4 and 25 disaccharides up-regulate important 
biological functions in the regenerative process, including angiogenesis and cell 
migration and proliferation [190]. For this reason, in addition to the 
characterization of the materials subjected to enzymatic degradation, the by-
products derived from the digestion were analysed by chromatography with the 
aim to determine the size of the fragments, and hence the biological functions up-
regulated by themselves may be estimated. 
The enzymatic degradation of HA by the activity of mammal hyaluronidases, as 
that employed in the present work, possess a well-known mechanism of action 
[157]. Therefore, the enzymes randomly hydrolyse HA chains cleaving the β(1-4) 
glyosidic linkage between disaccharide units. However, this reaction is initiated 
by the interaction of the enzyme with the N-acetyl glucosamine moiety and the 
oxygen forming the β(1-4) glyosidic bond. This specific mechanism suggests that 
the degradation of HA chains composing the different materials may be affected 
by their own conformation. In this sense, derivatives of HA and the different 
crosslinking methods, as well as the posterior purification processes, carried out 
in this work may affect the enzymatic degradation. For this reason, the enzymatic 
degradation on HA-DVS scaffolds and poly(MeHA-co-EA) copolymer networks 
was compared with that on the different HA-DVS polymer networks 
(solv_HA:DVS 1:0.9, WI_HA:DVS 1:0.9 and lyo_HA:DVS 1:0.9 samples), with 
the aim to determine the effect of the conformation and modification of HA chains 
on the degradation of the different HA-based materials. 
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Additionally, the different materials were incubated for 56 days immersed in 0.15 
M PBS at 37 ºC with the aim to estimate the degradation due to the hydrolysis of 
water molecules neglecting that due to the effect of hyaluronidases. However, 
any material showed hydrolytic degradation in the 0.15 M PBS, suggesting that 
the effect of this medium on the degradation of the different HA-based materials 
is very low to be noticed. On the other hand, the enzymatic degradation was 
carried out as accelerating degradation employing a concentration of 
hyaluronidase of 10 units/mL, such as previously reported [282]. Surprisingly, the 
HA-DVS scaffolds with different degree of crosslinking showed no significant 
degradation up 56 days (Figure 3. 45). Despite the higher concentration in the 
HA solution employed in the crosslinking of the HA-DVS polymer networks, the 
solv_HA:DVS 1:0.9 samples were completely degraded after 3 days of enzymatic 
incubation. The different results found in the degradation of HA-DVS scaffolds 
and polymer networks corroborate that the posterior processes of purification of 
the HA-DVS crosslinked materials affect the degradation against hyaluronidase, 
as well as the mechanical properties and swelling degree, as described above. 
The idea, above described, that the immersion in acetone of the crosslinked HA 
with DVS immediately after the crosslinking reaction affects to the hydrogel 
properties, it is explained because the HA molecules form stable entanglements 
and possible weak interactions between chains.  
On the other hand, the enzymatic degradation of the poly(MeHA-co-EA) 
copolymer networks yielded a slow degradation of the MeHA component 
compared with the HA-DVS polymer networks (Figure 3. 46). This phenomenon 
suggests that the freeze-drying process produces chain entanglement, but the 
MeHA chains are less contracted than those of the HA-DVS polymer networks 
summited to phase inversion in acetone after the crosslinking reaction. Moreover, 
the enzymatic degradation of the MeHA homopolymer network resulted to be 
complete after 28 days, whereas the degradation was partial in the copolymer 
networks. This phenomenon may be explained because only the fraction 
corresponding to the MeHA is susceptible to the hyaluronidase activity. 
Comparing the weight loss through the enzymatic degradation with the 
experimental weigh fractions of PEA, and hence MeHA (Table 4. 1), it can be 
stated that the MeHA component within the copolymer networks was only partially 
degraded.  
In order to determine the possible effect of the purification and drying processes 
on the stability of HA against the enzymatic degradation, polymer networks based 
on DVS-crosslinked HA were subjected to different processes after the 
crosslinking reaction. In addition to the solv_HA:DVS samples, the degradation 
study was extended to HA crosslinked with DVS in which water was removed 
using different methods: WI_HA:DVS 1:0.9 samples (described in section 2.2.2) 
were subjected to phase inversion using acetone, and HA crosslinked with DVS 
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in which water is removed by a freeze-drying process (lyo_HA:DVS 1:0.9). These 
samples were compared with the aim to estimate the effect of the water removal 
process on chain entanglements, and hence on enzymatic degradation. The 
results (Figure 4. 4) corroborate that the process employed for removing water 
has an important effect on the behaviour of crosslinked HA against the 
hyaluronidase action since the samples subjected to water inversion 
(WI_HA:DVS 1:0.9) and the lyophilized ones (lyo_HA:DVS 1:0.9) displayed 
different degradation rates. The WI_HA:DVS 1:0.9
 
samples were not degraded 
after 56 days (as in the case of scaffolds), whereas the lyo_HA:DVS 1:0.9 ones 
were completely degraded between 28 and 56 days (similarly to the MeHA 
homopolymer networks). 
 
 
Figure 4. 4. Percentage of weight loss in the different polymer networks based on DVS-crosslinked 
HA at different degradation times: solv_HA:DVS 1:0.9 (circles), lyo_HA:DVS 1:0.9 (squares) and 
WI_HA:DVS 1:0.9 (triangles). 
 
The HA-DVS polymer networks purified under different processes were analysed 
by FTIR with the aim to determine indicia of conformational changes in the HA 
molecules. Therefore, the different samples displayed similar spectra, but after 
the deconvolution of the overlapped bands between 1700 cm-1 and 1500 cm-1 
(Figure 4. 5) corresponding to the C=O stretching of carboxylic acids and amides 
and the N-H bending of amides, some differences in the relative intensity of these 
bands between each sample were found. The band centred at 1660 cm-1 was 
predominant in the solv_HA:DVS 1:0.9 samples, while the lyo_HA:DVS 1:0.9 
samples, the HA-DVS scaffolds and the WI_HA:DVS 1:0.9 samples showed a 
predominant band at 1600 cm-1. Therefore, the hypothesis that entanglements 
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between HA chains are formed modifying the conformation of the crosslinked HA 
chains is corroborated.  
 
 
Figure 4. 5. Deconvolution of the bands between 1700 and 1500 cm-1 obtained by FTIR for the HA-
DVS based materials subjected to different purification processes. 
 
In order to determine changes on the HA-based materials due to the activity of 
the hyaluronidase, the swelling degree was recorded for all the degradation times 
and microscopic images were taken for each sample. The swelling degree and 
the internal structure of the different HA-DVS scaffolds resulted in non-significant 
changes (Figure 3. 47, Figure 3. 49 and Figure 3. 50). However, the HA-DVS 
polymer networks and the different poly(MeHA-co-EA) copolymer networks 
change their swelling degree through the enzymatic digestion (Figure 3. 48). The 
solv_HA:DVS 1:0.9 samples and the MeHA homopolymer networks decrease the 
swelling degree through the degradation, but at later times such value is 
noticeably increased. The poly(MeHA-co-EA) copolymer networks showed a 
slightly reduction of their swelling degree through the enzymatic digestion, due to 
the reduction of the MeHA content, but this reduction is not in concordance with 
the real loss of MeHA chains because the pores remaining in the MeHA matrix 
are filled with media shielding the real swelling degree. On the other hand, the 
microscopic images of the internal structures in the different copolymer networks 
were altered after the degradation (Figure 3. 51 and Figure 3. 52). This fact 
produces certain collapse of the internal structure in the MeHA:PEA 1:0 and 
MeHA:PEA 1:1 samples, whereas the samples containing the highest PEA 
content, MeHA:PEA 1:10, resulted in a more open structure, due to the 
degradation of the MeHA matrix. 
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The determination of the molecular weights of the by-products produced during 
the enzymatic degradation was conducted by chromatography. The study of the 
supernatants in the different HA-DVS scaffolds resulted in non-presence of by-
products, which is in agreement with the lack of weight loss (Figure 3. 45). This 
phenomenon suggests that the enzymatic degradation of the HA-DVS scaffolds 
was not produced at least for 56 days or, in any case, resulted to be low. In the 
case of the solv_HA:DVS 1:0.9 samples the complete degradation was achieved 
after 3 days of exposure, showing an earlier degradation after few hours and 
yielding HA fragments of relative high weight average molecular weight (between 
25 and 50 kDa) (Figure 3. 53). Moreover, the HA fragments produced after 
prolonged degradation times (56 days) were further hydrolysed by the 
hyaluronidase action to lower weight average molecular weights (4 kDa), 
including an important fraction of oligosaccharides containing between 4 and 8 
disaccharide units. The fast degradation observed in the HA-DVS polymer 
networks corroborates the hypothesis that these materials contain chains without 
interactions and entanglements, and hence the effective coupling of the enzyme 
to HA chains to initiate the degradation is accomplished. However, after 56 days 
of enzymatic degradation the by-products derived from the HA-DVS polymer 
networks contains important fractions of HA with high molecular weight, 
suggesting that the crosslinking with DVS, which bond is not disrupted by 
hyaluronidases, may yield oligosaccharides linked by DVS molecules as final by-
products. Taking into account the Mn (3.1 KDa) of the solv_HA-DVS 1:0.9 
fragments after degrading for 56 days (Table 3. 13) and the impossibility of 
hyaluronidase to cleave the DVS crosslinking, the most fragments are composed 
of oligosaccharides close to 5 unmodified disaccharides or containing a 
crosslinking point between themselves. This observation is in agreement with the 
determination of the degree of crosslinking from swelling experiments since the 
oligosaccharides between crosslinks were estimated to contain 5.6 disaccharides 
(Table 3. 5). 
The degradation of the different poly(MeHA-co-EA) copolymer networks gave 
small HA fragments as by-products in the enzymatic degradation, even for short 
exposure times (Figure 3. 54); this fact may be explained by the relative lower 
amount of HA chains compared with the HA-DVS polymer networks (these 
materials were prepared employing solutions with a low HA concentration). 
However, the degradation in the copolymer networks yielded by-products of high 
molecular weight for times below 7 days compared with those for longer times, 
indicating that the enzyme continues cleaving the HA fragments composing 
MeHA derivative. Besides, the degradation times up 28 days the HA fragments 
in the copolymer networks were reduced to oligosaccharides containing between 
4 and 6 disaccharide units. These results, together with those found on the 
degradation of the HA-DVS polymer networks, arise that the hyaluronidase 
employed is limited to cleave HA chains until oligosaccharides containing 4 
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disaccharides, as is suggested by other authors [161]. On the other hand, the by-
products derived from the MeHA homopolymer networks resulted in a large 
amount of the mentioned oligosaccharides, as well as HA fragments with higher 
molecular weights for all the degradation times. This fact suggests that a fraction 
of the by-products derived from MeHA homopolymer networks contains an 
important fraction of crosslinked MeHA fragments, which are not affected by the 
hyaluronidase activity. In the case of the copolymer networks containing PEA, 
these bigger fragments were not observed suggesting that the incorporation of 
EA in the copolymerization reaction leads to MeHA chains crosslinked to the 
forming PEA network. Therefore, some MeHA fragments remained bonded to the 
PEA network being not influenced by the enzymatic action of the hyaluronidase. 
This idea is also suggested comparing the weight loss on the degradation of the 
copolymer networks (Figure 3. 46) and the calculated PEA weight fraction (Table 
4. 1), since the experimental weight fraction of PEA showed higher values than 
those deducted from the degradation. Additionally, the thermogravimetric 
analysis of the poly(MeHA-co-EA) copolymer networks under enzymatic 
digestion for 56 days (Figure 4. 6) displayed that the samples contains some 
amount of MeHA. Therefore, some MeHA fraction is bonded or occluded in the 
PEA matrix and is not susceptible of enzymatic degradation. 
 
 
Figure 4. 6. Thermograms of remaining weight of the poly(MeHA-co-EA) copolymer networks after 
56 days of enzymatic degradation. 
 
To conclude, the degradation study has demonstrated that the degradation of the 
HA-based materials could be tailored with the posterior treatments on the 
crosslinked HA employed in water removal, as well as by the incorporation of a 
biostable component such as PEA. In both materials, HA-DVS scaffolds and 
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poly(MeHA-co-EA) copolymer networks, the integrity of the structures remain 
after 56 days of enzymatic degradation. Despite these results cannot be extended 
to the degradation of a biological environment, the resistance against 
hyaluronidase activity of the different HA-based materials aimed for their 
application when longer residence time is required, since the HA molecule and 
some derivatives thereof are characterized by fast enzymatic degradation rates 
[213,372,379]. On the other hand, taking into account the low methacrylation 
degree of MeHA (12.5 %), the oligosaccharides derived from the enzymatic 
degradation are expected to not being composed of modified subunits.  
Additionally, the controlled delivery of small unmodified oligosaccharides, even 
at short times, in the different poly(MeHA-co-EA) copolymer networks could 
improve the regenerative process because small HA fragments promote 
important biological functions including angiogenesis, cell migration, cell 
adhesion… [189,190]. 
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4.5 Biological performance 
In the regenerative process of brain tissue, multiple cell types are involved 
including endothelial, glial and neural cells. After a brain damage, such as stroke 
or trauma, the capillary network constituting the BBB can be disrupted and the 
tissues are subjected to an abrupt loss of neural and glial cells, yielding a loss of 
the biological functions usually permanent [3]. The BBB is a unique structure and 
shows several differences with respect to the capillary network of other tissues, 
which result in an impermeable structure for molecules and peripheral cells. 
Additionally, these unique characteristics of the BBB are related with endothelial 
cells, as well as their interactions with brain cells including astrocytes, pericytes 
and neurons. Therefore, in the present work, a preliminary study was carried out 
using different cells implied in the BBB maintenance (astrocytes, neurons and 
endothelial cells), with the aim to address their interaction and viability in the HA-
DVS scaffolds. However, the different cell types employed here are models of the 
original ones: U373 cell line as astrocyte model, SH-SY5Y cell line as neuronal 
cell model, and primary endothelial cells from pig brains and hCMEC/D3 cell line 
as endothelial cell models. 
First of all, the cell viability in contact with material extracts (HA-DVS scaffolds 
and poly(MeHA-co-EA) copolymer networks) was addressed determining the 
cytotoxicity (Figure 3. 55 and Figure 3. 56), induction of cell apoptosis (Figure 3. 
57), effect on proliferation (Figure 3. 58) and the inflammatory effect (Figure 3. 
59) and taking as reference adequate controls. From the study of viability arises 
that the extracts of both materials, HA-DVS scaffolds and poly(MeHA-co-EA) 
copolymer networks, do not induce adverse effects, in terms of cytotoxicity and 
inflammation, over the different cell lines employed in the cell cultures. 
The initial cell colonization of the different cell types (glial, neural and endothelial 
cells) was enhanced in the HA-DVS scaffolds with higher amounts of DVS. This 
fact may be related with the change in the scaffolds properties induced by the 
degree of crosslinking. Several authors have suggested that softer HA based 
hydrogels enhance the adhesion of neurons but not that of glial cells [380]. Taking 
into account the enhancement of cell colonization by all cell populations and the 
similar properties of the scaff_HA:DVS 1:1.5 samples, it indicates that this 
material is a good candidate for further brain implants. Scaffolds from HA 
derivatives resulted in a low cell attachment because of the anionic nature of HA. 
However, the presence of specific proteins and other factors could enhance the 
ingrowth of cells in the scaffolds such as is corroborated in some studies [286]. 
Despite the low density, the astrocyte-like cell line cultured in the scaffolds shows 
their characteristic elongated shape (Figure 3. 60) indicating the absence of 
hypertrophic astrocytes, which are associated with the glial scar. On the other 
hand, the absence of stimulus for neurite development explains that the neural-
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like cells did not display longer processes, whereas some cells displayed longer 
neurites when they were cultured in both controls and scaffolds inducing certain 
degree of neurite development by themselves or due to the presence of 
fibronectin (Figure 3. 61). The endothelial-like cells have demonstrated to be 
morphologically homogeneous forming confluent monolayers when they are 
cultured on well plates, moreover this structure is observed when they are seeded 
on the scaffolds showing monolayers surrounding the pores of the scaffolds 
(Figure 3. 62). Additionally, the endothelial-like cells resulted to yield denser 
populations and the structures became more evident when they were cultured 
together with neural- and/or glial-like cells (Figure 3. 64 and Figure 3. 65). This 
phenomenon may be induced by U373 and SH-SY5Y cells, since these cells 
have demonstrated to deliver neurotrophic factors, such as VEGF, favouring the 
maintenance of the endothelial cell phenotype [381,382]. 
The colonization of the scaffolds by the different endothelial cells suggests that 
the scaff_HA:DVS 1:1.5 samples may act as a good substrate for brain 
regeneration purposes because the ingrowth of endothelial cells could guarantee 
the nutrient transport required in the regenerative process. Moreover, the 
colonization of the scaffolds by the endothelial cells is viable at least for 14 days 
(Figure 3. 66). 
On the other hand, preliminary studies of cell cultured on FN- coated poly(MeHA-
co-EA) copolymer and PEA homopolymer networks were performed with the aim 
of determining the effect of the PEA component. In the following figure is 
displayed the nuclei staining of the glial-, neural-, and endothelial-like cells in the 
pure MeHA and PEA homopolymer networks and in the poly(MeHA-co-EA) 
copolymer networks. 
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Figure 4. 7. Hoechst staining of U373, SH-SY5Y and hCMEC/D3 cell lines seeded on different 
poly(MeHA-co-EA) copolymer and PEA homopolymer networks and incubated for 7 days. Scale bar 
500 μm. 
 
Figure 4. 7 shows, as expected, that the higher the PEA content in the copolymer 
networks, the higher the density of the different cell populations. These results 
are in agreement with previous works, in which it has been demonstrated that 
PEA is a good substrate for different cells, including endothelial [354], glial [353] 
and neural [21] ones. Additionally, the different cells seeded on the MeHA 
homopolymer network display a low cell density compared with the materials 
containing PEA and they are arranged as isolated clusters, which are typical of 
HA based hydrogels [73]. On the other hand, cell density is increased in the 
copolymer networks, even the SH-SY5Y and hCMEC/D3 cell populations are 
arranged forming a continuous monolayer. Despite this study was considered as 
a preliminary one, the results found here aimed us to consider that the copolymer 
networks are a good substrate for the different cells involved in brain 
regeneration. This hypothesis is also corroborated by immunostaining studies of 
the different cells seeded as monocultures on PEA surface coated with FN and 
showed in the following figure. 
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Figure 4. 8. Immunostaining studies of different cells seeded as monocultures on the PEA 
homopolymer networks and incubated for 7 days. Expression of GFAP (red) in U373 cell line (A-B), 
Tuj-1 (red) in SH-SY5Y cell line (C-D) and CD-31 (green) in hCMEC/D3 cell line (E-F) and pBEC 
primary cells (G-H). Cell nuclei were stained in blue with Hoechst. 
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The immunostaining studies of the different cells seeded as monocultures on 
PEA (Figure 4. 8) corroborate the good biocompatibility of this material with the 
astrocyte-, neural- and endothelial-like cells. The different cell populations cover 
the material surface arranging in continuous structures. The U373 cells shows a 
high density covering the complete surface and, in the most cases, these cells 
display an elongated shape. Similarly, the SH-SY5Y cells cover the complete 
surface of PEA, and they are arranged in continuous clusters showing contact 
between cells. Moreover, some SH-SY5Y cells display neurite growth when 
localized in regions containing low cell density. In general, these processes are 
short ones, but Figure 4. 8-D suggests that the SH-SY5Y cells seeded on the 
PEA substrates express neurites, which also may form connections between 
cells. On the other hand, the cultures of hCMEC/D3 and pBEC cell populations 
on the PEA surface resulted in cells forming different structures depending on the 
cell type. In the case of hCMEC/D3 cell line, cells were arranged forming network-
like structures. This phenomenon, could be produced due to the early 
fibrillogenesis of FN onto PEA surfaces observed by other authors [383]. 
Additionally, the hCMEC/D3 are forming tubular-like structures and connections 
between themselves, but this phenomenon should be corroborated with 
additional studies. In the case of pBECs cultures on PEA, cell morphology 
resulted to be similar to that observed for pBECs seeded on controls (Figure 3. 
63). Therefore, pBECs are arranged forming continuous monolayers with a close 
contact between themselves. 
In the present work, the different biological studies showed no cytotoxic and 
inflammatory effects on cells exposed to the extract of the different materials. 
Besides, the results suggest the possibility to improve the initial cell colonization 
increasing the degree of crosslinking in the HA-DVS scaffolds and increasing the 
PEA content in the poly(MeHA-co-EA) copolymer networks. However, the BBB 
structure is a very complex system, and hence further studies are required with 
the aim to assess the effect of each cell type on the signal transduction of each 
other (crosstalk) and determine the unique characteristics of the BBB (low 
permeability, tight junctions between endothelial cells, specific carriers...).
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Conclusions 
Polymer networks based on HA have been developed by different methods: 
divinyl sulfone crosslinked HA and copolymers of methacrylated HA with a 
biostable component, PEA. The developed biomaterials permit to produce 3D 
structures (scaffolds) containing interconnected pores with sizes that allow 
access for cell colonization. Therefore, these structures may be employed in the 
regenerative processes of soft tissues, such as brain tissue. Varying the 
composition of the biomaterials has permitted to tune the mechanical and 
physical properties of the different polymer networks. The different cells types, 
modelling those involved in brain regeneration (neurons, glia and endothelial 
cells), have resulted to be viable for the different materials. The materials 
developed (HA-DVS scaffolds and poly(MeHA-co-EA) copolymer networks) have 
demonstrated resistance against the hyaluronidase activity. 
The characterization of each system has proportioned particular conclusions. 
Divinyl sulfone- crosslinked hyaluronan 
• Comparing the degree of crosslinking of HA with divinyl sulfone determined 
by semi-empirical methods with the real content of DVS estimated by 
experimental methods, it is deduced that the crosslinking reaction yielded 
low efficacies. 
• It was possible to develop a repetitive process to fabricate scaffolds based 
on HA crosslinked with DVS. 
• The mechanical and physical properties of the HA-DVS scaffolds were 
tailored by varying the molar ratio of HA to DVS. Additionally, the scaffolds 
showed similar mechanical properties with respect to those of the brain 
tissue. 
• The methods employed in the purification of the crosslinked polymer 
networks cause conformational changes in the HA chains, which influence 
on their resistance against the hyaluronidase activity. 
• The degree of crosslinking, and hence the mechanical properties, of the 
crosslinked HA scaffolds have resulted to influence the initial cell 
colonization of glial, neural and endothelial cells. 
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Poly(MeHA-co-EA) copolymer networks 
• Varying the composition of the copolymer networks is interesting for 
obtaining biomaterials with tuneable mechanical and physical properties. 
• The experimental weight fraction of PEA in the copolymer networks, 
determined by different methods, resulted to be lower than the nominal 
weight fraction of PEA (EA weight fraction used in the copolymerization 
reaction). 
• The incorporation of a biostable matrix, the PEA component, in the 
copolymer networks has permitted to develop semi-biodegradable 
materials. Moreover, the enzymatic digestion on the copolymer networks 
yielded to a sustained release of HA fragments with angiogenic properties. 
• The poly(MeHA-co-EA) copolymer networks might be employed in the 
development of interconnected porous scaffolds controlling pore sizes. 
• The copolymer networks have shown no cytotoxic effects on neural, glial 
and endothelial cells. Furthermore, these biomaterials have no significant 
inflammatory effect on the endothelial cells. 
• The preliminary biological studies suggest that the incorporation of PEA 
might help the compatibility of the copolymer networks with glial, neural 
and endothelial cells. 
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Abbreviations 
1H-NMR   Proton Nuclear Magnetic Resonance 
AC    Alternating Current  
ADH    Adipic Dihydrazide 
ALS    Amyotrophic Lateral Sclerosis  
ASA    Aryl/Alkyl Succinic Anhydride 
ATCC    American Type Culture Collection 
ATR-FTIR  Attenuated Total Reflectance Fourier Transformed Infrared 
spectroscopy  
BBB    Blood Brain Barrier   
BDDE    Butanediol-Diglycidyl Ether 
BDNF    Brain-Derived Neurotrophic Factor  
bFGF   basic Fibroblast Growth Factor  
BMP    Bone Morphogenetic Protein 
BSCB    Blood Spinal Cord Barrier  
CD-31     Cluster of Differentiation 31 
CD44   Cell-Surface Glycoprotein 44 
CDI    1,1’-Carbonyldiimidazole 
CDMT    2-Chloro-Dimethoxy-1,3,5-Triazine 
CMPI   2-Chloro-1-Methylpyridinium Iodide 
CNF   Carbon Nanofibre  
CNS    Central Nervous System  
CNT    Carbon Nanotube  
CSPG    Chondroitin Sulphate Proteoglycan 
CTA    Cetyltrimethylammonium Bromide 
DC    Direct Current   
DMEM/F12  Dulbecco's Modified Eagle Medium/nutrient mixture F-12 
DMF    Dimethylformamide 
DMSO    Dimethyl Sulfoxide 
DMTA    Dynamic Mechanical Thermal Analysis 
DRG    Dorsal Root Ganglia 
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DSC    Differential Scanning Calorimetry  
DTT    Dithiothreitol 
DVS    Divinyl Sulfone 
EA    Ethyl Acrylate 
ECBM    Endothelial Cell Basal Medium 
ECM    Extracellular Matrix  
EDC   1-Ethyl-3-(3-Dimethylaminopropyl)Carbodiimide 
EGF    Endothelial Growth Factor 
EPO    Erythropoietin 
ESC   Embryonic Stem Cell 
FCS    Foetal Calf Serum 
FDA    Food and Drug Administration  
FGF    Fibroblast Growth Factor 
FN    Fibronectin 
FPRL1   Formyl Peptide Receptor Like 1 
FVM    Foetal Ventral Mesencephalon  
GAG    Glycosaminoglycan  
GDNF   Glial-Derived Neurotrophic Factor  
GFAP   Glial Fibrillary Acidic Protein 
GLcA    ᴅ-Glucuronic Acid  
GLcNAc   N-Acetyl-ᴅ-Glucosamine 
GM    Glycidyl Methacrylate 
GPC   Gel Permeation Chromatography 
HA    Hyaluronan  
HA:DVS   Molar ratio of hyaluronan monomeric unit to divinyl sulfone 
HA-DTPH   3,3′-Dithiobis(propanoic dihydrazide)-modified HA 
HA-DVS   Hyaluronan crosslinked with divinyl sulfone 
HAGM    HA with Glycidyl Methacrylate groups 
HAMC    HA with Methylcellulose 
HARE    Hyaluronan Receptor for Endocytosis 
hCMEC/D3  human Cerebral Microvascular Endothelial Cell line 
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HD    Huntington’s Disease  
HEPES    Hydroxyethyl Piperazine Ethanesulfonic acid 
hGH    human Growth Hormone 
HOBt    1-Hydroxybenzotriazole 
HRP    Horse-Radish Peroxidase 
hRPE    human Retinal Pigment Epithelium Cell 
HYAL    Hyaluronidases 
Hyal    Hyaluronoglucosaminidase 
IPN    Interpenetrating Polymer Network 
iPS    induced Pluripotent Stem Cell 
LALS    Low Angle Light Scattering 
LDH   Lactate Dehydrogenase 
LEC receptor   Liver Endothelial Cell Clearance Receptor 
LN    Laminin  
LPS    Lipopolysaccharide 
lyo_HA:DVS  Lyophylized hyaluronan crosslinked with divinyl sulfone 
LYVE1   Lymphatic Vessel Endothelial HA Receptor 
MA    Methacrylic Anhydride 
MAG    Myelin Associated Glycoprotein  
MALS    Multi-Angle Light Scattering 
MBAA    N,N′-Methylenebisacrylamide 
MeHA    Methacrylated Hyaluronan 
MeHA:PEA  Weight ratio of methacrylated hyaluronan to ethyl acrylate in 
the copolymerization 
MEM   Minimum Essential Media 
MSC    Mesenchymal Stem Cell  
NHS    N-Hydroxysuccinimide 
NIH    National Institutes of Health  
NMM   N-Methylmorpholinium 
NPC    Neural Progenitor Cell  
NSC    Neural Stem Cells  
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NT-3   Neurotrophin-3  
OECs    Olfactory Ensheathing Cell  
PANI    Polyaniline   
pBEC    pig Brain Endothelial Cell 
PBS    Phosphate Buffered Saline. 
PBSA   1 % foetal calf serum in 0.1 M PBS 
PCL    Poly-ε-caprolactone  
PCLF    Poly(ε-caprolactone fumarate)  
PD    Parkinson’s Disease  
PDL    Poly-ᴅ-Lysine 
PDMS    Poly(dimethylsiloxane)  
PDS    Polydioxanone  
pDVS   Poly(divinyl sulfone) 
PEA    Poly(ethyl acrylate)  
PEDOT    Poly(3,4-ethylenedioxythiphene)  
PEG    Poly(ethylene glycol)  
PEMA    Poly(ethyl methacrylate) 
PGA    Polyglycolic acid   
PHEMA    Poly(hydroxyethyl methacrylate)   
PHPMA    Poly(hydroxypropyl methacrylate)  
PLGA    Poly(lactic-co-glycolic acid)  
PLLA    Poly(L-lactic acid)   
PMA    Poly(methyl acrylate) 
PMMA    Poly(methyl methacrylate)  
PNS    Peripheral Nervous System  
poly(MeHA-co-EA)     Poly(methacrylated hyaluronan-co-ethyl acrylate) 
PPy    Polypirrol  
RHAMM   Receptor for Hyaluronate-Mediated Motility 
ROS    Reactive Oxygen Species 
SAPN    Self-Assembling Peptides Nanofibre  
SC    Schwann Cell  
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Scaff_HA:DVS  Scaffolds of hyaluronan crosslinked with divinyl sulfone 
SCI    Spinal Cord Injury  
SDR-FTIR  Smart Diffuse Reflectance Fourier Transform Infrared 
spectroscopy 
SEC    Size Exclusion Chromatography 
SEM   Scanning Electron Microscope  
SH-SY5Y   Neuroblastoma Cell Line 
Solv_HA:DVS                   Solvent-cast polymer networks of hyaluronan crosslinked with 
divinyl sulfone 
SVZ    Subventricular Zone 
TACC    Transforming Acidic Coiled-Coil domain 
TBA    Tetrabutylammonium 
TBI    Traumatic Brain Injury  
TCD   Thermal Conductivity Detector 
TGA   Thermogravimetric Analysis 
TLR-4/2   Toll-Like Receptors 
Tuj-1   Neuron-specific class III beta-tubulin 
U373   Human glioblastoma-astrocytoma cell line 
VEGF    Vein Endothelial Growth Factor 
WI_HA:DVS Hyaluronan crosslinked with divinyl sulfone subjected to a 
phase inversion of water 
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Glossary of symbols 
M .   Molecular weight between crosslinking points 
d   Disaccharide units between crosslinking points 
e    Initial thickness of the sample (compression tests) 
vH2O     Specific volume of water v      Specific volume of hyaluronan 
Ф2 and Ф0   Polymer fractions in the hydrogel at equilibrium swelling and 
after the crosslinking reaction 
A    Initial cross-section of the sample (compression tests) 
CS*      Salt concentration outside the hydrogel.  
D   Diffusion coefficient 
dd     Diameter of the dry samples 
ds    Diameter of the swollen samples at equilibrium 
E or E0    Initial modulus (determined at strains between 0 and 0.1) 
E’    Storage modulus 
E’’    Loss modulus 
Ef     Final modulus (determined between 3.5 and 4 kPa) 
EWC    Equilibrium Water Content,  
F   Force (compression tests)  
i    Degree of ionization of hyaluronan 
K    Swelling constant 
l    Thickness of the hydrogel 
M0    Mass of the xerogel 
mHA     Mass of dry hyaluronan 
Mi   Molecular weight 
Mn    Number average Molecular weight 
moctane    Mass of octane (porosity experiments) 
Mt     Amount of water in the swollen hydrogel at time t  
Mw    Weight average Molecular weight 
n    Swelling exponent 
PDI   Polydispersity Index 
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Q   Reciprocal of hyaluronan volume fraction 
Qisotropic Reciprocal of hyaluronan volume fraction determined from the 
measure of diameter 
QM   Degree of mass swelling at equilibrium 
SW  Weight ratio of water to xerogel 
tan δ    Loss factor 
Tg   Temperature of glass transition 
V1    Molar volume of water 
Vd    Volume of the dry polymer network   
VHA    Volume of hyaluronan in the sample (porosity experiments) 
Vmacropores  Volume of the large pores (porosity experiments) 
voctane    Specific volume of octane 
Vpores   Volume of the small pores (porosity experiments) 
Vs    Volume of the swollen polymer network at equilibrium 
Vt   Total volume of the samples (porosity experiments) 
VU    Molar volume of ionisable groups per HA disaccharide unit 
wa   Mass of the sample in air (density experiments)  
wd   Mass of xerogel  
WEA       Nominal poly(ethyl acrylate) weight fraction in the copolymer 
networks  
wi   Fraction of each specie 
woctane     Mass of each sample in octane (density experiments) 
WPEA       Experimental poly(ethyl acrylate) weight fraction in the 
copolymer networks 
ws    Mass of hydrogel 
Δe   Change in thicknes (compression tests) 
ε   Strain (compression tests) 
εf    Interpolation of the final modulus slope with the strain axis 
λx, λy, λz and Λ  Stretching ratios between the swollen and dry samples 
πm   Macroporosity 
πp   Porosity 
ρ   Density 
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ρHA    Density of hyaluronan  
ρoctane    Density of octane at 25 ºC 
ρx   Crosslinking density 
σ   Tension (compression tests) 
Φ   Hyaluronan volume fraction 
 χ     Flory polymer-solvent interaction parameter  
 
 
 
  
 
 
 
 
